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Resumen en Español 
La vía mediante la cual la luz produce señales neuronales para iniciar la 
percepción y discriminación de objetos, movimientos, sombras y colores comienza 
en la retina. La retina está formada por varias capas celulares, siendo las células 
fotorreceptor cono y bastón las neuronas responsables de la fototransducción. Las 
células fotorreceptor de la retina, conos y bastones, son neuronas altamente 
compartimentalizadas y especializadas en responder a la luz.  La fototransducción 
comienza con la captación de un fotón por el pigmento visual, que desencadena una 
cascada de señalización por proteína G que en último término provoca la 
disminución de los niveles de cGMP. Esta disminución provoca el cierre de los 
canales dependientes de cGMP en la membrana, interrumpiendo la entrada de 
cationes y causando la hiperpolarización de la célula. Esta hiperpolarización 
disminuye la tasa de liberación de neurotransmisor en la terminal sináptica, que es 
la señal que se transmite a neuronas de orden superior, y en último término al 
cerebro.  Los procesos de terminación de la respuesta una vez se ha respondido a la 
luz también son esenciales para el funcionamiento correcto de conos y bastones.  Los 
fotorreceptores deben restablecer el equilibrio de oscuridad con la cinética adecuada 
para recuperar la sensibilidad a la luz, la capacidad de responder a nuevos estímulos 
visuales.  Defectos genéticos tanto a nivel de activación como de terminación de la 
señal dan lugar a distintas formas de ceguera hereditaria. 
El complejo proteico en cuya caracterización se centra este trabajo, 
responsable de la síntesis de GMP cíclico en conos y bastones,  juega un papel clave 
en la terminación de la señal, y ha sido vinculado a varias formas de distrofia de 
retina.  Para el restablecimiento del equilibrio de oscuridad, hay dos procesos 
importantes en la terminación de la respuesta: uno, la inactivación de los 
componentes enzimáticos en la cascada de activación; y dos, la restauración de los 
niveles de cGMP a los niveles de oscuridad por nueva síntesis.  El complejo 
responsable de la síntesis de cGMP en conos y bastones consiste en una forma 
particulada de guanilato ciclasa específica de retina (RetGC1 en su isoforma más 
relevante), y dos proteínas que le confieren sensibilidad a calcio (las Guanylate 
Cyclase Activating Proteins GCAP1 y GCAP2).  La actividad ciclasa es estimulada 
por la bajada en la concentración de Ca2+ que ocurre durante el cierre de los canales 
en respuesta a la luz.  La estimulación de la ciclasa restaura los niveles de cGMP, y 
con ello la apertura de los canales y los niveles de Ca2+.  El aumento en la 
concentración de Ca2+ inhibe a la ciclasa, cerrando el bucle.  Este bucle de 
regulación entre cGMP y Ca2+ es fundamental en el proceso de terminación de la 
respuesta a la luz y en adaptación visual.  Mutaciones en los genes que codifican 
RetGC1, GCAP1 y GCAP2 han sido ligadas a mutaciones en el complejo Amaurosis 
Congénita de Leber (LCA), Retinitis Pigmentaria (RP) y Cone-Rod Dystrophies 
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autosómicas dominantes (adCORD), debido a que provocan alteraciones de los 
niveles de cGMP en la célula, que resultan de alguna manera en una gran toxicidad. 
El modelo de regulación de la actividad guanilato ciclasa por las proteínas 
GCAP ha sido extensamente estudiado in vitro, a nivel bioquímico y estructural.  Sin 
embargo, hay muchos aspectos relevantes de la acción de este complejo en el entorno 
de la célula viva que se desconocen: - ¿Dónde se ensambla el complejo y cómo se 
transporta? – ¿Cómo se integra y se modula este complejo en la célula? – ¿Cómo 
conducen las mutaciones a la muerte celular? 
Para abordar estas preguntas, los objetivos principales de este trabajo son: i)  
caracterizar los mecanismos que gobiernan la distribución subcelular de las proteínas 
GCAP1 y GCAP2 en células fotorreceptor, para establecer dónde se ensambla el 
complejo; y ii) la búsqueda de nuevos interactores moleculares del complejo 
RetGC/GCAPs por una aproximación proteómica, que contribuyan a entender como 
este complejo se ensambla, se organiza y se transporta hacia el segmento sensorial, 
así como su regulación in vivo.  
Debido a que los estudios celulares en este campo se ven dificultados por la 
alta especialización de las células fotorreceptor, y la falta de modelos celulares en 
cultivo que permitan hacer estudios genéticos, bioquímicos y funcionales, un 
objetivo de esta tesis (precedente a los mencionados) era implementar estrategias 
genéticas para abaratar y acelerar los estudios de función génica in vivo.   Para ello, 
el trabajo se ha centrado en implementar la electroporación de DNA in vivo en retina 
para generar transgénicos transitorios (Matsuda and Cepko, 2004), y en tratar de 
lograr la electroporación de DNA in vivo en espermatogonia primaria para la 
generación de transgénicos estables.  
La generación de animales transgénicos estables mediante transfección por 
electroporación de línea germinal masculina desarrollada por S. Majumdar (NII, 
New Delhi, India)  (Dhup and Majumdar, 2008) hubiera supuesto una herramienta 
genética muy potente para nuestros estudios de haber funcionado.   Sin embargo, tras 
numerosos intentos de electroporación in vivo siguiendo diversos procedimientos 
quirúrgicos con vectores de expresión gradualmente optimizados -incluyendo la 
utilización de plásmidos libres de isletas CpG, el uso de secuencias aisladoras 
flanqueando el transgén, el acompañamiento de inhibidores de la acetilación de 
histonas…- no hemos observado transfección de células de espermatogonia a niveles 
significativos, ni logrado la producción de animales transgénicos. En último término 
diseñamos un experimento para determinar cuantitativamente la eficiencia con que 
la transfección de línea germinal por electroporación de DNA in vivo podía 
funcionar.  Para ello utilizamos el gen reportero fluorescente DsRed con señal de 
localización mitocondrial en un vector de expresión ubíquito y robusto, libre de 
isletas CpG, que permitiese contabilizar los espermatozoides fluorescentes 
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resultantes por citometría de flujo.   El porcentaje de espermatozoides fluorescentes 
en animales transfectados fue el 0,4% del total, en comparación al 0,15% de 
background en animales control.  Concluimos que esta metodología no es viable tal 
como está descrita. Futuros estudios establecerán los mecanismos y procedimientos 
adecuados para la transfección eficiente de las células germinales. 
Para la generación de ratones transgénicos transitorios en retina, hemos 
reproducido eficientemente la metodología desarrollada por C. Cepko (Harvard, 
EEUU) (Matsuda and Cepko, 2004). Mediante la electroporación subretinal de DNA 
in vivo, hemos caracterizado los determinantes moleculares para la localización 
subcelular de las proteínas GCAPs, estableciendo que el complejo RetGC/GCAPs 
se ensambla en el segmento interno del fotorreceptor antes de ser transportado hacia 
el compartimento sensorial. Así, para el tráfico de GCAP1 hacia el segmento externo 
del fotorreceptor es indispensable tanto la miristoilación de la proteína como su 
unión a la guanilato ciclasa. Por otro lado, la activación del complejo RetGC/GCAPs 
no es un requerimiento para su transporte hacia el segmento externo. Mediante 
electroporación subretinal en retina hemos demostrado también que la fosforilación 
juega un papel clave en la distribución celular de GCAP2, y que fallos en la 
localización de GCAP2 podrían contribuir a explicar la patofisiología de la mutación 
hG157R ligada a retinosis pigmentaria autosómica dominante. 
Para la consecución del segundo objetivo, hemos realizado una aproximación 
proteómica para identificar nuevos interactores de GCAP1 que nos ha conducido al 
descubrimiento inesperado de la interacción directa de la inosina monofosfato 
deshidrogenasa (IMPDH1) con la guanilato ciclasa en el compartimento sensorial, 
donde tiene lugar la fototransducción. IMPDH1 es la enzima responsable del paso 
limitante en la síntesis de novo de GTP, y mutaciones en el gen impdh1 han sido 
asociadas a adRP y Amaurosis congénita de Leber (LCA). La interacción, que ocurre 
con una afinidad en el orden micromolar, involucra a los dominios de dimerización 
y catalítico de RetGC1 y se afecta significativamente por los mutantes asociados a 
ceguera en IMPDH1. Este hallazgo une la síntesis de novo de GTP con la conversión 
de GTP en cGMP, agrupando genes asociados a enfermedad anteriormente 
considerados no relacionados y creando un nuevo marco conceptual para el 
desarrollo de nuevas estrategias terapéuticas. A la vez, contribuye a reducir la 
aparente complejidad de las distrofias hereditarias de retina debidas a la gran 
heterogeneidad genética que las originan –más de cien genes distintos han sido 
ligados a ceguera hereditaria-, a agrupar genes asociados a enfermedad en base a su 
implicación en procesos metabólicos comunes.   La finalidad última de esta 
estrategia de agrupamiento de genes en base a su función busca identificar “hubs” 
de daño celular. 
Además de esta interacción de RetGC1 con IMPDH1, también se ha 
caracterizado otro interactor de la ciclasa, la Creatina quinasa B (CKB), la cual 
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podría está proporcionando el ATP local necesario para mantener la actividad 
catalítica específicamente en conos.  
Este trabajo arroja luz sobre la regulación y transporte del complejo 
RetGC/GCAPs, así como la interconexión entre los complejos de síntesis de cGMP 
y síntesis de novo de GTP, abriendo un nuevo escenario para el tratamiento 
farmacológico de enfermedades que provoquen cambios en los niveles de cGMP 
intracelulares, los cuales de forma prolongada afectan a la supervivencia de la célula, 
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1. Introduction 
1.1. The eye and the retina 
1.1.1. The eye forms images of the natural world on the retina 
The way in which neuronal signals are evoked by light to produce our 
perception of scenes with objects and background, movement, shade, and color 
begins in the retina. The retina in the eye acts as a self-contained outpost of the brain. 
It collects information, analyzes it, and hands it on to higher centers through the well-
defined optic nerve pathway for further processing. The initial step in visual 
processing is the formation on each retina of a sharp, inverted image of the outside 
world. The essential for clear vision are correct focus of the image by adjustment of 
the thickness of the lens (accommodation), regulation of light entering the eye by the 
pupil diameter, convergence of the two eyes to ensure that matching images fall on 
corresponding points of both retinas, and eye movements that compensate for self-
generated or forced movements of the head. (Nicholls J.G et al. 2012. From Neuron 
to Brain. 5th ed. Sunderland, MA. Sinauer Associates, Inc.) 
1.1.2. Function of rod and cone photoreceptors 
The retina is a neural tissue formed by five types of neuronal cells, glial cells 
and support cells arranged in layers (Figure I.2.A). Neuronal cells are photoreceptor 
cells, bipolar cells, ganglion cells, horizontal cells and amacrine cells. The Muller 
glia and retinal pigmented epithelium (RPE) provide trophic support to 
photoreceptor cells.  
Figure I.1. Structure of the eye. Modified from Nicholls J.G et al. 2012. From 
Neuron to Brain. 5th ed. Sunderland, MA. Sinauer Associates, Inc. 
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In vertebrates, there are two types of classical photoreceptors: rods and cones. 
Rods are very sensitive to light, operate at low illumination and are responsible for 
black and white vision during dawn and dusk.  Cones are less sensitive to light but 
never saturate, operate during the widely varying illumination conditions of the 
diurnal cycle and are responsible for color vision. Both rods and cones are highly 
specialized and compartmentalized neurons. They have four differentiated cell 
regions with specific functions. The outer segment, where phototransduction takes 
places, contains a stack of membrane discs that are continuously renewed. The visual 
pigment, the protein that captures photons of light,  is the most abundant protein in 
this compartment (at a concentration of about ~3mM, Otto-Bruc et al. 1998; Fu & 
Yau 2007), being embedded at disc membranes. The dense stack of discs greatly 
increases the probability of photon capture. An interesting difference between rods 
and cones is that the rod discs (except for the nascent discs at the base of the outer 
segment) are completely internalized and therefore physically separate from the 
plasma membrane, whereas the cone discs remain as folding of the plasma 
membrane. In fact, membrane folding at cone outer segments allows having much 
more surface exposed, thus facilitating substances exchange, such as chromophore 
to regenerate the pigment or fast calcium dynamics which are key points during light 
adaptation (Figure I.2.B). (Fu and Yau, 2007) 
The outer segments separated by a thin connecting cilium from the inner 
segment. The inner segment or cell soma is the house keeping compartment of the 
cell.  It contains the endoplasmic reticulum and the Golgi apparatus for protein 
synthesis, and the packed mitochondria for ATP production. All phototransduction 
proteins are synthesized at the inner segment, and are transported across the 
connecting cilium to the light sensitive compartment, the outer segment. Proximal to 
the inner segment is the cell nucleus, with photoreceptor nuclei aligning at the outer 
nuclear region. Finally, the synaptic terminal (Figure I.2.B) is where changes in 
membrane potential caused by light are converted to changes in the rate of 
neurotransmitter release to second-order neurons, therefore sensing a signal to the 
brain.  Overall, both rods and cones respond to light by hyperpolaring, and by 
decreasing the rate of glutamate release at the synaptic terminal. This signal travels 
really fast to bipolar and ganglion cells in the direct pathway, to convey in the optic 
nerve for its transmission to the brain (Figure I.1 and Figure I.2.A). 
Furthermore, horizontal and amacrine cells enrich the variety of connections 
established between photoreceptors, bipolar and ganglion cells. While photoreceptor 
cells “measure” the light intensity at different points of the visual image, this 
information is transmitted to bipolar and ganglion cells in a way in which some 
important integration occurs, so that the output of ganglion cells to the brain is based 
on contrasts of light intensity, and on movement, rather than on the light intensity of 
the natural world. The integration of visual information starts at the retina, and in 
that sense the retina is usually referred to as an “outpost” of the brain. (Rodieck, 
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Robert W. 1998, The first steps in seeing. 1st ed. Sunderland, MA. Sinauer 
Associates, Inc.) 
 
Figure I.2. Retinal layers and cell types. A. The retina is organized into three layers 
of cell bodies (the outer nuclear layer (ONL), inner nuclear layer (INL) and the 
ganglion cell layer (GCL)) and two layers of neuropil (the outer plexiform layer 
(OPL) and the inner plexiform layer (IPL)). Retinal neurons comprise primary 
sensory cells (rods and cones), interneurons (horizontal cells, bipolar cells and 
amacrine cells) and output neurons (retinal ganglion cells (RGCs)). Rods and cones 
presents a sensory compartment, outer segment (OS) and a metabolic compartment 
(IS). The Retinal pigmented epithelium (RPE) provides nutritional support to 
photoreceptors, sustains disc shedding in the constant renewal of photoreceptor 
outer segments and sustains the chromophore cycle. Modified from Cepko 2014. B. 
Rods and cones present a specialized sensory compartment, the outer segment (OS) 
where phototransduction takes place, a metabolic compartment (IS) where proteins 
are synthesized. The IS is linked to the OS through a Connecting Cilium (CC). 
Nucleus (ONL). Considerable differences are observed in the synaptic terminal of 
both types of cells. 
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1.2. The Light response 
1.2.1. Activation phase and termination phase 
Phototransduction (Figure I.3.A) is the process by which an electrical signal 
is produced as a result of the absorption of a photon by the visual pigment rhodopsin 
in photoreceptor cells. As the visual system of higher vertebrates relays in rods and 
cones, being rods more abundant (97% in mouse retina)(Fu and Yau, 2007), 
phototransduction has been better studied in rods. Rods cover the range of dim light 
intensities. They are extraordinarily sensitive to light, and saturate at much dimer 
light intensities than cones, that cover the range of bright light (Fu and Yau, 2007). 
The apoprotein rod opsin, a seven-transmembrane domain G-protein coupled 
receptor, is covalently bound in darkness to the chromophore 11-cis retinal (Cohen 
et al., 1992) constituting the visual pigment rhodopsin. Absorption of a single photon 
by the chromophore causes its photoisomerization from 11-cis retinal to all-trans 
retinal, triggering a conformational change in rhodopsin that confers it its active 
state. In its active state, rhodopsin activates transducin by promoting the exchange 
of GDP for GTP in transducin α-subunit, causing its separation from the βγ-
transducin dimer. Gα-Transducin activates the retina-specific cGMP-
phosphodiesterase (PDE) which increases its rate of hydrolysis of cGMP, reducing 
the cGMP levels. As a consequence of light, there is a drop in the cGMP levels. This 
drop of cytoplasmic cGMP, is sensed by the cGMP-gated channels in the plasma 
membrane.  cGMP-channels are kept open in the dark, allowing the influx of Na+ 
and Ca2+ and keeping the cell partially depolarized.  The drop in cGMP causes the 
closure of the channels reducing the cation influx (Na+ and Ca2+) and therefore 
causing the hyperpolarization of the cell (Yau and Hardie, 2009). This light-driven 
hyperpolarization of the cell reduces the rate of release of synaptic vesicles in the 
synaptic terminal, sending a signal to higher order neurons.  
When the exposure to light ends (Figure I.3.B), everything that has been 
activated has to be inactivated in order to restore the darkness equilibrium. 
For that, photoactivated rhodopsin is phosphorylated by rhodopsin kinase and 
arrestin binding, that “caps” rhodopsin, preventing it from further interacting with 
transducin. In the case of the effector complex formed by Transducin Gα and PDE 
in rods, inactivation resides in a GAP (GTPase activating) complex consisting of 
RGS9 (G protein signaling 9), an RGS9-anchoring protein (R9AP) and an orphan G 
protein β subunit (Gβ5), that accelerate the intrinsic GTPase activity of Gα subunit, 
promoting the exchange of GTP for GDP (Yau and Hardie, 2009). 
Importantly, to restore the darkness equilibrium the cGMP levels have to be 
reestablished to the dark levels by new synthesis. The enzyme responsible for cGMP 
synthesis is retinal guanylate cyclase (RetGC). RetGC is regulated by Ca2+ 
(stimulated when the Ca2+ levels drop in response to light), by the Guanylate 
Cyclase Activating proteins, (GCAPs).  Therefore, the drop in Ca2+ that 
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accompanies the light response initiates a feedback loop that counteracts the effect 
of light by stimulating the replenishment of cGMP, the reopening of cGMP channels, 
the restoration of Na+ and Ca2+influx and with it the sensitivity of the photoreceptor 
cell to light (Lucas et al., 2000).  
Figure I.3. Phototransduction Cascade. A. Activation cascade. The absorption of a 
photon by 11-cis-retinal produces its photo-isomerization to all-trans-retinal. This 
isomerization produces a conformational change in rhodopsin that confers it its active 
state, leading to the exchange of GDP for GTP in the alpha subunit of transducin. 
Transducin-alpha in its active state (GTP-bound) activates Phosphodiesterase (PDE), 
leading to an increased hydrolysis of cGMP, which reduces its intracellular 
concentration. The fall in cGMP leads to closure of cGMP-gated channels at the 
plasma membrane, decreasing the influx of cations (mostly Na+ and Ca2+), 
hyperpolarizing the cell. B. Once the light extinguishes, the darkness equilibrium must 
be recovered. For that, every enzyme that was activated is now deactivated.  
Rhodopsin is deactivated by phosphorylation by rhodopsin kinase and arrestin 
binding. Transducin is deactivated by an enzymatic complex that catalyzes its GTPase 
activity.  Importantly, the cGMP levels are restored to the dark levels by new synthesis. 
For that, guanylate cyclase enzymatic activity is stimulated by the drop in Ca2+, 
through some Ca2+ binding proteins called “Guanylate Cyclase Activating Proteins, 
GCAPs).of transducing, hydrolyzing GTP to GDP, dissociating itself from PDE and 
inactivating it. In the plasma membrane, Calmodulin regulate the affinity of cGMP 
gated channel for cGMP participating in the mechanisms of adaptation to light. 
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The membrane potential in photoreceptor cells is determined, in part, by the 
number of cGMP open channels which in turn depends on the levels of free cGMP 
in the cytoplasm, which is ultimately controlled by the opposing effects of cGMP-
PDE and retGC. When light leads to the activation of PDE producing a drop in 
cGMP levels, light also sets in motion a Ca2+  feedback loop that activates RetGCs 
in order to replenish cGMP levels in the cell and ultimately restore sensitivity to 
photoreceptors (Lucas et al., 2000).  
 
1.2.2. Light adaptation 
Photoreceptor cells must respond to a wide range of light intensities in the 
natural world. As most sensory receptors, photoreceptor cells give a graded response 
to light, with response intensity being proportional to the stimulus intensity. 
However, this relationship is not fixed. Photoreceptor cells have the capacity to 
adjust their sensitivity to light depending on the ambient light intensity (Fain et al., 
2001). This capacity is called light adaptation. In the absence of light-adaptation 
capacity, photoreceptor cells would respond to light linearly until all cGMP-gated 
channel were closed and the photoreceptor cell saturated (Fain et al., 2001).  Light-
adaptation is Ca2+-dependent.  Light-adaptation is a Ca2+-mediated feedback signal 
to the phototransduction cascade that serves to counteract the effect of light –to 
reduce sensitivity- with higher ambient light intensities. This Ca2+-negative 
feedback is exerted at several points in the transduction cascade, always serving to 
restore light sensitivity and avoid saturation at high ambient light intensities. The 
most relevant molecular target of Ca2+ regulation during light adaptation is the 
protein complex responsible for cGMP synthesis. As Ca2+ drops during the light 
response –due to closure of the cGMP-gated channels interrupting Ca2+ influx-, this 
drop is sensed by the Ca2+-binding proteins “Guanylate Cyclase Activating 
Proteins” or GCAPs, that switch from an “inhibitor” to an “activator” conformational 
state, dramatically increasing guanylate cyclase catalytic activity.   
Replenishment of cGMP allows photoreceptors to reach a steady state in 
which both PDE and cyclase are accelerated and in which a proportion of the cGMP-
gated channels is still open, and thus available to be closed (Fain et al. 2001; Mendez 
et al. 2001). In other words, replenishment of cGMP serves to avoid saturation, 
restores sensitivity to light, making photoreceptor cells capable of responding to light 
again, even if in the presence of ambient light intensity. Light-adaptation is a 
fundamental property of rods and especially cones, absolutely required for our visual 
system to operate in the natural world. 
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1.3. The RetGC/GCAPs complex responsible for cGMP synthesis. 
1.3.1. Retinal guanylate cyclase.  
Guanylate cyclase proteins catalyze the formation of cGMP from GTP. Until 
date two main types of guanylate cyclases have been described: soluble or 
membrane-attachment. Soluble guanylate cyclase (sGC) is encoded by two genes, 
form a heterodimer and require a heme group for its function. It is the only receptor 
known for nitric oxide and plays an important role in regulation of blood pressure 
(Sharma and Duda, 2014). 
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Soluble GUCY1A2 Gucy1a2 sGC-α2 Nitric Oxide Endothelium  
Soluble GUCY1A3 Gucy1a3 sGC-α3 Nitric Oxide Endothelium  
Soluble GUCY1B2 Gucy1b2 sGC-β1 Nitric Oxide Endothelium  
Soluble GUCY1B3 Gucy1b3 sGC-β2 Nitric Oxide Endothelium 
Pseudogene 
in human 
Modified from (Karan et al., 2010). Ligands of GC binds to the extracellular domain, 
except for GCAPs that are bound to the intracellular region of the protein 
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Membrane-attached guanylate cyclases are integral membrane proteins 
encoded by more than 7 genes and act as homodimers. They present an extracellular 
domain, a single transmembrane domain and an intracellular domain that catalyzes 
the conversion of GTP to cGMP (Sharma and Duda, 2014). The extracellular domain 
presents the binding pocket for the molecules that activate guanylate cyclase 
catalytic activity. In Table I.1 are summarized the guanylate cyclase characterized 
until date. 
 
1.3.2. Neuronal Calcium Sensor family 
Neuronal Calcium Sensor (NCS) proteins are a family of proteins that 
belong to the Calmodulin superfamily.  These proteins detect changes in the 
intracellular Ca2+ concentration in neurons and regulate their target proteins to 
modify their function (Burgoyne and Haynes, 2012). NCS proteins are encoded by 
14 conserved genes. All gene products have four EF-hand domains and show a 
limited similarity with Calmodulin (<20%). From the four EF-hand domains (helix-
loop-helix domains that coordinate Ca2+), two or three are functional and able to 
bind Ca2+, depending of the member (figure I.4). 
 Their distinct properties as their own on-rate kinetics, Ca2+-affinities and 
localization allow them to carry out non-redundant roles that do not overlap with the 
functions of calmodulin (McCue et al., 2010).  
NCS are protein of about 22kDa that share about 30-70% of protein 
sequence identity. Many family members, but not all, are N-terminal myristoylated,  
Figure I.4. Alignment of main NCS of retinal photoreceptor cells. In green is 
show the Gly2, which it is modified by myristoylation. In red, EF-hands domains. 
In blue, phosphorylation site of GCAP2 
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Table I.2. Neuronal Calcium sensor proteins and their proposed functions 












A Yeast NCS-1 1 
Regulation of neurotransmission, 
stimulation of constitutive and 
regulated exocytosis, learning, 
short-term synaptic plasticity, Ca2+ 
channel and Kv4 channel 
regulation, phosphoinositide 
metabolism, dopamine D2 receptor 
endocytosis, GDNF signaling, 
neuronal growth and survival. 
B Nematodes Hippocalcin 1 
Anti-apoptotic, AMPA receptor 
recycling in LTD, MAPK signaling, 
learning. 
  Neurocalcin-δ 1 Guanylyl cyclase activation 
  VILIP1 1 
Guanylyl cyclase activation’s and 
recycling, traffic of nicotinic 
receptors, increase of cAMP levels 
and secretion 
  VILIP2 1 Regulation of P/Q-type Ca
2+-
channels 
  VILIP3 1 Unknown 
C Fish Recoverin 1 Light adaption by inhibition of rhodopsin kinase 
D Fish GCAP1 1 Regulation of retinal guanylyl cyclase 
  GCAP2 1 Regulation of retinal guanylyl cyclase 
  GCAP3 1 Regulation of retinal guanylyl cyclase 
E Insects KChip1 3 
Regulation of Kv4 and Kv1.5 
channels, repression of 
transcription. 
  KChip2 5 
Regulation of Kv4 and Kv1.5 
channels, repression of 
transcription. 
  KChip3 2 
Regulation of Kv4 channels, 
presinilin processing, APP 
processing, repression of 
transcription, pro-apoptotic, 
regulated ER Ca2+ 
  KChip4 6 
Regulation of Kv4 channels, 
presenilin-processing, repression 
of transcription. 
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what allow their association with membranes by a Ca2+-myristoyl switch in 
some cases,  hence playing a role in the regulation of their targets (Ames and Lim, 
2012).  
Five classes of NCS have been described in mammals, named from A to E, 
and summarized in table I.2. 
 
1.3.3. Historical perspective of RetGC/GCAPs complex.  
It has been known since the 70s that light lead to changes in the calcium and 
cGMP concentration of photoreceptor cells. Therefore, either of these two molecules 
could be the second messenger that carried the message from visual pigment 
excitations at the disk membranes to a change in membrane potential at the plasma 
membrane of photoreceptor outer segments. It was the identification of cGMP-gated 
channels in 1985 that established cGMP as the second messenger of 
phototransduction (Fesenko et al., 1985).  At the same time, biochemical and 
electrophysiological studies at different laboratories established Ca2+ as a key 
molecule regulating the gain and the rate of recovery of the light response in the 
process of light adaptation.  As mentioned above, retinal guanylate cyclase is the 
protein responsible for cGMP synthesis in phototransduction. In the early 70’s, RG. 
Pannbaker (Pannbacker, 1973) suggested that retinal guanylate cyclase could be 
regulated by calcium. In the late 80’s, KW Koch and L. Stryer showed that Ca2+ 
regulation of guanylate cyclase activity was very robust during the light response, 
boosting cGMP synthesis 5-20 fold when calcium went down from 1µM to 10nM 
(Koch and Stryer, 1988). They also showed that this Ca2+ regulation was not exerted 
directly to the guanylate cyclase, but through some soluble modulator. At that 
moment, several independent laboratories in the world started the search for this 
soluble protein. In the mid 90’s two independent laboratories, using different 
experimental designs, identified two related but not identical soluble calcium 
binding proteins that were assigned to the neuronal calcium sensor family. They were 
called guanylate cyclase activating proteins 1 & 2 (GCAP1 and GCAP2)(Dizhoor et 
al., 1995, 1994; Gorczyca et al., 1994; Lowe et al., 1995; Palczewski et al., 1994).  
GCAP proteins switch between two different conformational states: in their 
Ca2+-bound form in the dark, GCAP proteins inhibit cGMP synthesis (inhibitor 
state); while in their Ca2+-free form, acquired as the Ca2+ drops during the light 
response, they stimulate guanylate cyclase activity (activator state). In this way, 
GCAPs provide a calcium feedback regulation to guanylate cyclase, linking cGMP 
synthesis to Ca2+ concentration that serves to adjust the sensitivity of the 
photoreceptor to the background illumination.  
Several biochemical studies then addressed the mapping of functional 
domains in GCAP1 and GCAP2 involved in activation or inhibition of RetGC by 
analysis of deletion mutants and chimeric proteins in which different regions of the 
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GCAP proteins were substituted by the corresponding regions of Recoverin or 
neurocalcin (Krylov et al., 1999; López-del Hoyo, 2014; Olshevskaya et al., 1999).  
It was determined that several regions of the GCAP molecules are required 
for RetGC activation (Figure I.4): a) a region within the N-terminal region starting 
at Trp21 (numbering corresponding to GCAP1) that comprises a 5 to 7 amino acid 
stretch preceding EF-1, the EF-1 domain -non-functional at Ca2+ coordination- and 
some additional amino acids; b) the region between EF-hands 2 and 3, representing 
the “interdomain” or “hinge” region between the NH2- and COOH- terminal 
globular domains in the structure of GCAPs, is required for activation and 
determines the direction of the Ca2+-switch in GCAP2; and c) a stretch of about 20 
amino acids starting at Phe156 immediately adjacent to EF-4 within the COOH-
terminal domain (Krylov et al., 1999; López-del Hoyo, 2014; Olshevskaya et al., 
1999). 
 Within these domains, the stretches of amino acids Trp21-Thr27 preceding 
EF-1 in the NH2-terminal region, and Thr177-Arg182 within the COOH-terminal 
region in GCAP1 (Krylov et al., 1999), and the corresponding regions in GCAP2, 
appear to be critical for RetGC activation (Olshevskaya et al. 1999a). Therefore, a 
picture is emerging in which the signal in the GCAP proteins involved in RetGC 
recognition is discontinuous, involving the NH2- and COOH-terminal regions. In 
contrast, inhibition of RetGC requires the first 9aa of GCAP1 (Krylov et al., 1999), 
and the EF-1 domain in GCAP2 (Olshevskaya et al., 1999)(López-del Hoyo, 2014). 
Recently, the structure of GCAP1 has been resolved (Lim et al., 2013) making 
possible a functional characterization of the key residues implied in binding and 
regulation of RetGC by GCAP1 (Peshenko et al., 2014). Binding of GCAP1 to 
RetGC involves the EF-1 domain. The myristoyl group attached to an N-terminal 
glycine, is sequestered in an internal binding pocket independently of Ca2+-binding 
state, and it is essential for GCAP1 binding to RetGC (I. V Peshenko et al., 2012). 
As Ca2+ binds to EF-hand 4, it triggers a conformational change at the N-terminus 
through a Ca2+-myristoyl tug that controls the exposition of key residues of EF-1 and 
EF-2 that conform the target binding surface of GCAP1 to RetGC (Lim et al., 2014). 
By a thorough analysis of single residue GCAP1 mutants capacity to bind and 
activate RetGC, the target binding site of GCAP1 has been defined. It involves 
residues from  EF-hand 1 (Tyr-22, Lys-23, Lys-24, Met- 26, Glu-28, Pro-30, Ser-31, 
Gly-32, Tyr-37, and Glu-38) and EF-hand 2 (Phe-73, Met-74, Val-77, and Ala-78) 
(Peshenko et al., 2014). On the other hand, binding of GCAP1 to RetGC is required 
but not sufficient for activation of RetGC. RetGC acts as a dimer, and a fully active 
cyclase domain requires the dimerization of this domain. The binding of GCAP1 
enhances the dimerization of cyclase domain, but primary binding itself is not 
sufficient for activation. Some important secondary interactions or allosteric effects 
are provided in a second step once the complex with the cyclase is formed. The 
residues M26, K85 and W94 are localized in the patch that conforms the target 
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binding surface. Mutations in these residues allow GCAP1 binding to RetGC, but 
not its activation (Peshenko et al., 2014). 
On the other hand, GCAP2 presents an alternative regulation that is absent in 
GCAP1. It was described that GCAP2 can be phosphorylated at Ser201 in vitro in a 
conformational Ca2+-dependent manner (Peshenko et al., 2004). Recently, our 
group has shown that this phosphorylation at Ser201 determines the localization of 
GCAP2 in vivo. In response to constant light exposure as Ca2+ drops, the Ca2+-free 
form of GCAP2 is phosphorylated at Ser201,  triggering the binding of 14-3-3 to 
phospho-GCAP2 and its retention to the metabolic compartment, precluding its 
transportation to the sensory compartment (López-del Hoyo et al., 2014).  
While myristoylation of GCAP1 has been described to increase the affinity of 
GCAP1 for RetGC (I. V. Peshenko et al., 2012), myristoylation of GCAP2 did not 
affect its affinity for RetGC (Olshevskaya et al., 1997). Thus, this points to a 
difference in the regulation of both GCAPs by myristoylation. 
 
1.3.4. Regulation of RetGC/GCAPs complex. Role in termination of the 
light response and light adaptation. 
Both GCAPs can bind to RetGC, but different models have been proposed for 
the stoiquiometry of the complex and its regulation. Actually, two opposed models 
have been proposed for the mechanism of action of GCAPs in the RetGC/GCAPs 
complex. The first one establishes that both GCAPs can bind to RetGC at the same 
time through two different binding sites: GCAP1 to RetGC juxtamembrane domain, 
and GCAP2 to RetGC C-terminal domain (reviewed in Sharma & Duda 2014). The 
second one, defended by A. Dizhoor, establishes that both GCAPs bind to RetGC 
through a common or overlapping binding site at the dimerization domain around 
Met823, in a mutually exclusive manner (Figure I.5)(I. V. Peshenko et al., 2015; I. 
V Peshenko et al., 2015).  
Vertebrate photoreceptors contain two guanylate cyclases, RetGC1 and 
RetGC2, which share a high degree of sequence identity. RetGC1 is present at 
relatively high concentrations in rod and cone outer segments, whereas RetGC2 is 
restricted to rod outer segments in mice and humans. The relative amounts of 
RetGC1 and RetGC2 vary with species with a RetGC1 to RetGC2 ratio 4:1 in mouse 
and 30:1 in bovine photoreceptors (Molday et al., 2014).  
Thus, the basis of different roles of both GCAPs relies in their Ca2+ 
sensitivities and their affinities to both RetGCs. GCAP1 has a lower affinity for Ca2+ 
(K1/2= 130-140nM) than GCAP2 (K1/2= 50-60nM). Levels of free Ca2+ inside a 
mouse rod range from 250mM in darkness to a 23nM in saturating light. So, during 
the initial fall in Ca2+ incurred during the photon response, many more GCAP1 
molecules release their Ca2+ than GCAP2. The majority of GCAP2 molecules release 
their bound Ca2+ when intracellular Ca2+ falls to a lower degree, during saturating 
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responses to brighter light (Wen et al., 2014). GCAP1 presents higher affinity for 
RetGC1 than GCAP2. The population of RetGC1 presents a large fraction bound to 
GCAP1 and only a small fraction bound to GCAP2 (less than 20%). At the same 
time all RetGC2, which accounts for 25-30% of all RetGC activity, is bound 
exclusively to GCAP2 (I. V Peshenko et al., 2015; Peshenko et al., 2011). Taken 
together, RetGC2 is regulated only by GCAP2, and RetGC1 is regulated by both 
GCAPs, but with the majority of molecules bound to GCAP1. 
The mechanistic model of  GCAPs modulation of RetGC is today referred to 
as “Calcium relay mechanism” (Koch and Dell’orco, 2013) or “Calcium recruitment 
mechanism” (Wen et al., 2014). It establishes a modulation of cGMP synthesis at 
two stages:  when the calcium levels start to drop during the light response, GCAP1 
activates RetGC in a first boost of cGMP synthesis; and only when the calcium levels 
drop more substantially in response to brighter or longer light exposures GCAP2 
Figure I.5. Model of regulation of RetGC by GCAPs. RetGC (in green) is a 
transmembrane protein that functions as a dimer, permanently bound to GCAPs (in 
orange) by the Kinase homolog domain (KHD). GCAPs activate cGMP synthesis in 
light conditions, when the [Ca2+] is low, by prompting the dimerization of cyclase 
domain (CD_Cterm). Signal Peptide (SP), Extracellular domain (ECD), 
Transmembrane Domain (TM), Juxtamembrane domain (JMD), Dimerization 
domain (DD). Number represents localization of domains in base of primary 
structure of RetGC. 
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would come into play to produce a second stage of RetGC activation and second 
boost of cGMP synthesis. 
The fine-tuning of different Ca2+ affinities in the complement of different 
GCAP proteins that characterize each species (there are up to seven different GCAP 
proteins in zebrafish (Scholten and Koch, 2011) would increase the overall 
sensitivity of the regulatory mechanism, as the joint action of different GCAPs would 
expand the dynamic range of responses to Ca2+ without losing the sensitivity that is 
contributed by the cooperative effect of Ca2+ on retinal guanylate cyclase regulation 
by each GCAP (Burgoyne, 2007). 
 
1.3.5. Trafficking of RetGC/GCAPs complex. Role of RD3. 
Phototransduction proteins are synthetized at the inner segment “house-
keeping” compartment of the cell, and must be transported to the outer segment 
photosensitive compartment. Because the outer segment compartment of 
photoreceptor cells is constantly renewed (completely renewed each ten days in 
humans), this polarized vesicular trafficking occurs massively and is strictly required 
for photoreceptor viability.  Understanding the mechanisms that govern the 
assembly, organization and trafficking of signaling protein complexes to the outer 
segment where phototransduction takes place is a main focus of the photoreceptor 
cell biology field; as mutations at these processes lead to inherited retinal blindness.  
The RetGC/GCAPs complex is present exclusively in photoreceptor cells. 
Although the localization of GCAPs might vary in different species, there is a 
consensus that establishes thatGCAP1 is expressed in both rods and cones in high 
vertebrates, with a higher relative expression in cones than rods. On the other hand, 
GCAP2 is expressed preferentially in rods and to a much lower level in cones 
(Cuenca et al., 1998). 
Both GCAPs distribute along the cytoplasmic space of the cell, localizing to 
the inner segment or metabolic compartment,  the outer segment and the synaptic 
terminal (López-del Hoyo et al., 2012). RetGCs are localized mainly at the outer 
segment compartment. Retinal guanylae cyclases RetGC1 and RetGC2 have been 
shown to be  essential for the correct localization of GCAPs and other proteins 
involved in phototransduction (Baehr et al., 2007; Karan et al., 2010). This 
observation points to a group of signaling proteins, including GCAPs and proteins 
more generally involved in cGMP metabolism, being transported together, around 
RetGCs. 
Although the mechanisms underlying signaling protein trafficking to the outer 
segment in photoreceptor cells are still poorly understood, an analogy has been 
established to ciliary trafficking in other ciliated cells.  This analogy is based on the 
fact that the outer segment derives from a primary non-motile cilium.  In other 
ciliated cells, some “ciliary-targeting sequences” in the primary structure of proteins 
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have been identified that confer ciliary destination.  One such “ciliary targeting 
sequence” is the aminoacidic sequence “VxPx”.  In photoreceptor cells this sequence 
is present in rod opsin, and it has been shown to be essential for rod opsin transport 
to the rod outer segment compartment  (Mazelova et al., 2009). In photoreceptor 
cells, transport to the cilium occurs by vesicular trafficking, and different subset of 
vesicles might be guided to the cilium by one protein containing a “ciliary targeting 
sequence”, acting as a guide.  As an example, “rhodopsin transport carrier” vesicles 
have been characterized, that work their way to the cilium through protein 
interactions triggered by rod opsin C-terminus VxPx sequence.  Most membrane-
bound proteins are thought to be transported to the cilium “by default” by 
incorporating into cilium-fate vesicles.   
RetGC1 is thought to act as a “ciliary guiding” protein.  Until date no ciliary 
targeting signal has been identified in RetGC, however some genetic studies have 
shown that RetGCs are required for the transportation of a subsert of proteins to the 
sensory compartment. The work of W. Baehr has shown that in the RetGC1/RetGC2 
double knockout mouse model a subset of phototransduction proteins fail to be 
transported to the outer segment in rods and cones. In rods, the GCAP proteins and 
the different PDE subunits depend on RetGCs for their transport to the outer 
segment.  In cones, in addition to GCAPs and PDE subunits, transducin and GRK1 
have been shown to depend on RetGCs for their correct localization to the outer 
segments. RetGC1 transport might also involve cone opsin transportation to cone 
outer segments (Baehr et al., 2007; Karan et al., 2010). 
Recently, another member of the RetGC/GCAPs complex has been identified 
by R. Molday, emerging as a protein involved in the stabilization and transport of 
the complex: the protein Retinal Degeneration 3 or RD3 (Azadi et al., 2010). This 
protein is encoded by a locus that has been linked to inherited blindness: to the 
naturally-occurring mutant strain of mice rd3, and to Leber Congenital Amaurosis 
12 (LCA12) in humans. Robert Molday´s laboratory reported that the locus rd3 
encodes a protein (RD3) that interacts with RetGC1, and plays an essential role in 
the early stage of stabilization and transport of the RetGC/GCAPs protein complex. 
In the rd3 mice retGC1 and RetGC2 protein levels decrease dramatically, to the point 
that they cannot be detected. Likewise, the localization and/or protein levels of the 
proteins that are co-transported with RetGC are affected.(Azadi et al., 2010). 
Moreover, it has been demonstrated that RD3 interacts directly with GCAP1 
and this interaction facilitates the trafficking of RetGC1 to the outer segments. Also, 
the RetGC/GCAPs/RD3 complex is altered by most of LCA1-linked mutations in 
RetGC1. (Zulliger et al., 2015). 
How RD3 regulates, stabilizes or orchestrates the trafficking of the 
RetGC/GCAPs complex to the outer segment are still open-questions. The specific 
role of RD3 in the stabilization and trafficking of the RetGC/GCAPs complex is still 
unknown. 
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1.3.6. Mutations in the genes encoding the proteins in the 
RetGC/GCAPs/RD3 complex and disease. 
Mutations in the different components of the RetGC/GCAPs/RD3 protein 
complex have been linked to Retinitis Pigmentosa (RP), Cone-Rod Dystrophies 
(CORD) and to Leber Congenital Amaurosis (LCA).  
Retinitis Pigmentosa is the most common cause of photoreceptor 
degeneration. It presents poor night vision in early or middle life. It progresses to 
loss the mid-peripheral field of vision, which gradually extends and leaves many 
patients with a small central island of vision due to the preservation of macular cones. 
The most common form of RP results from a primary defect in rods, but this almost 
invariably leads to secondary loss of cones (Alan F. Wright et al., 2010).  RP can be 
present autosomal dominant, autosomal recessive or X-linked segregation.  
Cone-rod dystrophies (CRD) are a group of pigmentary retinopathies that have 
early and important changes in the macula. Cone dysfunction occurs first and is often 
followed by rod photoreceptor degeneration. Common initial symptoms are 
decreased visual acuity, dyschromatopsia, and photophobia which are often noted in 
the first decade of life. Night blindness occurs later as the disease progresses. Cone-
rod dystrophies are a group of disorders separate from rod-cone dystrophies where 
the primary defect is in the rod photoreceptors with typical pigmentary changes in 
the peripheral retina. The progression of vision loss is generally slower in rod-cone 
dystrophies. Cone dystrophies comprise another group of disorders with exclusive 
cone involvement in which the macula often has a normal appearance in association 
with loss of central acuity (Cross, 2016). 
Leber congenital amaurosis (LCA) is the most severe form of inherited retinal 
blindness. LCA is characterized and unified by the following clinical features: severe 
and early visual loss, sensory nystagmus, amaurotic pupils, and absent electrical 
signal on electroretinogram (den Hollander et al., 2008). The first signs are usually 
noted before the age of 6 months. These consist of a severe reduction in vision 
accompanied by nystagmus, abnormal pupillary responses, and photophobia. LCA 
is genetically heterogeneous with at least 22 known gene mutations associated with 
the phenotype, whose prevalence of each one may be different (Figure I.6).  It is also 
clinically heterogeneous both within and among families, which difficults the 
characterization of genotype-phenotype correlations for treatment purposes (Cross, 
2016). Although LCA has also been associated to other syndromes, such as Joubert 
syndrome, mental retardation, autism or olfactory dysfunction; some of this 
associations are under controversy due to the intrinsically difficulty of correct 
characterization and correlation between genotype and phenotype of LCA(den 
Hollander et al., 2008).  




- LCA-associated mutations to RetGC. 
Mutations in RetGC are a leading cause of LCA. About 12% of total mutations 
related to LCA are located in the GUCY2D gene encoding RetGC1. Until date, 41 
mutations have been described in the GUCY2D gene related to LCA (Stone, 2007). 
From these, 18 are located in the extracellular domain of the protein (ECD); 1 is 
located at the transmembrane domain (TM); 8 are located in the kinase homology 
domain (KHD), 3 are located in the dimerization domain (DD); and 10 are located 
in the catalytic domain (CD).  Most of these mutations are null mutations, resulting 
in truncated forms of the protein that are unstable (premature stop codons), or in loss 
of function by directly affecting the active site, the catalytic activity or dimerization 
capacity. However, mechanism of action of several of the mutations is still unknown. 
Recently, it has been proposed that some mutations mapping in the KHD and DD 
domains of RetGC (R768W, R795Q, R822P) lead to LCA by affecting the target 
binding site of GCAP1 (Jacobson et al., 2013; I. V. Peshenko et al., 2015). Although 
these mutations in RetGC1 were demonstrated to affect GCAP1 binding to the 
protein in vitro, it has not been demonstrated that the failure of GCAP1 binding to 
RetGC1 is what causes the loss of visual function and eventual cell death in vivo.  
Actually we known that GCAP1 and GCAP2 double knockout mice present largely 
normal retinas for up to one year of age, and almost functional responses by 
electroretinography (Mendez et al., 2001). Therefore, we cannot exclude that these 
Figure I.6. Prevalence of LCA-associated mutations for 14 of the 22 causative 
genes. CEP290 (15%), GUCY2D (12%) and CRB1 (10%) are the most frequently 
mutated genes. Mutations in approximately 30% of all cases remain to be identified 
(den Hollander et al., 2007). 
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mutations may affect some other functional aspect of RetGC in photoreceptors in 
vivo, such as some step in its trafficking to the outer segment, its anchoring or some 
as-yet-unforeseen aspect of its regulation in vivo. 
Mutations in GUCY2D gene encoding RetGC1 have also been linked to 
autosomal dominant CORD, namely CORD6 (Jiang et al., 2008). These mutations 
lead to constitutive activity of the cyclase in vitro, which explains its gain-of-
function (autosomal dominant) nature (Wilkie et al., 2000). 
 
- LCA-associated mutations to RD3. 
Recently, the protein encoded by the rd3 locus (protein RD3) has been 
identified as a protein that interacts with the RetGC/GCAPs protein complex.  The 
name rd3 originated from the naturally occurring strain of blind mice, the “retinal 
degeneration 3 mice” or “rd3 mice” that was characterized preceding the 
identification of the human rd3 locus linkage to LCA (type 12, LCA12).   RD3 was 
reported to interact directly with RetGC1 in bovine rod outer segments, and proposed 
to be involved in stabilization and transport of the RetGC/GCAPs complex, based 
on the fact that in rd3mice, the level of RetGC1 is dramatically reduced at the protein 
level, and neither RetGC1 or the GCAP proteins can be detected at the outer 
segments (Azadi et al., 2010). Instead, these proteins accumulate at the inner 
segment compartment, indicating that their trafficking fails in the absence of 
functional RD3 protein. Mutations in RD3 could lead to LCA by compromising the 
protein stability (by causing frameshifts or large deletions in the protein, Preising et 
al, 2012; Perrault et al, 2013).  Mutations in RD3 are mostly loss-of-function 
mutations that have an autosomal recessive pattern of inheritance.  
Specifically, 4 mutations have been identified in the RD3 locus that yield a 
premature termination of the protein (R38X, E46X, E46A2bp deletion 83 X, Y60X, 
Preising et al, 2012; Perrault et al, 2013), all of which present autosomal recessive 
inheritance.  
In addition, a point mutation has been linked to Retinitis Pigmentosa in a 
family from Spain (de Castro-Miró et al., 2014).  The reason why this RD3 mutation 
is linked to RP instead of LCA is not known, and it stresses the need to deepen the 
functional characterization of the RD3 protein in vivo.  There are clearly many 
aspects of RD3 putative implication in the stabilization, assembly and trafficking of 
the RetGC/GCAPs complexes that are still not known, as well as differences in these 
processes in rods and cones. 
 
- Disease-linked mutations in GCAPs. 
Many mutations have been reported in the genes encoding the GCAP proteins 
that are linked to retinal dystrophies. To date, twelve different mutations in guanylate 
cyclase activating protein 1 (GCAP1) have been linked to autosomal dominant cone 
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dystrophies, a disease characterized by the loss of color vision and central visual 
acuity, and to macular dystrophies (summarized in table I.3) (Dell’Orco et al., 2014; 
Kamenarova et al., 2013; Newbold et al., 2002, 2001; Nishiguchi et al., 2004; 
Palczewski et al., 2004).  GCAPs stimulate RetGC catalytic activity when 
intracellular Ca2+ decreases in response to light.  It is the “Ca2+-empty” form of 
GCAPs that activate cGMP synthesis.  Generally, the mutations leading to cone 
dystrophy affect one of the Ca2+ binding sites or alter protein structure in a way that 
impairs Ca2+-binding (Figure I.7). The resulting mutant proteins remain active with 
increasing [Ca2+], leading to constitutive activation of the cyclase independently of 
the lighting conditions, as reported by in vitro studies (Dizhoor and Hurley, 1996; 
Mendez and Chen, 2002).  A hypothesis for how GCAP1 mutations lead to 
photoreceptor cell death in vivo has been proposed.  Mutant GCAPs would cause 
constitutive cGMP synthesis, leading to abnormally high levels of cGMP.  As a 
consequence, a higher fraction of the cGMP-channels would be kept open, increasing 
the inward current of calcium.  Elevated intracellular calcium would induce 
apoptosis (Krizaj and Copenhagen, 2002).  Two recent studies characterizing 
transgenic mice expressing Y99C-GCAP1 in rod photoreceptors would support this 
hypothesis (Olshevskaya et al., 2004; Sokal et al., 1998). 
However, we have obtained evidence for other mechanisms by which 
mutations in GCAPs may contribute to toxicity, from studies performed in the 
laboratory on mutant GCAP proteins expressed on the GCAPs double knockout 
genetic background.  We have observed that a form of GCAP2 that is severely 
impaired at binding Ca2+ [with the three functional EF-hands disrupted, (EF-
GCAP2)] is deleterious for the cell even when it is not active and does not traffic to 
the light-sensitive compartment.  We expressed the EF-GCAP2 mutant in rod 
photoreceptors of transgenic mice.  While in vitro this mutant leads to constitutive 
activation of guanylate cyclase (Dizhoor and Hurley, 1996), just like the GCAP1 
mutants associated to autosomal dominant cones dystrophies (Olshevskaya et al., 
2004; Sokal et al., 1998), when expressed in vivo, we observed that this protein was 
inactive and accumulated at proximal compartments of the cell, likely due to 
misfolding. We demonstrated that this Ca2+-free form of the protein was 
phosphorylated at Ser201 and bound to 14-3-3 proteins in response to this 
phosphorylation event in vivo.  As a result, it was retained at the inner segment 
compartment and precluded from distributing to rod outer segments.  Its 
accumulation at the inner segment compartment led to its progressive aggregation, 
cell death and overall retinal degeneration (López-del Hoyo et al., 2014).  
In summary, there are two main mechanisms by which mutations in the 
GCAP proteins may lead to blindness:  i) by disrupting Ca2+-regulation of RetGC 
activity therefore causing constitutive guanylate cyclase activity resulting in 
abnormally elevated cGMP, higher-than-normal number of open channels and 
abnormally high entry of Ca2+, which causes cell death (Dizhoor and Hurley, 1996; 
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Peshenko and Dizhoor, 2007; Woodruff et al., 2007); and ii)  by affecting protein 
conformation, causing cell death by mechanisms independent of cGMP metabolism 
but more related to those in conformational disorders (López-del Hoyo et al., 2014).  
Characterizing the cGMP-independent basis of toxicity will help to guide combined 
therapies for patients in the future. 
Among GCAP1 mutations, P50L is interesting for us, because, it does not 
localize in an EF-hand and does not lead to constitutive activation of RetGC in vitro.  
GCAP1-P50L presents an affinity for RetGC and activation capacity similar to WT, 
but has been described to have lower thermal stability. So, GCAP1-P50L is a good 
candidate to cause toxicity by a mechanism independent of cGMP metabolism and 
more related to conformational disorders.  This is why one of the specific aims of 
this thesis is to express this mutant in transient transgenic mice to analyze the effect 
of this mutations on the protein subcellular distribution (Chapter III), to study the 
physiopathology of this mutation. 
On the other hand, in GCAP2 only one mutation has been described to be 
associated with autosomal dominant RP (Sato et al., 2005). It is localized in the EF-
4 hand and could be similar to mutants localized in EF-4 in GCAP1 (like G159V) 
(see table I.3). Based on this analogy GCAP2-G157R could result in lower affinity 
to Ca2+ and constitutive activation of RetGC. However, as described above, the 
Ca2+-free form of GCAP2 does not result in constitutive activation of the cyclase in 
vivo because GCAP2 (unlike GCAP1) presents additional regulation in vivo  by 
phosphorylation (López-del Hoyo et al., 2014). The observation that the Ca2+-free 
form of GCAP2 is phosphorylated to a much higher level than the wildtype protein, 
that it is retained at the inner segment by binding to 14-3-3 proteins, and its high 
Figure I.7. Three dimensional structure of GCAP1. Disease-related residues in 
GCAP1 are indicated in blue. In red, residue linked to RP in GCAP2. PDB: 2R2I. 
(Jiang et al., 2014) 
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tendency to aggregate upon accumulation, lead us to speculate that this could be 
mechanism underlying the pathology of the GCAP2-G157R mutant.  That is why 
one of the specific aims of this thesis is to study whether G157R mutation in GCAP2 
affects the subcellular distribution of the protein, which would indicate a cGMP-
independent physiopathology.  
Table I.3. List of identified mutants linked to disease in GCAPs 
GCAP Mutation Localization Dystrophy Activity of 
GC 
 
GCAP1 P50L  AD Cone, 
rod-cone 
Like WT Low thermal 
stability 







GCAP1 E89K EF3 AD Cone Constitutive 
Activation 
 






GCAP1 D100E EF3 AD Cone Constitutive 
Activation 
 
GCAP1 N104K EF3 AD Cone Constitutive 
Activation 
 










GCAP1 I143NT EF4 AD Cone Constitutive 
Activation 
 





GCAP1 E155GD EF4 AD Cone Constitutive 
Activation 
 
GCAP1 G159V EF4 AD Cone Constitutive 
Activation 
 
GCAP2 G157R EF4 AD RP   
Compiled from (http://www.omim.org/entry/600364, Jiang et al., 2014, Kamenarova et 
al. 2013; Dell’orco et al. 2014; Newbold et al. 2001; Palczewski et al. 2004; Nishiguchi 
et al. 2004; Sato et al. 2005). 
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Taken together, the fact that so many mutations map at the protein complex 
responsible for cGMP synthesis (RetGC/GCAPs/RD3) stresses the relevance to 
deepen our understanding of the mechanisms underlying the stabilization, assembly, 
trafficking to the outer segment, anchoring and functional regulation of this 
enzymatic complex, as well as its functional interconnexions with multienzyme 
complexes in interconnected metabolic pathways. 
 
1.4. IMPDH1. Role in photoreceptor cells and its relationship to 
inherited blindness 
1.4.1. Role of IMPDH1 in de novo synthesis of guanine nucleotides. 
GTP can be synthesized de novo, or by a salvage pathway. The biosynthetic 
pathway for de novo synthesis of GTP relies on two main metabolic pathways: i) the 
synthesis of IMP from PRPP by the purinosome multienzyme complex, culminating 
in IMP synthesis, which is the common precursor for ATP and GTP synthesis 
(Figure I.8.A); and ii) synthesis of GTP from IMP by four enzymetic activities 
(Figure I.8.C).   
The purinosome (Figure I.8.A) comprises six enzymes that catalyze the 
conversion of phosphoribosyl-pyrophosphate to inosine 5′-monophosphate (IMP). 
These six enzymes include one trifunctional enzyme (TrifGART: GARS, GART, 
and AIRS domains), two bifunctional enzymes (PAICS: CAIRS and SAICARS 
domains; ATIC: AICART and IMPCH domains), and three monofunctional 
enzymes (PPAT, FGAMS, and ASL) (French et al., 2013; Yu et al., 2014).  
Four enzymes catalyze the conversion of IMP to GTP. IMPDH catalyzes the 
rate-limiting step of GTP synthesis, acting as the gateway to guanine nucleotides 
(Hedstrom, 2009). IMPDH catalyzes the conversion of IMP to Xanthine 
Monophosphate (XMP), with the reduction of NAD+ to NADH. Subsequently, XMP 
is converted to GMP by GMP Synthetase (Figure I.8.C). Guanylate kinase 
phosphorylates GMP producing GDP with ATP consumption, and then GTP is 
produced by phosphorylation of GDP by nucleoside-diphosphate kinase. 
IMP and GMP can also be synthesized directly from hypoxanthine and 
guanosine respectively through the action of Hypoxanthine-guanine 
phosphoribosyltransferase (HPGRT), that transfers the 5-phosphoribosyl group 
from 5-phosphoribosyl 1-pyrophosphate (PPRP) to these nucleotides (Figure I.8.B).  
In this context, IMPDH plays an essential role in GTP synthesis, constituting 









Figure I.8. Biosynthetic pathway of purines. A. Reactions catalyzed by the 
purinosome, common pathway in de novo synthesis of adenine and guanine 
nucleotides. B. Salvage pathway in purines biosynthesis. HPRT catalyzes the 
transfer of a phophorybosyl group to hypoxanthine, yielding IMP or to guanine, 
yielding GMP. C. IMP is the last common intermediate in the synthesis of ATP and 
GTP. GTP is synthesized from IMP by the successive enzymatic steps by IMPDH1, 
GMPS, GK and NDK. ATP is synthesized from IMP by the action of ADSS, ASL, AK 
and NDK. Modified form Zhao et al. 2013. 
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1.4.2. Structure of IMPDH.  
Genes coding for IMPDH are highly conserved in evolution in all eukaryotes 
and also some prokaryotes. IMPDH is also conserved at the protein level. Like most 
mammals, humans have an IMPDH1 and an IMPDH2 gene. These genes encode 
enzymes that are 84% identical at the amino acid level and are virtually 
indistinguishable in its catalytic activity, but differ in its tissue expression pattern. 
IMPDH2 is dominant major isoform in most tissues and is up-regulated in 
proliferating cells and down-regulated upon differentiation. IMPDH1 is typically 
expressed at low levels but mRNA levels are high in tissues including retina, 
pancreas, brain, kidney and spleen (Thomas et al., 2012). Little or no Impdh2 
expression is detectable in photoreceptors and only low levels of HPRT transcript 
are observed (Aherne et al., 2004). However, mice lacking IMPDH1 present only a 
mild retinal degeneration at 11 months old, that indicates that other non-canonical 
pathways may be involved in the regulation of the guanine pool in the retina. 
IMPDH forms tetramers in solution, each monomer consisting of a catalytic and a 
regulatory domain. The catalytic domain is composed by an eight-stranded α/β barrel 
structure, which performs the enzymatic function, and the regulatory domain, of 
about 120 amino acids long, is inserted within a loop of the catalytic domain and is 
composed of two repeats of the cystathionine b-synthase (CBS) domain, constituting 
a CBS pair or Bateman domain (CBS domain or Bateman domain)(Bowne et al., 
2006a; Buey et al., 2015). (Figure I.9).  
CBS domains are also present in a variety of proteins such as voltage-gated 
chloride channels, AMP-activated protein kinase and CBS, where they regulate the 
protein function in response to the binding of adenosyl molecules (Buey et al., 2015). 
The physiological importance of CBS domains is emphasized by the fact that 
Figure I.9. Structure of IMPDH1.  IMPDH1 forms a tetramer (also octamer), 
where catalytic domain are guided to the center of structure and CBS domains 
are guided out (Hedstrom, 2009; Pimkin and Markham, 2008). 
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mutations in these domains are associated with a variety of human hereditary 
diseases, such as homocystinuria, Wolff-Parkinson-White syndrome, myotonia 
congenital, etc. (Buey et al., 2015; Pimkin and Markham, 2008).  Mutations in the 
CBS domain also have been linked to Retinitis pigmentosa and Leber Congenital 
Amaurosis (see below 1.4.3).  
 IMPDH1 presents a complex regulation that is not well understood with 
multiple mechanisms that regulate its activity in the cell. 
 
1.4.3. Retina-specific isoforms of IMPDH: mutations linked to RP and LCA  
IMPDH1 has been linked to blindness. In 2002, a mutation linked to 
autosomal dominant retinitis pigmentosa 10 (adRP10) was identified from a large 
family from Spain (Arg224Pro,(Kennan et al., 2002), Table I.4); and another 
mutation (Asp226Asn) in two American and one British families (Bowne et al, 
2006b, Table I.4). Mutations R105W and N198K were later linked to rare adLCA 
(Bowne et al, 2006b, Table I.4).  These mutations cluster at the CBS-“similar to 
cystathione-b-synthase gene”-structural domain of the protein.   This is a domain 
that flanks the α/β barrel structure which performs the enzymatic function, 
dispensable for catalytic activity and whose function is not known.  Furthermore, 
mutations in IMPDH1 are autosomal dominant, assumed to cause a “gain-of-
function” rather than a “loss-of-function” phenotype, based on the observation that 
the IMPDH1 knockout presents only a mild retinopathy (Aherne et al., 2004). Today 
it is estimated that mutations in IMPDH1 account for 5-10% of autosomal dominant 
retinitis pigmentosa (adRP) cases (Bowne et al., 2002).  Despite IMPDH1 
conservation and ubiquity, the clinical manifestations of missense mutations in 
IMPDH1 are limited to the retina.  The mechanism underlying the disease is 
currently unknown.  It has been predicted that IMPDH1 would have some specific 
or distinctive function in photoreceptor cells of the retina.  Extensive structural and 
biochemical IMPDH1 characterization has provided important insights in this 
respect, even if IMPDH1 unique or distinctive function in the retina is still not 
completely understood. 
The first important insight towards understanding a retinal-specific phenotype 
of IMPDH1 mutations is that IMPDH1 expression levels are very high in 
photoreceptor cells of the retina, compared to other tissues, and that there are several 
retinal-specific isoforms of IMPDH1 that are produced by alternate splicing and/or 
alternative start sites of translation (Bowne et al., 2006a). There are four to seven 
major isoforms of IMPDH1 in high vertebrates, with their specific sequence and 
relative abundances varying between species (Bowne et al., 2006a, 2006b; Spellicy 
et al., 2007) (Figure I.10). Figure I.10 shows that although the canonical isoform of 
IMPDH1 (514aa) is the same in both humans and mice, major retinal-specific 
isoforms can be different (546aa in human and 603-604aa in mouse). 
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 Table I.4 shows the mutations in IMPDH1 that have been linked to retinal 
dystrophies. 
 
1.5. Brain-type Creatine Kinase 
1.5.1. Role of Brain-type Creatine Kinase (CKB). 
Creatine kinase (CK) catalyzes the reversible transphosphorylation from ATP 
to creatine (Cr) to yield phosphocreatine (PCr). The action of CK contributes to 
maintain the cellular energy homeostasis by guaranteeing stable and locally buffered 
ATP/ADP ratios (Andres et al., 2008; Wallimann et al., 1998).   
Four isoforms of CK can be found in vertebrates: Muscle-type (M), Brain-
type (B), sarcomeric mitochondrial-type (sMt) and ubiquitous mitochondrial (uMt). 
These enzymes are associated in two different combinations depending on tissue 
expression, dimeric MM-CK and octameric sMT-CK, which is expressed in 
differentiated sarcomeric, cardiac and skeletal muscle; and dimeric BB-CK with 
Table I.4. Mutations linked to retinal degeneration found in IMPDH1. 
Mutations Disease Localization inside 
 
Frequency Identified population 
R105W LCA   American subject 
T116M adRP CBS Domain  American subject 
N198K LCA CBS Domain  American subject 
R224P adRP CBS Domain  Large Spanish 
 D226N adRP CBS Domain 2%RP American subject 
V268I adRP   American subject 
G324D adRP Catalytic Domain  American subject 
H372P adRP Catalytic Domain  American subject 
Compiled from Bowne et al. 2006; Kennan et al. 2002; Bowne et al. 2002 
Figure I.10. Genomic structure and detected proteins in retina in A. human and B. 
mouse.(Spellicy et al., 2007) 
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octameric uMt-CK, which is expressed in brain, neuronal cells, retinal photoreceptor 
cells, hair cells bundles of the inner ear (Shin et al., 2007), smooth muscle, kidney, 
endothelial cells, spermatozoa and skin.  
Both combinations of isoenzymes contribute to generate an intracellular pool 
of PCr, which represents a temporal energy buffer that prevent a fall on ATP levels 
in high cell energy requirements scenarios. Cytosolic and mitochondrial CK are 
specifically localized in those focus of high ATP consumption of the cell, like 
ATPases of different ions pumps, myosin ATPase of contractile muscle apparatus, 
or the calcium pumps in the sarcoplasmic reticulum. Due to the specific localization 
of both types of isoenzymes, and the much faster diffusion rate of PCr and Cr 
compared with ATP and ADP, the CK/PCr system is the energy shuttle of the cell 
(Andres et al., 2008). 
1.5.2. ATP cycle in mitochondria.  
ATP is synthetized by oxidative phosphorylation in mitochondria or by 
glycolysis. CK is associated to those points of ATP synthesis to generate a pool of 
PCr. Mt-CK is located at intermembrane space of mitochondria, and synthetize PCr 
from mitochondrially generated ATP. PCr leaves mitochondria by Cr-transporters. 
PCr is used to generate a PCr pool that is used to buffer cytosolic ATP/ADP ratios 
and for local ATP consumption (Figure I.11) (Andres et al., 2008; Wallimann et al., 
1998). 
1.5.3. Phosphocreatine cycle in muscle and neurons. 
Cells with high and fluctuating energy demand, like muscle cells and 
neurons, which must change in seconds (or miliseconds) from an idle state to a fully 
active state, may increase the rate of ATP hydrolysis in several orders of magnitude 
within seconds, but ATP levels remains stable. Thus, these cells require the action 
of immediately available, fast and efficiently working energy supporting systems 
that connect sites of energy consumption with those of energy production via a 
phosphoryl transfer network (Andres et al., 2008). Diffusion coefficient of PCr is 
higher than ATP (Hubley et al., 1995). For this reason, the CK/PCr system plays a 
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Figure I.11. Phosphocreatine/Creatine Cycle. ATP is produced by oxidative 
phosphorylation in the mitochondrial matrix. Mitochondrial Creatine Kinase 
(Mi-CK) which is bound to outer side of mitochondrial inner membrane (IM) 
close to outer membrane (OM) acts as a shuttle catalyzing the tranfer of a high 
energy phosphate group from ATP to Creatine, exporting phosphocreatine (PCr) 
to cytosol and maintaining the levels of ADP in mitochondrial matrix. PCr can 
also be produced by cytosolic Creatine Kinase (CKc) transfering a phosphate 
group form ATP produced by glycolysis. PCr acts as a reservoir of energy into 
cytosol diffuse to high energy demand places to supply ATP by local action of 
specifically associated creatine kinase (CKa).(From Wallimann et al. 1998) 
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1.5.4. Differences in energetic requirements of rods and cones 
 Major ATP consumers in rods and cones are the Na+ influx through cGMP-
gated channel, maintained by ATPase ion-pumps and enzymatic processes 
necessary for signal transduction (eg. GTP consumption by Transducin and 
Guanylate cyclase, visual pigment phosphorylation…). Changes on ATP 
homeostasis can board from 5.7·107 molecules of ATP in rod disk in darkness to 
zero in bright light that closes all cGMP-gated channels in a time-window of 
milliseconds (Okawa et al., 2008). 
In darkness, rods and cones have a similar ATP consumption, as they have 
similar dark currents and similar amplitude and voltage-dependence of inner 
segment Ca2+ current. However, in light, cones consume much more ATP than rods. 
In cones, at the brightest bleaching intensity, the influx of Na+ through cGMP-gated 
channels never falls further than about half that in darkness. Therefore, cones have a 
higher metabolic cost than rods (Okawa et al., 2008). Cones have a similar 
biochemical cascade to rods, but the kinetics of the response to light are faster than 
rods (Kawamura and Tachibanaki, 2008; Rodieck, 1998), pointing to higher ATP 
requirements of cones than rods.  
 
1.6. Development of innovative methodologies for gene function 
studies in the retina. 
1.6.1. Genetic heterogeneity of Retinal Dystrophies 
Inherited retinal dystrophies, affecting one in 4000 individuals worldwide, are 
very heterogeneous at the genetic level and at their clinical manifestations. This great 
heterogeneity difficults their study and treatment.  Gene defects might primarily 
affect rod function (causing retinitis pigmentosa, RP); cone function (cone-rod 
dystrophies and age-related macular degeneration); or both types of photoreceptor 
cells in a severe congenital form of retinal dystrophy (Leber congenital amaurosis, 
LCA). These disorders have autosomal recessive, autosomal dominant or X-linked 
patterns of inheritance and are clinically and genetically heterogeneous. Some of 
these genes are listed in Figure I.12 and include those that code for proteins directly 
involved in the light response at the light sensitive compartment but also genes 
encoding proteins whose function is required for the expression, stabilization, 
trafficking or anchoring of phototransduction proteins. This group includes 
transcription factors, splicing factors or proteins involved in ciliary membrane 
trafficking.    
To study the effect of mutations in phototransduction genes is relatively 
straight-forward because phototransduction has been intensely studied for the last 
three decades. The major molecular players and enzymatic steps have been well 
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characterized. However, many genes that have been recently linked to retinal 
disorders encode proteins of unknown function that are likely involved in other 
central aspects of photoreceptor cell biology that are less understood. One of these 
is the underlying mechanisms of polarization that sustain the high degree of 
compartmentalization of these cells. Many genes linked to Retinitis or LCA are 
suspected to be involved in polarized membrane trafficking across the cilium, or in 
cilium biogenesis and maintenance, but their specific functions remain unknown: 
some gene examples are RP1, TULP1, RP9, TOPORS, RPGR, RPGRIP1, CEP290, 
RD3, RP2, and LCA5. 
 One of the difficulties to address gene function studies in photoreceptor cells 
of the retina resides in the high degree of specialization of these cells. There are no 
established cell lines that reproduce their high degree of compartmentalization. For 
this reason it is required the production of genetically modified mice, a crucial tool 
for understanding the role of a gene in biology and disease in the context of the living 
cell.  
1.6.2. Historical perspective of Transgenic Animals. 
Mankind has always wanted to modify his environment for his own benefit. 
The methods of modification of animals and plants have evolved with mankind itself, 
beginning with domestication of wild animals and plants up to reaching the era of 
DNA recombinant technology. Genetic engineering era began in 1972, stablishing a 
milestone in the evolution of this field (Figure I.13), when the first genetically 
modified organism was created (Cohen et al., 1972) by transfering genes from an E. 
Figure 1.12. List of Retinal Dystrophies (RD) causative genes and their 
subcellular localization. arRP, adRP, XlRP: autosomal recessive/dominant/X-
linked retinitis pigmentosa. LCA: Leber’s congenital amaurosis. adCORD: 
autosomal dominant cone-rod dystrophy. 
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coli to another to confer it with new characteristics. In 1974, Rudolf Jaenisch et al. 
(Jaenisch and Mintz, 1974) got the first genetically modified mammal, but the 
generated mouse could not transmit the acquired characteristic to its offspring. This 
milestone was achieved eight years after, when the first stable transgenic mouse that 
passed exogenous genes to its offspring was obtained (Palmiter et al., 1982)(Figure 
I.13). Palmiter and collaborators injected exogenous DNA carrying the gene for 
human growth factor into the pronucleus of fertilized eggs, which led to generation 
of transgenic mice with a dramatic growth. 
 
The heterologous expression of a gene in a given cell type or tissue (generation 
of transgenic animals) opened great opportunities to the study of human diseases and 
molecular and cellular basic processes.  However sometimes loss-of-function studies 
are required in the study of these same processes.  The first loss-of-function mouse 
was generated in 1989 on the basis of independent work of M. Capecchi 
(Homologous Recombination); O. Smithier, (Homologous recombination); and M. 
Evans (developing procedures for injection of modified cells into embryos).  
Today there are several established ways to generate transgenic animals: 
- Microinjection of pronucleus of fertilized eggs.  Used by Palmiter et al. to generate 
the first stable transgenic mouse. 
- Embryonic stem cells injection. This methodology was used for generation of the 
first knockout mouse (Capecchi, 1989; Doetschman et al., 1987; Koller et al., 1989; 
Thomas and Capecchi, 1987). Nobel Prize in Physiology and Medicine in 2007. 
- Virus delivering into fertilized eggs. Modified virus, that can infect but cannot 
replicate itself, are injected into fertilized eggs (Lois et al., 2002). This methodology 
Figure 1.13. Milestone in evolution of transgenic animals. 
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can be used for transfect directly the egg at stage of pronucleus or to transfect 
embryonic stem cells, improving transfection efficiency. 
- Somatic cell nuclear transfer. In which the cell of a somatic cell is transferred to 
cytoplasmic of an enucleated egg. This technique was used for the first mammal 
cloned, Dolly the sheep (Wilmut et al., 1997).  
New tools have arisen in more recent years, like Zinc-Finger Nucleases 
(ZFN), Transcription-activator like effector Nucleases (TALEN) and Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR), that have enabled 
custom gene editing, easing and increasing efficiency of homologous recombination. 
Briefly, ZFN and TALEN are designed proteins, that act as dimer, composed by two 
domains, the nuclease domain from FokI nuclease, and a DNA recognition domain, 
that can be formed by three Zinc-finger, where each one recognize three base pair, 
or by 8-10 Talen repeats, where each subdomain recognized only one base pair. 
These characters have done difficult to work with ZFN or TALEN because of they 
involve the precise design of a nuclease protein that must be refined for its correct 
function (Gaj et al., 2013).  On the other hand, CRISPR involve a site-directed 
nuclease, Cas9, whose recognition site is defined by a specific sequence of 20 
nucleotides in a RNA molecule (Cong et al., 2013; Jinek et al., 2013; Mali et al., 
2013; Qi et al., 2013; Wang et al., 2013; Yang et al., 2013). This fact facilitates 
working with this kind of nucleases and make it a powerful tool revolutionizing gene 
editing and transgenic animal fields. 
Despite of the numerous milestones in generation of transgenic animals, these 
techniques already need a great amount of resources, with highly specialized 
facilities and staff. 
Because of photoreceptor cells are highly compartmentalized and 
differentiated neurons, the absence of stablished cells lines that reproduce its 
complexity and the heterogeneity of genetic disorders linked to blindness, forces up 
to work in vivo with genetically modified animals. Owing to this has been needed 
the development of new transgenic tools and so by-passing the challenges of 
traditional transgenic mice generation. 
In this work, we going to deal about stable transgenesis by transfection and 
electroporation of male spermatogonia in vivo (Matsuda and Cepko, 2004) (Chapter 
II) and transient transgenesis by subretinal electroporation in vivo (Chapter III) 
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Aims 
The Retinal guanylate cyclase / Guanylate Cyclase Activating Proteins 
(RetGC/GCAPs) complex, responsible for cGMP synthesis in rod and cone 
photoreceptor cells of the retina, plays a fundamental role in termination of the light 
response and in light adaptation.  Mutations in the genes encoding these proteins or 
their regulators lead to different forms of inherited human blindness.  The MAIN 
AIM of this work is to characterize this protein complex by identifying new protein 
interactors that may contribute to understand the complex assembly, trafficking, 
organization and modulation in vivo.  The complexity of the visual system and the 
high degree of compartmentalization of photoreceptor cells is hard to reproduce in 
culture or reconstituted systems. Because of that, we also aimed at developing novel 




1. Develop new methodology for the generation of stable transgenic mice 
rapidly and at low cost by in vivo DNA electroporation of the male germline, 
and subsequent breeding.  Development of expression vectors for efficient 
transgene expression in retinal rods and cones (Chapters II & III).   
 
2. Study the mechanisms governing GCAP1 and GCAP2 subcellular 
distribution in photoreceptor cells, by studying the molecular determinants 
of GCAPs distribution to rod outer segments in vivo (Chapter III). 
 
2.1. Identify new interacting partners of the RetGC/GCAPs complex by 
performing a pull-down assay with GCAP1 followed by liquid 
chromatography and tandem mass spectrometry identification of the 
bound proteins: biochemical and functional characterization of prime 






































El complejo proteico formado por la guanilato ciclasa y las proteínas 
activadoras de la guanilato ciclasa (RetGC/GCAPs) en retina, responsable de la 
síntesis de cGMP en las células fotorreceptor de la retina, conos y bastones, juega un 
papel fundamental en la respuesta y adaptación a la luz. Mutaciones en genes que 
codifican para estas proteínas conducen a diferentes formas de cegueras hereditarias. 
El objetivo principal de este trabajo es caracterizar este complejo proteico mediante 
la identificación de nuevos interactores moleculares que puedan contribuir a 
entender como este complejo se ensambla, transporta, organiza y modula in vivo. La 
complejidad del sistema visual y el alto grado de compartimentalización de las 
células fotorreceptor de la retina son difíciles de reproducir en células en cultivo o 
en sistemas reconstituidos. Debido a esto, nuestro objetivo es también desarrollar 
nuevas metodologías de transgénesis que podrían acelerar el análisis de la función 




1. Desarrollar una nueva metodología para la generación de ratones 
transgénicos estables de forma rápida y a bajo coste mediante la 
electroporación in vivo de DNA en la línea germinal masculina y 
subsecuente cruzamiento. Desarrollo de vectores de expresión para la 
expresión eficiente de genes en retina. 
 
2. Estudiar los mecanismos que gobiernan la distribución subcelular de 
GCAP1 y GCAP2 en fotorreceptores de retina, mediante el estudio de los 
determinantes moleculares que regulan la distribución de las proteínas 
GCAPS al segmento externo del fotorreceptor in vivo. 
 
3. Identificar nuevos interactores del complejo RetGC/GCAPs mediante 
ensayos de Pull-Down con GCAP1 seguidos de la identificación de las 
proteínas unidas por cromatografía líquida y espectrometría de masas en 









































Chapter II. Stable transgenesis by electroporation of 
spermatogonia. 
Chapter III: Molecular determinants of localization of 
GCAPs 
Chapter IV: Unanticipated interaction between IMPDH1 
and RetGC1 proteins associated to 
blindness. 
Chapter V: Characterization of RetGC1 association to 
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We are in debt to Dr. Alvaro Gimeno at the Vivarium facility for his 
assistance at training us in surgery protocols for mice. We also acknowledge Esther 
Castaño´s assistance with cell-sorting experiments and data interpretation.  
My contribution to this chapter was the design and cloning of all presented 
expression vectors; the presented electroporation procedures with the different 
surgical protocols, and the extensive analysis of the progeny from electroporated 
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Chapter II. Stable transgenesis by electroporation of spermatogonia 
 2.1. DNA electroporation in the germ line: rationale and basis of the 
procedure. 
Because of the high degree of compartmentalization and differentiation of 
photoreceptor cells of the retina and their highly specialized function in visual 
transduction, there are no cell lines that completely reproduce this complexity in 
culture.  Therefore, the study of basic processes at the first steps of seeing as well as 
the physiopathology underlying inherited retinal dystrophies are best studied in vivo 
using gain-of-function and/or loss-of-function animal models. Genetic studies in 
animal models are a powerful tool for the study of gene function in the context of 
the living cell.  There are hundreds of different genes involved in various forms of 
inherited retinal dystrophies, many of them of still unknown function.  Therefore, 
the development of new, more efficient methods for rapid gene function analyses in 
vivo would greatly benefit research on photoreceptor cells.  
One limitation of genetic studies is the cost associated to generation of 
transgenic animals, particularly mammals such as mice.  Standard procedures for 
transgenic production involve costly and technically demanding procedures, such as 
DNA microinjection into the pronuclei of fertilized eggs. These procedures involve 
expensive equipment for microinjection and for the culture of embryos, highly 
qualified staff, and the permanent maintenance of mouse colonies ready for the 
production of embryos, and the reception of embryos.  Overall, transgenic facilities 
are very expensive to run, and generating transgenic mice is very costly and time-
consuming. Our goal here was to implement in the laboratory a method for 
generation of stable transgenesis in the retina based on in vivo DNA electroporation 
into the male germ line.  That way we would bypass the use of standard transgenic 
technical platforms, if we could bypass the need to isolate the embryos, put them in 
culture, or microinject them. The cost and the duration of generation of transgenic 
mice would be dramatically reduced, and anybody could do it. 
When we first conceived the idea of using in vivo electroporation for 
transfection of DNA into the male germ line, we did a thorough revision of the 
literature and realized that the group of S. Majumdar, from the National Institute of 
Immunology at New Delhi, India, had apparently developed the methodology to 
generate stable transgenic mice this way (Dhup and Majumdar, 2008).  
Conceptually, the methodology relied on the fact that spermatogonial cells are 
located out of the blood-testis barrier (formed by tight junctions between Sertoli 
cells), at the base of seminal tubules and hence directly in contact with interstitial 
fluid (Figure II.1).  Therefore, the injection of linearized naked DNA into the 
interstitial fluid of testis, followed by electroporation, should allow incorporation of 
the DNA into primary spermatogonial cells.  Briefly, the methodology consisted on: 
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i) injection of linearized DNA into the interstitial fluid of testis followed by 
electroporation at postnatal day 30, ii) a waiting period of 35 days of normal rearing 
of electroporated male to allow for one cycle of spermatogenesis, and iii) breeding 
of the electroporated mice at p65, to obtain progenies that would carry the genetic 
modification ubiquitously.  
To implement this methodology in the laboratory, we visited Dr. S. 
Majumdar´s laboratory at the National Institute of Immunology in New Delhi in 
August of 2012, in the collaborative frame of a project of Bilateral Cooperation 
Spain-India.  There we observed and learned to perform the different procedures. 
We implemented three different methods of injection over time. The first one 
involved the removal of one of the testis by surgery (hemicastration), while the 
remaining testis was injected with DNA at three different sites and then 
electroporated by a square-wave electroporator as described in materials and 
methods. The second one involved surgery to perform an opening in the wall of the 
scrotum to perform DNA injection and electroporation of both testis in the same 
procedure. Finally, the third method avoided surgery, and involved DNA injection 
and electroporation of both testis in the same procedure, performed through the wall 
Figure II.1. Anatomy of the testis. Seminiferous tubules are coiled inside the testis. 
A cross-section of a seminiferous tubule shows that spermatogonia stem cells are in 
the periphery of the tubule, out of the blood-testis barrier (hematotesticular barrier) 
formed by tight-juctions of the sertoli cells. A complete cycle of spermatogenesis 
takes about 35 days in mouse, from differentiation of stem cells up to mature 
spermatozoa. 
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of scrotum. These methods are described in detail at the chapter of material and 
methods. With each change, the procedure evolved to a less-invasive method, with 
the goal of leaving the DNA into the interstitial fluid of the testis with the minimal 
possible alteration of the organism.  
 
2.2. Progressive development of improved expression vectors for DNA 
electroporation in the germ line: the importance of avoiding gene 
silencing.    
2.2.1. Results of electroporating a reporter gene under a ubiquitous 
promoter: use of pL_UG plasmid. 
Our first attempt to generate stable transgenics by DNA electroporation of the 
male germ line was based on electroporation of 9 C57Bl/6J males with the plasmid 
pL_UG (#L01GLUG001XA. Signaling Gateway). This plasmid of 9Kbp expresses 
the reporter gene Green Fluorescent Protein (GFP) under the control of the Ubiquitin 
C promoter (UbiC) (Figure II.2). This plasmid drives constitutive and ubiquitous 
expression of GFP, and should result in the generation of mice that would emit green 
fluorescence upon exposure to UV-light. Electroporated C57Bl males were bred to 
2-3 60-day-old females, and the obtained progeny was analyzed by exposure to UV-
light, by PCR analysis and by Western Blot of different tissues. 
Figure II.3 shows a representative result of the PCR genotyping (Figure II.3A) 
and Western Blot (WB) analysis (Figure II.3B) of the progeny. Several PCR 
positive-mice are detected among the F1 (Figure II.3A, where the last lane in the 
panel labeled as +ctrl shows the PCR-amplified product from the electroporated 
plasmid).  However, most of the PCR-positive mice did not show GFP expression 
by Western Blot analysis (Figure II.3B).  We detected just one mouse that showed 
GFP expression in liver tissue by Western blot, even if it did so at much lower levels 
than a control mouse line.  The positive control for Western blot was tissue obtained 
from an established mouse line that expresses GFP under the strong and ubiquitous 
CAG promoter (composed by the cytomegalovirus early enhancer element, the 
Figure II.2. Scheme map of linearized pL_UG plasmid as injected in mice. Red box 
represents the Ubiquitin C promoter (1.3Kb), green box represents the Green 
Fluorescence Protein (GFP) reporter gene, and the yellow box the polyadenylation 
signal. The brown box is the plasmid backbone, proceeding from the plasmid 
collection of the Alliance for Cell Signaling.  
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promoter,  first exon and first intron of chicken beta-actin gene; and the splice 
acceptor of the rabbit beta-globin gene (Okabe et al., 1997)). Table II.1 summarizes 
the results of the progeny analyzed in this experiment. The fact that we obtained 
several mice that were PCR-positive but did not show noticeable protein expression 
by Western blot, led us to hypothesize that gene silencing was likely taking place in 
the progeny.  
Figure II.3.C shows representative testis of the electroporated mice, sacrificed 
at p90 after several rounds of breeding.  Even 60 days after electroporation, GFP 
expression was clearly observed in all testis examined.  Cross-sections of the testis 
(Figure II.3.D) highlighted isolated transfected cells with the appearance of Sertoli 
cells.  No green spermatozoa were observed in these samples at p90, but it is not 
clear to us whether GFP would be expressed from the UbiC promoter in 
spermatozoa.  Spermatozoa are highly specialized cells that express only a few 
selected proteins required for flagellar movement.  Therefore, the absence of green 
signal at spermatozoa did not necessarily indicate failure of DNA integration in the 
germ line. 
The fact that we obtained several PCR-positive mice in the progeny that did 
not express the protein to noticeable levels by Western blot led us to consider that 
gene silencing could be taking place.  Therefore, experiments from here on had to 
take into account that gene silencing could be precluding the heterologous gene 
expression.  Expression vectors from here on were designed to take this 
consideration into account. 
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Figure II.3. Representative analysis of the progeny obtained from mice 
electroporated with pL_UG-GFP. A. Representative PCR analysis of the progeny, 
showing some PCR-positive mice. B. Western blot of liver extracts from PCR positive 
mice. 4µg total protein of liver homogenates were loaded in the GFP lane (positive 
control line, see text for details), while 40µg total protein of liver homogenates were 
loaded for each of the mice analyzed of the progeny. GFP expression was only 
observed in mouse #113. Because this lane had 10 times more amount of tissue 
protein than the GFP positive control, we estimate that the level of expression of 
GFP in mouse 113 was about 100-fold less than in the GFP established transgenic 
mouse. C. Testis from the electroporated mice obtained at p90 after several rounds 
of breeding, showing GFP fluorescence under UV-light. D. Cross-sections of 
electroporated testis show sporadic transfected Sertoli cells. 
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Date of first 








#1 21/06/2010 13/08/2010 4 37 1   NO 
#2 21/06/2010 20/08/2010 3 13 ND   NO 
#3 21/06/2010 16/08/2010 3 17 ND   NO 
#4 21/06/2010 16/08/2010 3 29 1   NO 
#5 21/06/2010 28/08/2010 4 21 4  1? NO 
#6 21/06/2010 23/08/2010 3 17 ND   NO 
#7 21/06/2010 27/08/2010 6 33 4   NO 
#8 21/06/2010 16/08/2010 6 36 2   NO 
8/9 (88.89%)  32 203 12 5.9 1 NO 
ND- Not determined. NO- Not Observed. 
 
2.2.2. Ruling out silencing by parental imprinting 
The original paper of S. Majumdar was based on the FVB strain of mice. 
The FVB is an albino strain that is commonly used for generation of transgenic mice 
because of its prominent pronuclei in fertilized eggs and the large litter size 
(Jackson´s Lab). We used C57Bl in the laboratory because our research on the retina 
precludes us from using albino strains.  It has been described that FVB and C57Bl 
strains, the most widely used strains in the field of transgenics, have different 
mechanisms of parental imprinting and gene silencing by methylation (Chaillet et 
al., 1995; Weichman and Chaillet, 1997). Therefore, we hypothesized that parental 
imprinting could be causing gene silencing in the progeny.  
In order to test if  parental imprinting might be responsible for gene silencing 
in the progeny in the C57Bl strain used in our previous experiment, four C57Bl males 
were injected and electroporated with plasmid pL_UG, and crossbred with FVB 
females. Table II.2 summarizes the results from this experiment, where only 4 PCR-
positive mice were obtained in the progeny, and none of which showed detectable 
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Table II.2 Summary of the analysis of the progeny from mice injected with pL_UG, 
after breeding to FVB females. 
Fertile 
Males 
Date of first 
litter Litters 
%Fertile 






#9 13/11/2010 6  54 4  NO 
#10 02/11/2010 4  42 0  NO 
2/4  10 50.00 96 4 4.17  
 
2.2.3. Implementing the use of DNA barrier insulators to prevent gene 
silencing by heterochromatin condensation. 
Transgene silencing in vertebrates occurs at the chromatin level.  Insulators 
are DNA sequences that prevent inappropriate interactions between adjacent 
chromatin domains. Two main types of insulators have been described: those that 
isolate and block the activation of a promoter by an enhancer, known as enhancer-
blocking insulators; and those that prevent gene-silencing by creating a barrier 
against the spread of heterochromatin, known as barriers insulators (Gaszner and 
Felsenfeld, 2006).  
One of the most characterized barrier insulators is Matrix and scaffold 
Attachment Region (S/MAR) originally isolated from the chicken lysozyme locus 
(Gaszner and Felsenfeld, 2006), that are typically AT-rich sequences that are able to 
form barriers between independently regulated domains, by forming interactions 
with the nuclear matrix, allowing higher expression of transgenes independently of 
chromosomal position (Bode et al., 1996; Stief et al., 1989). 
In order to test whether we could prevent silencing of the transgene by using 
barrier insulators, we performed another electroporation experiment in which 
linearized pL_UG was co-injected with the insulating sequences 5’ S/MAR from 
chicken lysozyme gene, at a molar ratio of 1:2 into 6 C57Bl males. Co-injection of 
two sequences of DNA has been demonstrated to allow the co-integration of both 
sequences at the same site (Chen and Chasin, 1998). In this experiment, 72 mice 
were obtained in the progeny, of which 9 were PCR-positives. None of them were 
positive by WB or UV-light exposure.  Although this was a straightforward and rapid 
experiment because it did not involve cloning, it could still be argued that the pL_UG 
plasmid backbone, of prokaryotic origin, was in the DNA cassette flanked by the 
DNA barrier insulators, and could in itself promote transgene silencing. Therefore 
we proceeded with further development of the expression vectors.   
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2.2.4. Elimination of CpG islands from the promoter sequence in expression 
vectors. 
DNA methylation is the most common epigenetic modification that causes 
gene silencing. Only the cytosines adjacent to guanine (CpG sites) are substrates for 
methylation by methyltransferases in mammalian cells. Methylation has two distinct 
functions: it acts as a protection barrier from endonucleases designed to destroy 
foreign DNA and as a regulator of gene expression. Vertebrate CpG islands (CGIs) 
are short interspersed DNA sequences that deviate significantly from the average 
genomic pattern by being GC-rich, CpG-rich, and predominantly nonmethylated. 
CGIs are associated with more than three-quarters of all known transcription start 
sites and are defined as DNA sequences with: GC content above 50%, ratio of 
observed-to-expected number of CpG dinucleotides above 0.6, and length greater 
than 200 base pairs. (Bock et al., 2007; Deaton and Bird, 2011). Silencing of CGI 
promoters is achieved through dense CpG methylation. (Deaton and Bird, 2011).  
An in silico analysis of the Ubiquitin C promoter (1287bp) by Methyl Express 
Software 1.0 (#4376041. ThermoFisher Scientific) revealed that it contained a 
CGI of 1280bp of length. So, we decided to change the plasmid in order to avoid 
CpG dinucleotides in the promoter.  
We acquired the plasmid pCpG from Invivogen (#pcpgf-mcs, Invivogen), 
which is completely devoid of CpG dinucleotides and presents a strong constitutive 
and ubiquitous quimeric promoter composed by the early enhancer of 
cytomegalovirus promoter, the human elongation factor 1 alpha core promoter and 
a synthetic intron in 5’UTR. A CpG-free version of SV40 polyadenylation sequence 
is used and two S/MAR sequences form chicken lysozyme gene flank the expression 
cassette. The EGFP cDNA was cloned into the multi-cloning site of this plasmid 
(Figure II2.4). Two C57Bl males were electroporated with this linearized DNA 
Table II.3 Summary of analysis of the progeny from mice injected with pL_UG in the 
presence of 5´S/MAR insulating sequences. 
Fertile 
Males 
Date of first 
birth Litters 
%Fertile 






#11 14/04/2011 1  3  0 NO 
#12 14/04/2011 1  4  0 NO 
#13 24/03/2011 3  14  0 NO 
#14 19/01/2011 8  51 9 17.6 NO 
4/6  13 66.67 72 9 12.5  
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(pCpGfree-GFP). A progeny of 56 pups were obtained and analyzed. No PCR-














2.2.5. Development and testing of plasmids based on the mouse opsin 
promoter.  
Because our objective was to develop and characterize transgenic mouse 
models of gain- or loss-of function in photoreceptor cells, and given that the design 
of the expression vector seemed crucial, we decided to focus in parallel on the 
development of expression vectors based on a photoreceptor-specific strong 
promoter. One of the most frequently used and better characterized promoters for 
transgenic expression in photoreceptor cells is the rod opsin promoter. Rod opsin 
promoter is the strongest promoter in rod photoreceptor cells and controls the 
expression of the most abundant protein expressed in rods, which is the visual 
pigment rod opsin (3mM concentration at the outer segments). 
We based our vectors on the 4.4 kb version of the Mouse Opsin Promoter 
(MOP), which has been extensively used for transgene expression in rod 
photoreceptor cells by pronuclear injection (López-del Hoyo et al., 2014, 2012). In 
Table II.4 Summary of progeny from mice injected with pCpG-EGFP 
Fertile 
Males 
Date of first 
birth Litters 
%Fertile 
males Progeny PCR 
%PCR 
Positives 
#15 11/04/2013 8  44  0 
#16 09/06/2013 2  12  0 
2  10 100.00 56 0 0 
Figure II.4.  Map of the linearized pCpGfree-GFP plasmid used in the 
electroporation of mice. MAR (insulator matrix-Attachment region), ZeoR 
(Zeomicin resistance cassette), R6K origin (Origin of replication).  
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the 90’s, the MOP was extensively characterized by Melvin I. Simon and Jeremy 
Nathans’s groups (Kumar et al., 1996; Lem et al., 1991; Nie et al., 1996; Peng and 
Chen, 2011; Tummala et al., 2010; Zack et al., 1991). Several regulatory elements 
have been characterized in this promoter (Figure II.5).  
 
 
Based on the known regulatory elements of the mouse opsin promoter, we 
designed different promoter variants in the search for a version that could drive 
transgene expression efficiently upon construct incorporation in the genome, by 
DNA electroporation of spermatogonial stem cells. An in silico analysis of the MOP 
revealed a CpG island close to the RPPR.  
As explained above, several types of DNA insulator sequences are available, 
that have proven successful at preventing transgene silencing and improving 
transgene expression efficiency in transgenic procedures by pronuclei injection. 
Besides S/MAR sequences, another insulator element that is widely used in the 
generation of transgenic mice, is the 5’HS4 sequence from the chicken β-globin 
locus.  This sequence was characterized by G. Felsenfeld (Bell et al., 1999) and acts 
as a blocking barrier for heterochromatin propagation. We introduced this barrier 
sequence flanking the transgene cassette in some of our constructs.  As detailed in 
materials and methods, we designed five different vectors for photoreceptor-specific 
transgene expression based on the mouse opsin promoter. The first one, (MOP_I in 
figure II.6) is a vector that we have previously used for the generation of transgenic 
mice by pronuclear injection (described in López-del Hoyo et al. 2012; López-Del 
Figure II.5. Regulatory elements of the Mouse Opsin Promoter. Main elements that 
control the activity and expression pattern of MOP are: Rhodopsin Enhancer 
Region (RER, 116bp; Orange Box), CpG Island (246bp; Pink Box) and Rhodopsin 
Proximal Promoter Region (RPPR, 286bp; Red Box). Inside the RPPR, green lines 
represent the binding site of Cone-Rod-Homeobox transcription factor (Crx) and 
blue line represents the binding site of Neural Retina-specific Leucine zipper 
protein (Nrl). RER is localized at 1,446Kb upstream of Transcription Start Site 
(TSS) and the CpG Island at 364bp upstream of TSS. The yellow box represents 
the 5’UTR (85bp). 
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Hoyo et al. 2014). It comprises an expression cassette composed of the MOP 4.4Kb 
version, bovine GCAP2 cDNA as the gene of interest and mouse protamine 1 
polyadenylation sequence, into the pBlueScript plasmid. Because this vector has 
been previously used to generate transgenic mice by the conventional procedure 
(pronuclear injection), the vector itself can be considered to be quality-proved.  The 
second construct, (MOP_II in figure II.6) was derived from construct I by removing 
a 2Kb region upstream of the RER element (Matsuda and Cepko, 2004) as well as 
the CpG island. The third construct was based on the MOP minimal version of 286bp 
(MOP_III), that carries only the RPPR (Rhodopsin proximal promoter region). This 
version has been demonstrated to be sufficient to drive heterologous gene expression 
in rod photoreceptor cells (Quiambao et al., 1997; Zack et al., 1991). The fourth 
version was derived from construct II by introducing 5´HS4 insulator sequences 
flanking the transgene cassette.  The fifth version contains the cassette in MOP_I 





These vectors were injected and electroporated into GCAP1 and GCAP2 
double knockout mice (Mendez et al., 2001). The goal was to express different 
mutant forms of the GCAP proteins in mice lacking endogenous GCAP1 and 
GCAP2, for a rapid assessment of the mutant phenotypes.  Overall, we injected 32 
males with the different constructs based on the MOP promoter. Of the 32 operated 
males 24 were fertile (75%).  These 24 mice produced a total of 809 pups, grouped  
Figure II.6. Expression vectors designed for photoreceptor-specific expression, 
based on different versions of the mouse opsin promoter (MOP) 
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pMOP_I H 5/5   26 100.00 172 42 24.4 
  #21 04/05/2011 03/07/2011 7  65 24 36.9 
  #22 04/05/2011 26/06/2011 5  26 7 26.9 
  #23 04/05/2011 25/06/2011 7  40  0.0 
  #24 04/05/2011 10/07/2011 6  37 11 29.7 
  #25 04/05/2011 09/09/2011 1  4  0.0 
pMOP_I H 2/6   7 33.33 33 0 0.0 
  #26 03/07/2012 06/10/2012 2  7  0.0 
  #27 03/07/2012 21/10/2012 5  26  0.0 
pMOP_III H 2/2   13 100.00 85 24 28.2 
  #28 03/06/2011 27/07/2011 3  18  0.0 
  #29 03/06/2011 27/07/2011 10  67 24 35.8 
pMOP_II H 1/2   16 50.00 77 28 36.4 
  #30 11/08/2011 19/10/2011 16  77 28 36.4 
pMOP_II+
HS4 H 3/5   27 60.00 188 38 20.21 
  #31 11/08/2011 13/11/2011 12  77 34 44.2 
  #32 19/03/2012 17/05/2012 8  57 4 7.0 
  #33 19/03/2012 19/06/2012 7  54  0.0 
pCpG-
MOP_I H 3/4   11 75.00 64 39 60.9 
  #34  30/09/2013 5  28 17 60.7 
  #35  30/09/2013 2  9 3 33.3 
  #36  08/10/2013 4  27 19 70.4 
pCpG-
MOP_I T 8/8   27 100.00 190 2 1.05 
  #37  15/09/2013 4  28  0.0 
  #38  15/09/2013 5  30 2 6.7 
  #39  14/04/2013 6  31  0.0 
  #40  22/04/2013 4  22  0.0 
  #41  12/06/2013 1  9  0.0 
  #42  01/06/2013 2  23  0.0 
  #43  31/05/2013 2  24  0.0 
  #44  07/06/2013 3  23  0.0 
Total  24/32   127  809 173 21.4 
Surgery Type: H, Surgery with Hemicastration and injection of a single testis, T, trans-scrotum; S, 
surgery and injection of both testis (See Methods) 
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in 127 litters. More than 30 mice were analyzed for each of the five constructs. 
Of the 809 pups in the progeny, 173 mice were PCR-positive (21.4%).  However, 
none of them expressed detectable levels of the transgene by Western blot (see 
below). Table II.5 summarizes these rounds of experiments.   
Despite of the large number of PCR-positive mice detected at the genotyping 
level in the F1 (Figure II.7.A), none of them showed expression of the GCAP2 
protein when analyzed by Western blot (Figure II.7.B).  
Therefore, in all of our attempts to generate transgenic mice by DNA 
electroporation, regardless of the promoter used or the presence or absence of 
insulator sequences, we invariably obtained PCR positive mice (which indicated 
integration of the heterologous DNA), that failed to express the heterologous protein 
to detectable levels.  One possible explanation for these results was that the 
heterologous DNA was integrated in the genome (hence mice are PCR positive), but 
silenced epigenetically (no protein expression).  Another possible explanation was 
that PCR positive results were not indicating an integration of the transgene, but were 
rather false positives.   In order to distinguish between these two possibilities we 
decided to assess whether there had been integration of the transgene in PCR-
positive F1 mice by Southern blot analysis of genomic DNA. 
Genomic Southern blots are typically used in the genotyping and sorting of 
transgenic founders and their progeny during the establishment of transgenic lines, 
because pronuclei injection of heterologous DNA can result in multiple integration 
sites.  A transgenic mouse with multiple integration sites of the transgene will 
segregate the transgene in each round of breeding, introducing experimental 
variability. This is why it is very relevant to carefully characterize transgene 
integration in founder mice, by Southern blot.   
Figure II.7. Electroporation of expression vectors based on the MOP results in 
PCR positive mice in the progeny that do not express the protein by Western blot. 
A. Representative PCR genotyping of the transgene. Conventional transgenic line 
as Positive control. GCAPs knockout as negative control. B. Representative WB 
shows that PCR-Positive mice lack expression of GCAP2.  
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Figure II.8. Characterization by Southern Blot of progeny from electroporated 
males. A. Genomic structure of double Knockout GCAPs (modified from Mendez et 
al. 2001). Exons II, III and IV from GCAP1 and III and IV from GCAP2 were 
substituted by Neo expression cassette. E (EcoRI), H (HindIII), X (XbaI). B. Structure 
of transgene employed in generation of transgenic mice by electroporation. For 
conventional transgenic mice, the same construct was used but without pBlueScript 
backbone, so KpnI-XbaI fragment. In red, probe against rhodopsin promoter; in blue 
probe against bGCAP2 cDNA. C. Southern blot genomic DNA digested with EcoRI 
of C57Bl, Conventional transgenic line (MOP-GCAP2-Mp1), double knockout 
GCAPs and PCR positive mice. Membrane was incubated with GCAP2 probe that 
recognize a band of about 6Kb in Conventional transgenic line that represent the 
fingerprint of this line. The visible band in C57Bl and conventional transgenic line 
of 7,9Kb represent of binding of probe to genomic DNA of GCAP2, lacked in double 
knockout GCAPs. The misleading band of >12Kb present in PCR-positive mice was 
also present in conventional transgenic line. D. Structure of genomic DNA of 
Rhodopsin. In red probe against MOP. E. Southern blot genomic DNA digested with 
EcoRI of C57Bl, Conventional transgenic line (MOP-GCAP2-Mp1), double 
knockout GCAPs and PCR positive mice. Membrane was incubated with MOP probe 
that recognize a band of about 5Kb in Conventional transgenic line that represent 
the fingerprint of this line with this probe. Endogenous MOP was detected as a band 





  Results: Chapter II 
79 
When mouse genomic DNA is digested using a restriction enzyme and 
separated in an agarose gel, a probe mapping at the transgene might identify an 
internal band corresponding to the digestion of the transgene or its multiple 
sequential integrated copies (typically common to all integration sites); and also a 
unique band including the “flanking region of the transgene” which will be revealing 
of unique integration sites, therefore “fingerprinting” each founder mouse. 
We performed a Southern blot analysis of selected PCR-positive mice, to 
investigate whether there was integration of the transgene.  To assist in the 
identification of bands corresponding to the transgene (versus the endogenous GCAP 
genes or the endogenous rhodopsin promoter), we also included C57Bl (WT) mice, 
and GCAPs-/- mice.  Furthermore, we also included the genomic DNA from a 
transgenic mice established by pronuclei injection with the same construct, to prove 
that at the technical level we were able to identify the proper bands (see loci maps 
and probe location in Figure II.8).  
Although in a first approximation by Southern Blot, an apparent differential 
band was detected (Figure II.8.C) using a probe against GCAP2, an ulterior bona 
fide characterization using probes against MOP, showed that this band was also 
present in both in double knockout GCAPs and in C57Bl (Figure II.8.B).   
Therefore, these results show that: i) PCR-positive mice could result from 
contamination and did not necessarily prove DNA integration; or ii) that integration 
sites are not that easily revealed by Southern blot, may be because of a low copy 
number. One putative interpretation is that DNA integration at spermatogonia fails 
because of a highly compacted chromatin (although spermatogonia are cells 
mitotically active and under continuous division). Alternatively, as already 
mentioned integrations could be taking place with a low transgene copy number that 
are hard to detect by Southern blot.                                                
We designed two rounds of experiments to address these two possibilities: one, we 
designed electroporation experiments with the use of histone deacetylase inhibitors, 
to prevent the tight compaction of DNA; and two, we developed an expression vector 
with a strong fluorescent marker that we know for sure that would be expressed and 
detected in spermatozoids (the Mito-dsRed), based on its localization to 
mitochondria (necessarily active in sperm cells), that would allow detection of 
transfected sperm cells by flow cytometry. 
 
2.2.6. Use of Histone deacetylases Inhibitors to prevent the compaction of 
DNA. 
Histone proteins are responsible for the compaction of DNA. Histones are 
basic proteins with high affinity for DNA. The degree of compaction of DNA is 
determined by the degree of acetylation of histones, that is, acetylation of histones 
diminish their affinity for DNA.  
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Histone deacetylases (HDAC) are the enzymes responsible for removing of 
acetyl-groups from lysine in the NH2-terminus of histones, and therefore increase 
the affinity of histones for DNA. HDACs allow histones to wrap DNA more tightly 
(Dokmanovic et al., 2007).  
Valproic acid (VPA) has been described to act as an inhibitor of HDAC 
allowing dynamic changes through decondensation of chromatin structure and 
enhance the sensitivity of DNA to nucleases and intercalating agents (Dokmanovic 
et al. 2007; Huangfu et al. 2008; Marchion et al. 2005; Felisbino et al. 2011).   
We therefore tried a VPA treatment of mice immediately preceding DNA 
electroporation. Four C57Bl mice at p30 were treated with VPA (5mg VPA in 100ul 
of saline buffer was administered by peritoneal injection every 12h for 60h preceding 
the injection and electroporation with pCpGfree-GFP DNA (Backliwal et al., 2008; 
Marchion et al., 2005). In two of the four injected mice, the injected DNA contained 
3mM of VPA. See table II.6 for a summary of the results obtained in these 
experiments. 
 
















males Progeny PCR 
  4/4   6 100.00 83 0 
Yes T #19 19/07/2013 15/09/2013 5  39  
Yes H #17 19/07/2013 15/09/2013 5  31  
No T #20 19/07/2013 15/09/2013 1  9  
No H #18 19/07/2013 23/09/2013 1  4  
Surgery Type: H, Surgery with Hemicastration and injection of a single testis, T, trans-scrotum; S, 
surgery and injection of both testis (See Methods) 
 
 
2.2.7. Quantification of the efficiency of heterologous DNA transfection of 
spermatozoa by in vivo DNA electroporation by flow cytometry.  
A single transfected spermatogonial stem cell can generate many 
spermatozoids, by clonal expansion first by mitosis and later by meiosis. 
Spermatozoids are haploid specialized cells that bring the male genetic information 
to female haploid cells. Spermatozoids can be easily isolated by dissection of the 
epididymis and its incubation in a glucose-rich culture medium for some minutes. 
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Spermatozoids swim out of the epididymal tissue to the medium, where they are 
collected.  Because of the high specialization of spermatozoids, they have a highly 
condensed nucleus, and a reduced cytoplasm with minimal expression of proteins. 
However, spermatozoids contain a large number of mitochondria that ensure the 
energy supply for flagellar movement. It has been reported that, although detection 
of a standard  fluorescent protein in spermatozoids  is difficult due to the reduced 
size of the cytoplasm and low level of expression of cytoplasmic proteins, the 
detection of fluorescent spermatozoids is feasible by transfecting fluorescent fusion 
proteins with a mitochondrial localization signal (Hibbitt et al., 2006; Huang et al., 
2000).  
Therefore, we designed an ultimate experiment that would allow us to 
conclusively answer the questions: -Can transgene integration take place in 
spermatogonial cells by DNA in vivo electroporation, and be preserved at sperm 
cells?, -With what efficiency?  
We cloned the fusion protein DsRed and a mitochondrial localization signal 
into the vector pCpG-free from Invivogen (Figure II.9), which is completely devoid 




Ten C57Bl males at p30 were injected and electroporated with this “ultimate” 
expression vector (both testis).Two non-injected C57Bl mice were carried as 
negative controls. Between 35 and 50 days post-electroporation (after a whole cycle 
of spermatogenesis), the epididymis of both testis were dissected and spermatozoids 
were collected. The amount of fluorescent spermatozoids was determined by flow 
cytometry. Table 2.7 shows a summary of the total events detected by flow 
cytometry, and the percentage of red fluorescent events from the total.  
Total events were counted in a channel detecting Hoechst 33342 
(Excitation/Emission 350/460 nm) which stains live cells (R1).  The events detecting 
DsRed fluorescence were counted in a different channel (563/582nm) (R6) (Figure 
II.10.A). The percentage of total events detected in R6 versus R1 is plotted in Figure 
Figure II.9. Schematic representation of pCpG-mitoDsRed 
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II.10.B and it ranges from 0.06 to 1.43% in 18 determinations, with a mean value of 
0.40%. The mean value obtained for this parameter in wildtype mice (non-
electroporated negative control mice) is 0.15.  
Figure II.10.C to J show transversal sections of the electroporated testis, 
showing isolated Sertoli cells and what appear to be Leydig cells with red fluorescent 
mitochondria, which proves the reporter gene expression from the vector, and that 
technically the electroporation of DNA in testis worked.   
Therefore, we can conclude that the efficiency of this technique is extremely 
low, with our numbers indicating that at best 1 mouse out of 250 mice in the 
progeny of an electroporated male would be transgene positive.   
 
Table II. 7. Summary of events detected by Flow cytometry 
Mouse ID Testis Total event Counts DsRed events % 
1 R 79920 676.5 0.85 
1 L 99535 812.5 0.82 
3 R 49725 711 1.43 
3 L 74088 689 0.93 
4 R 70438 195 0.28 
4 L 62026 173 0.28 
5 R 39955 158.33 0.40 
5 L 40395 154.66 0.38 
6 R 99639 102 0.10 
6 L 91105 55 0.06 
8 R 4286 30 0.70 
8 L 23934 189 0.79 
11 R 42470 89.5 0.21 
11 L 27625 57 0.21 
12 R 96929 182 0.19 
12 L 97417 313 0.32 
13 R 95508 75 0.08 
13 L 87187 106 0.12 
Total  1182182 4768.5 0.40 
Ctrl R 97683 85 0.09 
Ctrl L 35942 63 0.18 
Ctrl R 97742 89 0.09 
Ctrl L 99563 247 0.25 
Total  330930 484 0.15 
 




 2.3. Discussion. 
Conceptually, the generation of transgenic animals by electroporation of 
spermatogonial stem cells in vivo offered a novel promising genetic strategy for gene 
function analysis, by making the generation of stable transgenic animals affordable 
and fast.  Conceivably, this method could allow by-passing conventional transgenic 
facilities and their associated cost. 
Testis Mediated Gene Transfer (TMGT) or Sperm Mediated Gene Transfer 
(SMGT) -the transfer of exogenous gene to male gonadal tissue or gametal cells 
Figure II.10. Flow cytometry quantification of the efficiency of transfection in the 
protocol of DNA in vivo electroporation of testis. A. Isolated spermatozoids marked 
with Hoechst 33342 were sorted by flow cytometry (R1) and then sorted for presence 
of DsRed (R6). B. Percentage of events detected in R6 (DsRed positives) with respect 
to R1 (Hoechst positives) in electroporated mice (Treated) and control (Untreated). 
C-J. Cross-section of transfected testis. Nucleus are stained with Draq5. Red signal 
is seen mainly outside of seminiferous tubule or in sertoli cells. 
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have already been tried, for gene therapy purposes or the generation of transgenic 
animals.  There is controversy in the literature regarding the feasibility, efficiency 
and underlying molecular mechanisms of these techniques. with controversial results 
about efficiency and mechanism of action (Parrington et al., 2011). 
Table II.8 summarizes all the electroporation experiments.  Eight different 
constructs were electroporated, based on two different ubiquitous promoters and 
three versions of the strong photoreceptor-specific rod opsin promoter.  Plasmids 
devoid of CpG islets were used, and transgene cassettes were flanked by two 
different types of DNA barrier insulators. DNA electroporation were performed by 
three different experimental procedures, learnt at the laboratory from which this 
methodology originated.  Out of more than 1.300 mice analyzed from the progeny 
of 57 electroporated mice, 15% were PCR positive at the genotyping level (198 
mice).  However, transgene expression could not be detected at the protein level in 
any of the 198 PCR-positive mice. From our last experiment using the DsRed 
reporter gene with mitochondrial localization we can conclude that the maximal 
efficiency with which this technology could be working is 0.40%.  That is, out of 
250 mice from the progeny of an electroporated male, one transgenic animal might 
be expected. We conclude that this methodology is not practically feasible as 
performed. 
Table II.8. Summary of electroporated mice and progeny analyzed (Continuation 
in next page) 










pL_UG No   H 60 4x2 1 C57Bl 
pL_UG No  H 60 4x2 1 C57Bl 
pL_UG MAR  H 60 4x2 1 C57Bl 
pCpG-GFP MAR  T 40 4x2 2 C57Bl 
pCpG-GFP MAR VPA S 40 4x2 2 C57Bl 
pCpG-GFP MAR VPA T 40 4x2 2 C57Bl 
MOPI No  H 60 4x2 1 GCAPs KO 
MOPIII No  H 60 4x2 1 GCAPs KO 
MOPII No  H 60 4x2 1 GCAPs KO 
MOPII-HS4 HS4  H 60 4x2 1 GCAPs KO 
pCpG-MOP MAR  H 40 4x2 1 GCAPs KO 
pCpG-
 
MAR   T 40 4x2 2 GCAPs KO 
HDAC: Histone deacetylase Inbibitor. Surgery Type: H, Surgery with Hemicastration and injection 
of a single testis, T, trans-scrotum; S, surgery and injection of both testis. 
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The conceptual basis of DNA electroporation of spermatogonia cells relies on 
the fact that spermatogonial stem cells are outside the blood-testis barrier and in 
direct contact with the interstitial fluid. Therefore, they should be readily accessible 
by DNA injected in the interstitial fluid (Dhup and Majumdar, 2008).  Despite of 
that, the fact is that in our extensive trials we observed transfected Sertoli and Leydig 
cells, but no transfected spermatogonial cells.  Our interpretation of the results is that 
spermatogonial cells in vivo are not easily transfected by heterologous DNA because 
they likely have unique mechanisms in place to protect the integrity of their genomic 
DNA.  In this sense, adenovirus-mediated gene transfer has been reported to work 
on Sertoli and Leydig cells, but not on spermatogonial or sperm cells. (Kojima et al., 
2008, 2003).  
Furthermore, as an immuneprivileged tissue, testis can trigger innate immune 
responses through Toll-like Receptor 4 expressed in Sertoli cells in response to tissue 
damage or viral or bacterial infections (Shang et al., 2011; Zeuner et al., 2015).  A 
deeper knowledge of the protective mechanisms guarding the genome of germ cells 
might be required in order to design a DNA transfection strategy.  Alternatively, 
transfection of messenger RNAs to transient expression of CRISPR/Cas9 to get 
knockout or stable transgenic may be attempted.  
    
 









males Progeny PCR 
%PCR 
Positives 
C57Bl 9 8 32 88.89 203 12 5.91 
FVB 4 2 10 50.00 96 4 4.17 
C57Bl 6 4 13 66.67 72 9 12.50 
C57Bl 2 2 10 100.00 56 0 0.00 
C57Bl 2 2 6 100.00 35 0 0.00 
C57Bl 2 2 6 100.00 48 0 0.00 
GCAPs KO 11 7 33 63.64 205 42 20.49 
GCAPs KO 2 2 13 100.00 85 24 28.24 
GCAPs KO 2 1 16 50.00 77 28 36.36 
GCAPs KO 5 3 27 50.00 188 38 20.21 
GCAPs KO 4 3 11 75.00 64 39 60.94 
GCAPs KO 8 8 27 100.00 190 2 1.05 
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Chapter III: Molecular determinants of localization of 
GCAPs 
3.1. Rationale 
Retinal guanylate cyclase (RetGC) and guanylate cyclase activating proteins 
(GCAPs) constitute the protein complex responsible for cGMP synthesis in rods and 
cones of the vertebrate retina.  With cGMP being the second messenger in 
phototransduction, these proteins play a central role in the physiology of the light 
response.  In response to light, photoexcitation of the visual pigment in rods and 
cones triggers a G-protein-mediated enzymatic cascade that results in stimulation of 
cGMP hydrolysis by cGMP phosphodiesterase (cGMP-PDE), a reduction of the 
cGMP levels, and the closure of cGMP-gated channels at the plasma membrane. 
Closure of these channels causes the hyperpolarization of the cell and a reduction of 
neurotransmitter release at the synaptic terminal, which is the signal transmitted to 
higher order neurons (Burns and Arshavsky, 2005).   Timely recovery of the darkness 
equilibrium and the sensitivity to light in rods and cones after photoexcitation 
requires the replenishment of cGMP to its dark-adapted levels.  cGMP levels are 
restored by the stimulation of cGMP synthesis that is inherent to termination of the 
light response. This is mediated by the GCAP proteins stimulation of RetGC 
catalytic activity in response to the reduction in the intracellular Ca2+ that ensues 
the closure of cGMP-channels upon photoexcitation (Mendez et al., 2001). 
  Multiple structural and biochemical studies have characterized the mode of 
regulation of RetGC catalytic activity by the two main GCAP isoforms in high 
mammals: GCAP1 and GCAP2 (Dizhoor and Hurley, 1996; Ermilov et al., 2001; J.-
Y. Hwang and Koch, 2002; Laura et al., 1996; Peshenko et al., 2014, 2004; Peshenko 
and Dizhoor, 2004).  These proteins are thought to be permanently bound to RetGC 
(a homodimer of GCAPs bound to a homodimer of RetGC) at rod outer segments, 
and regulate cyclase activity by switching between two conformational states: a 
Ca2+-bound “inhibitor” state, characteristic of the dark-adapted state, that inhibits 
cyclase activity; and a Ca2+-free, Mg2+-bound “activator” state, acquired as the 
Ca2+ levels drop during the light response, that activates cyclase catalytic activity.  
Based on a slight difference in the Ca2+ sensitivities of GCAP1 and GCAP2 (Koch 
and Dell’orco, 2013; Wen et al., 2014), and in the reported kinetics of the light 
response of mice expressing GCAP1 or GCAP2 individually (Howes et al., 2002; 
Mendez et al., 2001), a “Ca2+-relay model” of RetGC regulation by GCAPs has 
been proposed (Koch and Dell’orco, 2013).  According to this model cGMP 
synthesis would be boosted in two stages during termination of the light response.  
GCAP1, less sensitive to Ca2+ than GCAP2, would be the first to acquire its 
activator conformation as the Ca2+ level decreases during the light response, being 
responsible for the first boost of cGMP synthesis.  GCAP2 would contribute to 
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cGMP synthesis in a second stage, as the Ca2+ levels decrease even further, in 
response to brighter or more prolonged light exposures. 
 While the mode of regulation of RetGC by GCAPs has been extensively 
investigated, much less is known about the mechanisms that regulate the protein 
complex assembly and its subcellular distribution in the context of living cells.  
RetGC1, an integral membrane protein, appears to be confined to the outer segment 
compartment and the synaptic terminal of rods and cones.  Its distribution to these 
compartments is expected to rely on vesicular polarized trafficking, although the 
mechanisms underlying this trafficking remain elusive (Baehr et al., 2007; Karan et 
al., 2010).  The soluble proteins GCAP1 and GCAP2, however, appear to fill the 
cytosolic space of photoreceptor cells, being abundant also at the inner segment and 
perinuclear region.  This distribution does not simply result from equalization of 
their concentrations in the cytosol.  Two independent lines of studies point to a 
regulated subcellular distribution of the GCAP proteins.  First, it has been reported 
that GCAP1 and GCAP2 fail to distribute to the rod outer segment compartment in 
the absence of functional RetGC (Baehr et al., 2007; Karan et al., 2010), or when the 
stability of RetGCs is compromised in the absence of functional RD3 (Azadi et al., 
2010).  This line of results indicates that GCAP1 and GCAP2 distribution to rod 
outer segments depends on RetGC.  Second, GCAP2 subcellular distribution post-
synthesis has been proposed to be regulated by phosphorylation at Ser201 and 14-3-
3 binding, depending on the illumination state of the cell (López-del Hoyo et al., 
2014).  Taken together, these are strong indications that GCAP1 and GCAP2 
subcellular distribution is dependent on RetGC1, at the same time that it is strictly 
regulated. 
It is not known, however, whether GCAPs dependence on RetGCs for their 
distribution to rod outer segments implies a direct interaction.  GCAPs direct binding 
to RetGC (i.e. complex assembly at the inner segment) might be a prerequisite for 
their incorporation into vesicle transport carriers with ciliary destination. 
Alternatively, GCAPs might simply incorporate by default to vesicle transport 
carriers that are somehow dependent on functional RetGC for their ciliary fate, in 
the same way that PDE6 subunits in rods, and cone PDE alpha and transducin 
subunits in cones depend on RetGC for their trafficking to the cilium (Baehr et al., 
2007; Karan et al., 2010).  The residues in GCAP1 that are involved in primary 
binding to the cyclase, versus those involved in its activation, have been precisely 
mapped in a recent structural-functional study (Lim et al., 2013; Peshenko et al., 
2014).  This mapping has allowed us to address whether GCAP1 direct binding to 
RetGC1 is required for GCAP1 distribution to the outer segment by using a genetic 
approach.  In this study we expressed a GCAP1 mutant impaired at RetGC1 binding 
(K23D), and one that preserved binding but was impaired at RetGC1 activation 
(W94A) as transient transgenes in the rods of GCAP1/2 double knockout mice.  Then 
we assessed their subcellular distribution.  We here report that precluding GCAP1 
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binding to RetGC1, but not its activation, prevented its distribution to rod outer 
segments.  
Conversely, GCAP1 and GCAP2 are myristoylated at Gly2 at the NH2-
terminus.  Whether myristoylation affects GCAPs subcellular distribution in living 
photoreceptors has not been addressed.  An emerging number of reports have 
involved the lipid moiety of acylated membrane-associated proteins in regulation of 
protein trafficking or its restricted diffusion.  In photoreceptors, several acylated 
proteins involved in phototransduction interact with lipid-binding proteins that 
regulate their localization.  Lipid-binding proteins in photoreceptors include PrBP/δ 
and UNC119.  The protein PrPB/δ encoded by the Pde6d gene functions as a prenyl 
binding protein that binds to the three catalytic subunits of PDE (α, β in rods and α´ 
in cones), two G protein-coupled receptor kinases (GRK1 and GRK7) and the rod 
and cone γ subunits of transducin. These proteins are synthesized in the cytosol, 
posttranslationally prenylated at the COOH-terminus by soluble prenyl transferases, 
and docked to the ER surface for further processing.  Following ER processing, these 
proteins are targeted to the outer segment disk membranes where phototransduction 
takes place.  PrPB/δ has been proposed to extract these proteins from the ER to allow 
their incorporation to transport carrier vesicles (Zhang et al., 2012).  In the absence 
of PrPB/δ, GRK1 and PDEα´ fail to be transported to rod and cone outer segments, 
affecting photoreceptor physiology.  UNC119A is an acyl-binding protein that 
shows specificity for the lauroylated and myristoylated N-termini of G-protein α-
subunits. It is involved in Tα redistribution between rod outer segment and proximal 
compartments during light- and dark-adaptation periods (Constantine et al., 2012; 
Zhang et al., 2011).  Collectively, the concept is emerging that acylation of 
membrane-associated proteins regulates their subcellular distribution, and therefore 
our interest in studying the role of GCAP1 and GCAP2 myristoylation in rods and 
cones. 
We have recently proposed a unique mechanism of regulation of GCAP2 
subcellular distribution.  This mechanism is based on light-dependent 
phosphorylation at Ser201 followed by the binding of 14-3-3, that sequesters the 
protein at the inner segment compartment (López-del Hoyo et al., 2014).  This 
mechanism was proposed based on observations made on a transgenic line 
expressing a GCAP2 mutant locked in its Ca2+-free conformation, EF-GCAP2.  In 
this study we provide a genetic demonstration that phosphorylation at Ser201 
effectively determines the subcellular distribution of the wildtype GCAP2 protein. 
The S201D GCAP2 mutant is retained at the inner segment, and does not distribute 
to rod outer segments.  As we had predicted in our previous study, a disease-linked 
mutation in GCAP2 (Sato et al., 2005), G157R, results in a significant fraction of 
GCAP2 retention at the inner segment in a high number of cells.  This 
mislocalization, based on GCAP2 toxicity at the inner segment when accumulated 
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at its activator conformational state (López-del Hoyo et al., 2014) is likely the basis 
of the pathophysiology of the associated retinitis pigmentosa disorder. 
In summary, in this study we set to characterize the molecular determinants of 
protein localization in GCAP1 and GCAP2.  We conclude that GCAP1 distribution 
to rod outer segments requires its capacity to bind to RetGC1, but not the capacity 
to activate it.  It also requires the NH2-terminal myristoyl group.  In contrast, GCAP2 
does not require myristoylation, and its distribution is regulated by light, via 
phosphorylation at Ser201 and 14-3-3 binding.  The only disease-linked mutation in 
GCAP2 (hG157R GCAP2), (Sato et al., 2005), alters GCAP2 subcellular distribution 
in vivo, which likely explains its toxicity (López-del Hoyo et al., 2014). 
3.2. Results 
3.2.1. Study of the molecular determinants of GCAP1 subcellular 
distribution in vivo. 
In order to study the molecular determinants of GCAP1 subcellular 
distribution in vivo, we expressed the wildtype GCAP1 protein and selected mutants 
as transient transgenes in the rods of GCAP1/GCAP2 knockout mice.  Transgene 
expression vectors were based on the Mouse Opsin Promoter (MOP, 4.4-Kb 
version).  The expression cassette consisted of the MOP, the human GCAP1 cDNA 
and the mouse protamine polyadenylation sequence.  Plasmids were injected in the 
subretinal space in newborn pups and transfected by in vivo DNA electroporation 
(see Methods). 
Transgenic expression of wildtype GCAP1 in rods resulted in a GCAP1 
distribution between the inner and outer segment of 50:50% (Figure III.1B).  This 
percentage of GCAP1 distribution to rod outer segments was calculated from the 
analysis of GCAP1 signal distribution in 17 individual cells (Appendix I Figure 2, 
and Figure III.1.M), where rhodopsin staining was used to label the rod outer 
segment layer.  This pattern of localization reproduced the pattern of endogenous 
GCAP1 localizacion in murine rods (López-del Hoyo et al., 2012).  
To assess whether the myristoyl group at GCAP1 NH2-terminus is required 
for GCAP1 distribution to rod outer segments in vivo, we expressed the mutant G2A-
GCAP1.  This mutant was massively retained at the inner segments, with its 
distribution to rods precluded, (Figure III.1.E-F).  This protein distribution was 
consistent in 13 individual cells analyzed (Appendix I Figure 2, Figure III.1.M).  This 
result indicates that myristoylation of GCAP1 is required for its distribution to rod 
outer segments in vivo. 
To address whether GCAP1 localization to rods depends on GCAP1 direct 
binding to RetGC1, we expressed a mutant form of GCAP1 impaired at RetGC1 
binding.  A recent structure-function analysis of GCAP1 established a fine mapping 
of the residues involved in binding to RetGC1, at the target binding surface of 
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GCAP1.  The residues involved in binding are located at EF-hand 1 (Tyr-22, Lys-
23, Lys-24, Met- 26, Glu-28, Pro-30, Ser-31, Gly-32, Tyr-37, and Glu-38) and EF-
hand 2 (Phe-73, Met-74, Val-77, and Ala-78) (Lim et al., 2013; Peshenko et al., 
2014).  Lys23 is one of the key residues at the binding interface, and its mutation to 
aspartic acid precludes GCAP1 binding to RetGC1.   Therefore we expressed K23D-
GCAP1 as a transgene in rods.  Similar to G2A-GCAP1, the K23D-GCAP1 mutant 
accumulated at the inner segment, and failed to be transported to rod outer segments 
(Fig1 H, I). This observation was made in 13 individual cells (Appendix I Figure 3). 
This result provides the first demonstration that GCAP1 must be assembled with 
RetGC1 at the inner segment compartment in order to be transported to the outer 
segment.  Curiously, it also excludes the possibility that GCAP1 diffuses freely in 
the cytosolic space between the inner and outer segment compartments. 
Is GCAP1 activation of the cyclase required for its transport to rod outer 
segments?  The aforementioned structure-funtion study established that GCAP1 
binding to RetGC is needed but not sufficient for its activation.  RetGC1 acts as a 
dimer, and a fully active cyclase domain requires the dimerization of this domain. 
The binding of GCAP1 enhances the dimerization of the cyclase domain, but primary 
binding itself is not sufficient for activation.  Some important secondary interactions 
or allosteric effects are provided in a second step once the complex with the cyclase 
is formed.  Three residues that are localized in the patch that conforms the target 
binding surface, M26, K85 and W94, have shown to be important for this second 
step.  Mutations in these key residues are able to bind to RetGC, but not able to 
activate it (Peshenko et al., 2014).  We transfected W94A-GCAP1 into rods, and 
observed that its pattern of localization reproduced that of the wildtype protein 
(Figure III.1.K-L), in ten individual cells (Figure III.1.M and Appendix I Figure 3). 
Taken together, our results show that GCAP1 distribution to rods does not 
take place by simple diffusion.  GCAP1 transport to rods depends on GCAP1 binding 
to retGC1, although this binding does not involve RetGC1 activation.  Strikingly, 
myristoylation of GCAP1 is required for this transport, which suggests that 
myristoylation of GCAP1 might trigger the binding of a myristoyl-binding protein 
required for some step in the trafficking process (e.g. the extraction of GCAP1 from 
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3.2.2. Molecular determinants of GCAP2 subcellular localization in 
photoreceptor cells. 
Similarly to GCAP1, when GCAP2 was transfected into GCAP1/GCAP2 
knockout rods, it distributed to about 50%:50% between the inner and outer segment 
compartments [mean value of  52.58% ± 3.09 of GCAP2 localization in rod outer 
segment, of the total GCAP2 signal at outer and inner segments], in 16 individual 
cells (Figure III.2.B-C and Figure III.2.M, Appendix I Figure 4).  This mimicked the 
endogenous localization of GCAP2 in wildtype mice (López-del Hoyo et al., 2014).   
In order to test whether myristoylation of GCAP2 affected its subcellular 
distribution, we transfected rods with G2A-GCAP2.  Abolishing myristoylation of 
GCAP2 did not have the “all or nothing” effect observed for GCAP1.  However, 
GCAP2 distribution to rod outer segments was diminished by 20% in the absence of 
myristoylation, with statistical significance (Figure III.2.E-F, and Figure III.2.M, T-
test P=0.01, 11 and 16 cells analyzed, see Appendix I Figure 4).  Therefore, our 
results point to a facilitation of GCAP2 localization to rod outer segments by the 
myristoyl group, even if not strictly required. 
We could not test whether GCAP2 binding to retGC1 is a prerequisite for its 
trafficking to rod outer segments, because the residues involved in GCAP2 binding 
to RetGC1 have not been mapped.  However, we have previously reported that 
GCAP2 subcellular distribution presents additional regulatory steps, not present in 
GCAP1.  We have reported that in wildtype mice raised under standard 12h dark:12h 
light cycles, about 50% of GCAP2 is phosphorylated at S201.  It is the Ca2+-free 
form of GCAP2 that is phosphorylated more efficiently, and this phosphorylation 
results in 14-3-3 binding, that retains the protein at the inner segments (López-del 
Hoyo et al., 2014).  Our study rigorously demonstrated the phosphorylation of EF-
Figure III.1. Molecular determinants of GCAP1 distribution to rod outer segments 
in vivo. Wildtype and different mutant forms of GCAP1 were expressed as transient 
transgenes in the rods of GCAP1/GCAP2 knockout mice.  Mosaicism results from 
the in vivo DNA electroporation method of transfection.  GCAP1 WT (green signal 
in B-C) distributed 50%:50% between the inner and outer segment compartments. 
G2A-GCAP1 (D-F) and K23D-GCAP1 (G-I) were retained at the inner segment, as 
if their distribution to rod outer segments was precluded . W94A_GCAP1 (J-L) 
reproduced the wildtype localization. In red, rhodopsin mAb1D4. In green, GCAP1 
pAb. M. Percentage of GCAP1 signal at the outer segment compartment (from the 
combined signal at outer and inner segments). Horizontal bars represent mean 
values. Mean±SEM were: WT () 52.86±3.08, n=17; G2A () 6.49±1.08, n=13; 
K23D () 6.47±1.77, n=13; W94A () 48.26±4.06, n=10. T-test was used to 
determine statistical significance versus WT. In G2A mutant and K23D mutant, p-
value <0.0001. 
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GCAP2 (locked in its Ca2+-free conformational state), and how it resulted in protein 
sequestration by 14-3-3 proteins. However, we did not directly prove in our previous 
study that phosphorylation of wildtype GCAP2 causes its retention at the inner 
segment compartment. We here transfected rods with the Ser201Gly and Ser201Asp 
GCAP2 mutants, to study the effect of introducing a negative charge at position 201 
in subcellular localization.  The results show that the constitutive mimic of the 
phosphorylated form S201D-GCAP2 is retained at the inner segments (Figure 
III.2.H-I), while S201G-GCAP2 is not (Figure III.2-K, L). Taken together, these 
results are perfectly consistent with the model of GCAP2 subcellular localization 
that we have previously proposed (López-del Hoyo et al., 2014), but also point to 
the myristoyl group facilitating GCAP2 distribution to rod outer segments, likely by 







Figure III.2. Molecular determinants of localization of GCAP2. Wildtype and mutant 
GCAP2 constructs were used to transfect the rods of GCAP1/2 knockout mice.  
GCAP2 WT (B-C) distributed between the inner and outer segment compartments to 
about 50%:50%. G2A-GCAP2 (E-F) distribution to rod outer segments diminished 
by 20%, but was not completely impaired. S201D-GCAP1, a constitutive mimick of 
phosphorylated GCAP2 was mainly retained at the inner segments (H-I), while 
S201G-GCAP2 (G-I) reproduced the wildtype localization. In red, rhodopsin mAb 
1D4, in green, GCAP2 pAb. M. Percentage of signal at rod outer segments 
(expressed as a fraction of the combined signal in outer and inner segments). 
Horizontal bars represent the mean. Values Mean±SEM. WT () 52.58±3.09, n=16; 
G2A () 41.63±1.68, n=11; S201D () 6.99±2.75, n=9; S201G () 48.01±3.18, 
n=15. T-test was used to determine statistical significance versus WT. In G2A 
mutant, p-value <0.01; in S201D mutant, p-value <0.0001. 
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 3.2.3. Subcellular localization of CORD mutation P50L-GCAP1 
More than ten mutations in GUCA1A encoding GCAP1 have been linked to 
autosomal dominant cone rod dystrophy (adCORD) (Dell’Orco et al., 2014; 
Kamenarova et al., 2013; Newbold et al., 2001; Nishiguchi et al., 2004; Palczewski 
et al., 2004).  Most mutations decrease the Ca2+ binding affinity of the protein, either 
directly or indirectly, ultimately resulting in an alteration of the Ca2+ sensitivity of 
cyclase activity.  Mutations mostly result in constitutive activation of the cyclase 
catalytic activity in most of the physiological range of Ca2+ concentrations.  
However, P50L-GCAP1 is an exception.  This mutation does not appear to affect the 
GCAP1 Ca2+ regulation of guanylate cyclase activity in vitro (Newbold et al., 2001).  
Due to its localization towards the NH2-terminal part of the protein, near the binding 
surface with RetGC1, we set to examine the effect of this mutation in GCAP1 
subcellular localization in vivo.  
P50L-GCAP1 was transient expressed as a transgene in the rods of GCAP1/2 
knockout mice.  The analysis of these mice showed that the P50L mutation did not 
affect GCAP1 subcellular distribution.  P50L-GCAP1 showed a subcellular 




 3.2.4. An autosomal dominant Retinitis Pigmentosa mutation in GUCA1B 
encoding GCAP2 affects its subcellular distribution. 
Only one mutation has been described in the GUCA1B gene encoding 
GCAP2: hG157R.  It has been linked to autosomal dominant retinitis pigmentosa 
(Sato et al., 2005).  The pathophysiology of this mutation is currently unknown.  In 
order to study whether this mutation could affect GCAP2 subcellular distribution, 
Figure III.3. Subcellular distribution of P50L-GCAP1. Transient expression of 
P50L-GCAP1 in the rods of GCAP1/2 knockout mice shows a subcellular 
distribution of the mutant (A-C) similar to the wildtype protein. In red, rhodopsin 
mAb 1D4. In green, GCAP1 pAb. D. Percentage of GCAP1 signal at rod outer 
segments (expressed as a fraction of the combined signal in outer and inner 
segments). Horizontal bars represent the mean. Values Mean±SEM. WT () 
52.86±3.08, n=17; P50L () 53.29±3.74, n=9.  
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we expressed the equivalent mutation in the bovine GCAP2 isoform, bG161R-
GCAP2 as a transient transgene in mouse rods of the GCAP1/2 knockout.   
An analysis of the subcellular localization of bG161R-GCAP2 in 32 
independent cells revealed two different populations of transfected cells. 
Approximately a third of analyzed cells (29%) (Figure 4. Group 1) presented a 
subcellular localization that resembled that of the wildtype protein, while near of 
two-thirds (71%) of analyzed cells retained GCAP2 at the inner segment (Figure 
III.4. Group 2).  
This result indicates that the G161R mutation in bGCAP2 (equivalent to 
hG157R) likely conferred the protein a conformational structure that resembled to 
some extent that of the Ca2+-free state.  Based on our previously proposed model of 
GCAP2 distribution, it is likely that this protein was retained at the inner segment by 
constitutive phosphorylation at Ser201 and 14-3-3 binding.  This finding emphasizes 












In this study, we pursued the characterization of the molecular determinants 
of subcellular localization of Guanylate Cyclase Activating Proteins GCAP1 and 
GCAP2 in photoreceptor cells of the retina.  GCAPs are Neuronal Calcium Sensor 
(NCS) proteins that play an important role during termination of the light response 
and light adaptation (Mendez et al., 2001).  GCAPs present 4 conserved EF-hand 
domains for Ca2+-coordination, although EF-hand 1 is not functional at binding 
Ca2+. EF-1 is instead involved in GCAPs binding to RetGC1.  GCAPs are 
Figure 4. Subcellular distribution of bG161R-GCAP2 in transfected rods of 
GCAP1/2 knockout mice. Two different groups of cells could be distinguished 
among bG161R-GCAP2 expressing cells. Group 1 (29%) presented a distribution 
that ressembled that of the wildtype protein; while group 2 (71%) presented 
substantial retention of the protein at the inner segment. In red, rhodopsin mAb 
1D4, in green, GCAP2 pAb. D. Percentage of signal at the outer segments 
(expressed as percentage of the combined GCAP2 signal at inner and outer 
segments). Horizontal bar represents the mean. Values Mean±SEM. WT () 
52.58±3.09, n=16; Group1 () 56.89±2.57, n=9; Group2 () 19.16±2.44, n=23. 
p-value <0.0001 
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myristoylated at Gly2 at the NH2-terminus.  In this study we have evaluated whether 
key residues in GCAP1 required for RetGC1 primary binding (K23) or post-binding 
activation (W94) are required for GCAP1 distribution to rod outer segments.  The 
subjacent question was whether GCAPs post-synthesis need to assemble to their 
molecular target at the rod outer segment, RetGC1, in order to be transported to this 
compartment.  We have also evaluated the effect of myristoylation in GCAP1 and 
GCAP2 subcellular distribution.  The study was based on a genetic approach.  We 
expressed the wildtype and mutant proteins as transient transgenes in the rods of 
GCAP1/GCAP2 knockout mice. 
Our results show that K23D-GCAP1 fails to be transported to rod outer 
segments, while W94A-GCAP1 presents a normal distribution (Figure III.1).  These 
results constitute the first direct demonstration that GCAP1 needs to bind to retGC1 
at the inner segment, post-synthesis, in order to be transported to rod outer segments.  
Cyclase activation, however, is not required for transportation.  These results are 
consistent with previous indirect reports that GCAP1 and GCAP2 fail to be 
transported to rod outer segments in the absence of a functional RetGC, in the 
RetGC1/2 knockout mice (Baehr et al., 2007; Karan et al., 2010) or the rd3 mice 
(Azadi et al., 2010).  Therefore, we can conclude that the RetGC1/GCAP1 complex 
is assembled at the inner segment and is transported as a complex.  This transport is 
expected to rely on polarized vesicular trafficking.  Our results are also consistent 
with previous studies in that it discards free passive diffusion of GCAP1 and GCAP2 
between the inner and outer segment compartments.     
By expressing G2A-GCAP1 and G2A-GCAP2 in rods, we have observed that 
precluding the myristoylation of GCAPs in vivo had a substantial effect on their 
subcellular localization.  Unmyristoylated GCAP1 was substantially retained at the 
inner segment (Figure III.1).  Unmyristoylated GCAP2 distributed to rod outer 
segments, although to a lesser extent than the myristoylated protein (20% less in 
G2A-GCAP2 versus GCAP2, Figure III.2).  This effect of the myristoyl group in 
vivo came as a surprise. The resolved structure of GCAP1 shows that the myristoyl 
group, attached to NH2-terminal Gly2, is permanently buried inside a hydrophobic 
pocket in the protein, independently of the Ca2+-bound state (Lim et al., 2013).  
GCAP1 and GCAP2 do not exhibit the “Ca2+-myristoyl switch” reported for 
recoverin (J. Hwang and Koch, 2002; I. V. Peshenko et al., 2012).  In recoverin, the 
fatty acid is extruded from the hydrophobic pocket in response to Ca2+ binding, and 
contributes to membrane attachment (Ames et al., 1997; J. Hwang and Koch, 2002). 
In contrast, crystallographic and NMR studies have documented that the myristoyl 
group in GCAP1 and GCAP2 is maintained inside the hydrophobic pocket both in 
the “inhibitory” and the “activator” states, not being exposed (Lim et al., 2013; 
Stephen et al., 2007).  Recently it has been proposed that the myristoyl group in 
GCAP1 serves to adjust the Ca2+-binding affinity and the extent of cyclase 
activation by establishing a dynamic connection between the two semiglobullar parts 
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of the protein, that link conformational changes driven by Ca2+-binding at EF-4, to 
changes at the RetGC recognition surface in GCAP1 (Lim et al., 2013; Peshenko et 
al., 2014).  The apparent affinity of myristoylated GCAP1 for RetGC was determined 
to be 5-fold higher than that of unmyristoylated GCAP1, using a RetGC activation 
assay (I. V. Peshenko et al., 2012).  
Our result that unmyristoylated GCAP1 is mostly retained at the inner 
segment might be interpreted in two ways:  i) that unmyristoylated GCAP1 shows a 
very diminished binding affinity for RetGC1, and therefore it is the binding to 
RetGC1 that fails; and ii) that the myristoyl group mediates an as-yet-undescribed 
additional step in polarized membrane trafficking: e.g. by involving the role of a 
lipid-binding protein such as UNC119 (Figure III.5).  This putative intermediate step 
Figure III.5. Model of vesicular transport of GCAP1. Newly synthetized and 
myristoylated GCAP1 could:   i) directly bind to RetGC or ii) be anchored to a 
sorting membrane compartment from where it would be extracted by an acyl-
binding protein (i.e. UNC119) prior to its binding to RetGC at the vesicular 
membrane. 
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could serve to extract GCAP1 from a sorting membrane organelle in the secretory 
pathway, that may define its destination (Figure III.5).  Future experiments will be 
addressed to distinguish between these two possibilities.  We will determine the 
difference in the dissociation constant of myristoylated and unmyristoylated GCAP1 
for RetGC1, by measuring the steady state binding of recombinant proteins by 
Surface Plasmon Resonance (SPR).  On the other hand, we will investigate whether 
myristoylated GCAP1 binds to UNC119 (identified in our proteomic databases from 
GCAP1 pull-down assays) in vitro and in vivo.  
Interestingly, there are similitudes and differences in the mechanisms 
determining the subcellular distribution of GCAP1 and GCAP2 in photoreceptor 
cells.  We could not address whether GCAP2 requires its binding to RetGC1 for its 
transport to the rod outer segment, because its RetGC1 binding surface has not been 
characterized in detail (Ames et al., 1999).  Previous studies indirectly point to the 
requirement of GCAP2 association to RetGC1 for its transport to rod outer segments 
(Baehr et al., 2007; Karan et al., 2010).  The effect of precluding myristoylation in 
GCAP2 was much less than in GCAP1.  Biochemical studies have determined that 
myristoylation of GCAP2 has only a minor effect on Ca2+ binding affinity and the 
extent of cyclase activation, compared to GCAP1 (J.-Y. Hwang and Koch, 2002; J. 
Hwang and Koch, 2002).  The myristoyl in GCAP2 may serve to thermally stabilize 
the protein (Schröder et al., 2011).    
Importantly, GCAP2 subcellular distribution is regulated by phosphorylation.  
In wildtype mice reared in standard cyclic light, 50% of GCAP2 is phosphorylated 
at Ser201. This phosphorylation triggers the binding of 14-3-3 proteins, that 
sequester the protein at the inner segment.   GCAP2 is preferentially phosphorylated 
in its Ca2+-free conformation (predominant in light-adapted states).  In this study, 
we further validate this model of regulation, by showing that a mutant that is a 
constitutive mimic of phosphorylated GCAP2 at position 201 (Ser201Asp-GCAP2) 
is retained at the inner segment.  Simply precluding phosphorylation at this position 
(Ser201Gly) results in an inner:outer segment distribution of 50%:50% similar to the 
wildtype protein.  This is consistent with our previous interpretation that the maximal 
distribution to the rod outer segment of GCAP2 is about 50% (López-del Hoyo et 
al., 2014).  
A mutation in GUCA1B encoding GCAP2 has been linked to retinitis 
pigmentosa, hG157R (Sato et al., 2005). This residue is localized in EF-hand 4, and 
is therefore expected to diminish GCAP2 Ca2+ binding affinity. This reduced Ca2+ 
sensitivity of guanylate cyclase regulation could result in constitutive cyclase 
activity at the physiological range of calcium concentrations as the basis of the 
pathology. However, we have reported that a GCAP2 mutant blocked in its Ca2+-
free conformation fails to be transported to the rod outer segments, leading to a 
severe retinal degeneration by a mechanism that is independent of cyclase activation.  
Toxicity in this case results from EF-GCAP2 accumulation at the inner segment, and 
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is independent of cGMP metabolism (López-del Hoyo et al., 2014).  We here show 
that the equivalent bovine mutation to hG157R (bG161R) causes retention of 
GCAP2 at the inner segment in 71% of transfected photoreceptors.  In about 29% of 
transfected rods GCAP2 distributes normally.  The two different populations of 
bG161R-GCAP2 transfected cells might result from variability of GCAP2 
expression levels among cells.  For some reason, GCAP2 expression levels have 
been shown to vary significantly from cell to cell, in previous genetic studies 
(Makino et al., 2012; Mendez et al., 2001).  Ultimately our result shows that the 
human mutation leads to GCAP2 retention at the inner segment in a high fraction of 
cells, and we have already demonstrated that its accumulation at this compartment 
in an unstable conformation results in severe toxicity.  We are currently investigating 
the molecular basis of this toxicity.  
In this study we have also analyzed the effect of P50L-GCAP1 mutation on 
subcellular distribution.  The reason is that P50L is the only characterized mutation 
in GCAP1 that does not result in a significative change in Ca2+ sensitivity of 
guanylate cyclase activity, and constitutive cGMP synthesis.  We reasoned that it 
could affect protein trafficking, and lead to toxicity by accumulating at the wrong 
compartment.  However, transgenic expression of P50L-GCAP1 in rods resulted in 
normal distribution.  Therefore, we conclude that the P50L mutation in GCAP1 does 
not affect its subcellular distribution. 
Taken together, our results show that the RetGC/GCAPs complex is 
assembled at the inner segment, and transported to the rod outer segment as a protein 
complex.  This initial study sets the ground to investigate the mechanisms regulating 
the assembly, transport and in vivo regulation of the RetGC/GCAPs, a central protein 
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Chapter IV: Unanticipated interaction between IMPDH1 
and RetGC1 proteins associated to blindness. 
Contributions 
I cloned all mutants of IMPDH1, stablished protocols for expression and 
purification of recombinant proteins IMPDH1 and RetGC, isolated bovine ROS for 
proteomic and biochemical studies and performed such studies (proteomic data 
analysis, pull-down and immunoprecipitation of IMPDH1 and GCAP1, size-
exclusion chromatography, and Surface Plasmon Resonance (SPR)).  
Antibodies against IMPDH1 and RetGC1, expression and purification of 
MBP-RetGC1 fusion fragments proteins for SPR and Pull-down; immunostaining 
figures IV.4 & 5, acquisition, together Jordi Andilla at ICFO (Institute of photonic 
sciences), and quantification of figure IV.5 were performed by Anna Plana.  
We acknowledge the assistance of Dr. Marta Taulés at the molecular 
interaction analysis facility of CCiTUB with the Surface Plasmon Resonance (SPR, 
Biacore) system as well as her assiatnce in the interpretation of the results. We kindly 
aknowlege the implication of Dr. Josep Maria Estanyol and Dr. Maria José Fidalgo 
at the Proteomic facility of CCiTUB in the processing of the different samples by 
LC-MS/MS and their guidance with data analysis. 
My contribution to this Chapter was the cloning of all expression vectors for 
the different recombinant proteins, establishing the protocols for purification of 
GCAP1, GCAP2, RetGC1 and IMPDH1, the isolation of bovine rod outer segment 
preparations for pull-down assays and biochemical studies, and the presented 
GCAP1 pull-down assays, crossed immunoprecipitation protocols, size-exclusion 
chromatography experiments and Surface Plasmon Resonance analysis.  In addition, 






































  Results: Chapter IV 
109 
Chapter IV: Unanticipated interaction between IMPDH1 and RetGC1 
proteins associated to blindness. 
4.1. Rationale 
Inherited retinal dystrophies, that affect 1 in 4000 individuals, are 
characterized by a vast clinical and genetic heterogeneity.  Gene defects might 
primarily affect rod function and lead to retinitis pigmentosa (RP); cone function and 
cause cone-rod dystrophies (CORD) or macular degeneration (MD); or both types 
of photoreceptors in a severe form of inherited blindness manifested in early 
childhood (Leber congenital amaurosis, LCA).  These disorders have autosomal 
recessive, autosomal dominant or X-linked patterns of inheritance and are 
genetically and functionally very diverse.  Retinitis pigmentosa is caused by 
mutations in over 58 different genes; cone-rod dystrophies by mutations in 19 genes, 
while 24 different genes have been linked to LCA (www.sph.uth.tmc.edu/RetNet).  
Mutations may affect genes encoding signaling proteins directly or indirectly 
involved in the light response, regulators of gene expression, chaperones, trafficking 
proteins or structural proteins required for photoreceptor development and viability 
(Daiger et al., 2015; den Hollander et al., 2008; Stone, 2007).  This genetic and 
functional diversity has hampered the study of these disorders.  An in-depth 
comprehension of the physiological pathways in which these proteins are involved 
would allow to group them according to common signaling pathways or cellular 
processes, and greatly assist in the design of novel therapies.  
One such functional group is constituted by the proteins involved in cyclic 
guanosine 3´,5´-monophosphate (cGMP) metabolism.  Cyclic GMP is the second 
messenger in visual transduction.  Light sets in motion an enzymatic cascade that 
ultimately results in hydrolysis of cGMP, a reduction of cGMP levels, closure of the 
cGMP-gated channels at the plasma membrane (permeable to Na+ and Ca2+) and 
the hyperpolarization of the cell, which is the signal transmitted to higher order 
neurons (Burns and Arshavsky, 2005).  Free cGMP levels therefore determine the 
transmembrane potential of rods and cones at any moment.  At any illumination 
condition, cGMP levels are determined by the rate of synthesis by guanylate cyclases 
and the rate of hydrolysis by cGMP-phosphodiesterase (PDE6) (Gross et al., 2015, 
2012).  The enzymes responsible for cGMP synthesis in human photoreceptors are 
retinal guanylate cyclases RetGC1 and RetGC2 (also known as GC-E and GC-F), 
with RetGC1 being the more abundant isoform in rods and cones and the one 
relevant for disease (Lowe et al., 1995; Peshenko et al., 2011; Shyjan et al., 1992; 
Sokal et al., 2003; Yang et al., 1995).  Specific subtypes of PDE6 are responsible for 
cGMP hydrolysis in rods and cones (Bender and Beavo, 2006; Gillespie and Beavo, 
1988).   
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Mutations that cause alterations in the levels of cGMP are very deleterious for 
photoreceptor cells.  Autosomal recessive mutations in the GUCY2D gene encoding 
RetGC1 have been linked to Leber Congenital Amaurosis type I (LCA1), accounting 
for 6-12% of LCA cases in the USA and Northern Europe (Jacobson et al., 2013; 
Perrault et al., 1996).  Loss-of-function mutations in RetGC1 are thought to impair 
visual transduction by causing the closure of cGMP-channels due to the lack of 
cGMP synthesis (Baehr et al., 2007).  LCA1 is considered an “equivalent-light” 
disorder because visual impairment and progressive cellular damage are thought to 
result from the permanent closure of the channels and ensuing hyperpolarization of 
the cell, which is much the same situation that results from excessive or prolonged 
light exposure (Fain, 2006).  The physiopathology underlying LCA12 caused by 
mutations in RD3 is likely to be very similar, since RD3 has been shown to be 
required for RetGC1 stability and transport to the outer segments (Azadi et al., 2010; 
Molday et al., 2013).  
On the other hand, mutations in other loci that result in abnormally elevated 
levels of cGMP are also deleterious for photoreceptor cells.  The enzyme responsible 
for cGMP hydrolysis in rods is the heterotetrameric phosphodiesterase 6 (PDE6), 
made up of an alpha, a beta and two gamma subunits (Bender and Beavo, 2006). The 
genes PDE6B and PDE6A encoding PDEα and PDEβ were the second and seventh 
loci identified as associated to arRP (Huang et al., 1995; McLaughlin et al., 1993); 
and mutations in PDEG encoding PDEγ were subsequently described (Dvir et al., 
2010).  Naturally occurring or gene-targeted strains of mice functionally deficient in 
PDE6B, PDE6A or PDE6G have revealed that abnormally high cGMP levels 
underlies the retinal degeneration in these scenarios (Bowes et al., 1990; Farber, 
1995; Sakamoto et al., 2009; Tsang et al., 1996).  That is, mutations in any subunit 
of PDE6 that ultimately impair light-stimulated cGMP hydrolysis lead to an increase 
of cGMP levels that results in cell damage.  The same phenotype results from arLCA 
and adCD-associated mutations in aryl hydrocarbon receptor interacting protein like-
1 (AIPL1), a photoreceptor specific protein required for the stability, assembly and 
membrane association of PDE in rods and cones (Kolandaivelu et al., 2009; 
Ramamurthy et al., 2004).  Elevated cGMP levels are predicted to be deleterious for 
cones as well.  Mutations in PDE6C and PDE6H encoding the cone-specific α and γ 
subunits of PDE6 have been linked to autosomal recessive cone dystrophy (arCD) 
and achromatopsia, respectively (Kohl et al., 2012; Thiadens et al., 2009).  Although 
not functionally demonstrated in vivo, the mutations are predicted to decrease cone 
PDE activity and trigger a pathophysiological mechanism similar to that affecting 
rods (Chang et al., 2009).  Gain-of-function mutations in GUCY2D gene encoding 
RetGC1 and GUCA1A gene encoding guanylate cyclase activating protein 1 
(GCAP1) have also been reported, linked to adCORD (Hunt et al., 2010; Payne et 
al., 1998; Wilkie et al., 2000).  Most of these mutations lead to constitutive activity 
of the cyclase in vitro, and to accumulating levels of cGMP in rod outer segments 
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when expressed in animal models (Olshevskaya et al., 2004; Sokal et al., 1998; 
Woodruff et al., 2007).  In brief, mutations in nine different genes have been 
identified that cause inherited retinal dystrophies by altering the cGMP levels, which 
leads to severe toxicity in rods and/or cones.  Regulation of cGMP metabolism is 
vital for rod and cone photoreceptors. 
An additional gene involved in guanine nucleotide metabolism has been 
linked to blindness: IMPDH1, encoding inosine monophosphate dehydrogenase 1.  
This enzyme catalyzes the rate-limiting step in de novo GTP synthesis by converting 
inosine monophosphate (IMP) to xanthosine monophosphate (XMP) with the 
reduction of NAD.  Mutations in IMPDH1 linked to adRP10 were identified in 2002 
from a large family from Spain [Arg224Pro, (Kennan et al., 2002)] and two 
American and one British families [Asp226Asn, (Bowne et al., 2002)], and together 
account for 5-10% of adRP cases (Tam et al., 2008).  Mutations R105W and N198K 
were later linked to rare adLCA (Bowne et al., 2006b).  Three of these mutations 
map at the CBS -“similar to cystathione-b-synthase gene”- structural domain of the 
protein, that is dispensable for catalytic activity and whose function is unclear.  
IMPDH1 mutations are expected to have a “gain-of-function” rather than “loss-of-
function” phenotype, since the IMPDH1 presents only a mild retinopathy (Aherne et 
al., 2004).  Despite IMPDH1 conservation and ubiquity, the clinical manifestations 
of missense mutations in IMPDH1 are limited to the retina.  IMPDH1 gene 
expression analysis has revealed retinal-specific transcripts generated by alternative 
splicing and alternative start sites of translation (Bowne et al., 2006a); and structural 
and biochemical characterization of IMPDH1 unveiled its capacity to bind single-
stranded nucleic acids (McLean et al., 2004) and its tendency to aggregate (Aherne 
et al., 2004).  However, the specific or distinctive function of IMPDH1 in 
photoreceptor cells that underlies the pathophysiology in adRP10 and adLCA 
remains unclear.     
In this study we show an unanticipated association of IMPDH1 with the 
RetGC1/GCAPs complex responsible for cGMP synthesis at the outer segment of 
photoreceptor cells.  We prove that there is a direct interaction between RetGC1 and 
IMPDH1 in the micromolar range of affinity that requires the dimerization domain 
of RetGC1 and is modulated by the CBS domain of IMPDH1.  This interaction is 
affected by IMPDH1 mutations linked to adRP10 and arLCA.  This study outlines 
the RetGC1/GCAPs complex as part of a multienzyme complex comprising enzymes 
in de novo synthesis of GTP, setting a new scenario for the interpretation of IMPDH1 
and RetGC1 mutations linked to inherited retinal dystrophies.    
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4.2. Results 
4.2.1. A search for new GCAP1 binding proteins revealed new interactors of 
the RetGC1/GCAPs complex responsible for cGMP synthesis in rods and 
cones. 
A proteomic approach was originally devised to identify new molecular 
targets of the calcium sensor protein GCAP1 in photoreceptor cells, in order to 
expand our understanding of the integrated Ca2+-mediated adaptation response to 
light, a fundamental process in photoreceptor cell physiology.  To that goal, a 
recombinant form of GCAP1 fused to a Histidine tag was expressed in bacteria, 
purified, and covalently linked to magnetic beads.  Pull-down assays were performed 
from bovine rod outer segment preparations (bov ROS) solubilized in 1% Triton 
X100.  Parallel pull-down assays were performed under Ca2+ or EGTA conditions, 
to identify proteins with preferential affinity for the Ca2+-bound or Ca2+-free form of 
GCAP1 (Figure IV.1). Bound proteins in both conditions were identified by liquid 
chromatography and mass spectrometry and subjected to label-free quantitative 
analysis.  For each identified protein, the equation in Figure IV.1 determined the 
fold-change ratio in relative abundance in the two experimental conditions, based on 
the spectral count ((Old et al., 2005), see Methods).  The distribution of fold-change 
values in the Ca2+ versus EGTA condition is shown in the scatter plot in Figure IV.1, 
in which dots represent individual proteins in alphabetical order.  Only those proteins 
that were unequivocally assigned based on unique peptides were considered (332 
proteins, Table IV.I).  Nearly 80% of these proteins were found in the -3 to +3 -fold-
change range (light shaded area, Figure IV.1).  These included the highly abundant 
cytosolic proteins that typically constitute the background in proteomic analysis:  
glycolytic enzymes (e.g. GAPDH, pyruvate kinase), cytoskeletal proteins (e.g. actin, 
spectrin, tubulin, vimentin), chaperones, ribosomal proteins and keratins.  Highly 
abundant proteins in bov ROS, such as the visual pigment rhodopsin, the cGMP-
gated channel, cGMP-phosphodiesterase, rhodopsin kinase, arrestin, phosducin and 
other signaling proteins in the light response were also identified in this range.  
However, many of these proteins were also identified with similar spectral counts in 
a negative control pull-down assay performed with Ran, a soluble protein of a similar 
size to GCAP1 (data not shown).  Therefore, most proteins in this range were not 
considered for further analysis in this study, despite the fact that the bonafide GCAP1 
molecular target, retinal guanylyl cyclase 1 (RetGC1), was also found in this group 
[27 peptides (35 spectra) in the Ca2+ condition; 16 peptides (18 spectra) in the EGTA 
condition, fold-change of 0.18].  We here focused on proteins that bound 
preferentially to one of the conformational states of GCAP1.  
We found 37 proteins with a fold-changeCa2+/EGTA > 3 (scatter plot in Figure 
1).  These proteins that showed a clear preference for the Ca2+-bound form of GCAP1 
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are listed in Table IV.1.  On the other side, 34 proteins showed a fold-changeCa2+/EGTA 
< -3, Table IV.2.  These tables include the spectral counts in the negative control 
pull-down with Ran under identical Ca2+ or EGTA conditions.  While the proteins 
that preferentially bound the Ca2+-empty (Mg2+-bound) form of GCAP1 were mostly 
identified in the control pull-down, most of the proteins that showed preferential 
binding affinity for the Ca2+-bound form of GCAP1 appeared highly specific.  As a 
sample, heat shock protein 90 alpha (HSP90α) was identified with 33 peptides (53 
spectra); creatine kinase B (CKB) with 19 peptides (114 spectra); and annexin A6 
(ANXA6) with 23 peptides (30 spectra); while none of these proteins were identified 
in the control pull-down assay under the same Ca2+ conditions.  Interestingly, we 
found several proteins known to play essential roles in photoreceptor cell 
physiology.  For instance, we identified four of the eight subunits of the Chaperonin 
Containing TCP-1 complex (CCT, also called TCP-1 Ring Complex, TriC), that is 
known to be required for the morphogenesis of the rod outer segment compartment 
(Posokhova et al., 2011), which points to a role of this complex on the assembly of 
the RetGC1/GCAPs complex .  We also found five proteins associated to Bardet-
Biedl Syndrome (BBS), a disorder affecting 1/100.000 individuals caused by defects 
in primary cilia biogenesis, that curses with retinal dystrophy in addition to deafness, 
obesity, diabetes and polydactyly (Sheffield, 2010).  The identified proteins BBS2, 
BBS4, BBS7 and BBS9 (Table I) form part of the BBSome, a conserved protein 
complex found within primary cilia enriched at the ciliary base and presumably 
involved in ciliary protein trafficking, while Leucine zipper transcription factor-like 
1 (LZTFL1, Table IV.1) is a BBSome-interacting protein that regulates ciliary 
localization of the BBSome. These results point to the BBSome involvement in 
RetGC1/GCAP1 ciliary trafficking. . 
Most interestingly, three proteins involved in de novo synthesis of GTP were 
identified robustly in a highly specific manner:  inosine monophosphate 
dehydrogenase 1 (IMPDH1: 18 peptides, 24 spectra); guanylate kinase 1 (GUK1, 11 
peptides, 24 spectra) and the bifunctional purine biosynthesis protein PURH (ATIC 
gene, 19 peptides, 20 spectra).  
In this study we focused on the characterization of IMPDH1 association to the 
RetGC1/GCAP1 complex because mutations in IMPDH1, the enzyme that catalyzes 
the rate-limiting step in de novo synthesis of GTP, have been linked to very severe 
inherited retinal dystrophies for more than ten years, of so far unclear 
pathophysiology.  
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Figure IV.1. Identification of GCAP1 binding partners by pull-down assays 
followed by liquid chromatography and mass spectrometry. A. Sketch of the 
procedure.  Recombinant GCAP1 was cross-linked to Epoxi Dynabeads, and 
parallel pull-down assays were performed from bov ROS solubilized in 1% Triton 
X100, under Ca2+ or EGTA conditions.  Elution fractions were subjected to liquid 
chromatography and mass spectrometry (LC-MS/MS) analysis.  Proteomic 
databases were filtered so that only proteins with at least a unique peptide were 
retained.  A label-free quantitative comparative analysis was performed between 
Ca2+ and EGTA samples, according to(Old et al., 2005), by applying the equation 
shown, where, for each protein, RSC (Ratio from Spectral Count) is the log2 ratio of 
abundance between Samples 1 (Ca2+) and 2 (EGTA); n1 and n2 are spectral counts 
for the protein in Samples 1 and 2, respectively; t1 and t2 are total numbers of spectra  


















over all proteins in the two samples; and f is a correction factor set to 0.5.  B. 
Scatter plot of RSC-Ca2+/EGTA (Fold-change Ca2+/EGTA) for the list of proteins identified 
in both samples.  Each dot represents an individual protein, in alphabetical order 
of protein identifier.  Its position represents the preference for the Ca2+-bound 
form or the Ca2+-free form of GCAP1.  Protein identifiers are shown for proteins 
at very high and very low fold-change values: ANXA6, annexin A6; ATIC, 5-
aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP 
cyclohydrolase; CKB, creatine kinase B; GUK1, Guanylate Kinase 1; HSP90α, 
Heat Shock Protein 90 alpha; IMPDH1, inosine monophosphate dehydrogenase 1; 
GABARAPL2, Gamma-aminobutyric acid receptor-associated protein-like 2; 
Hnrnpm, Heterogeneous nuclear ribonucleoprotein M; INA, alpha-internexin; 
NEFL, neurofilament light polypeptide; RP1, Retinitis Pigmentosa 1. 
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Table IV.1. Proteins identified by LC-MS/MS in GCAP1 pull-down assays from bovine 
rod outer segment preparations in Ca2+ or EGTA conditions, that show a higher affinity 
for the Ca2+-bound form of GCAP1 
 
 































Protein 90 α 
Q76LV2 HSP90AA1 5.99 53 33 0 0 0 0 
Creatine Kinase B Q5EA61 CKB 5.53 114 19 1 1 0 0 




Q62188 Dpysl3 5.02 27 16 0 0 0 0 
Inosine -5´-
monophosphate 
dehydrogenase  1 
A0JNA3 IMPDH1 4.85 24 18 0 0 0 0 













Q9CWF6 Bbs2 3.98 13 9 0 0 2 2 




Q3SYU2 EEF2 3.98 13 13 0 0 0 0 
T-complex protein 
1 theta 
Q3ZCI9 CCT8 3.98 13 13 0 0 0 0 




Q28139 SLC24A1 3.87 12 10 0 0 3 2 
Retinaldehyde 
binding protein 1 
P10123 RLBP1 3.75 11 10 0 0 1 1 
Calmodulin P62157 CALM 3.62 10 8 0 0 0 0 





A4FUG8 RABEP2 3.48 9 9 0 0 0 0 
T-complex protein 
1 beta 
Q3ZBH0 CCT2 3.48 9 9 0 0 0 0 





















Q3ZBD7 GPI 3.32 8 6 0 0 0 0 





Q3ZBL4 LZTFL1 3.32 8 7 0 0 0 0 
Phosphoglycerate 
kinase 1 
Q3T0P6 PGK1 3.32 8 8 0 0 0 0 
Retinoid 
isomerohydrolase 
Q28175 RPE65 3.32 8 6 0 0 0 0 
T-complex protein 
1 gamma 





e subunit alpha' 
P16586 PDE6C 3.20 23 21 1 1 0 0 
Syntaxin-binding 
protein 1 
P61763 STXBP1 3.18 53 28 3 3 0 0 




   
Q29460 PAFAH1B3 3.13 7 6 0 0 0 0 
Aspartyl
aminopeptidase 
Q2HJH1 DNPEP 3.13 7 7 0 0 0 0 
T-complex protein 
1 subunit δ 





Q5BIN5 PIN1 3.13 7 4 0 0 0 0 
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Table IV.2:  Proteins identified by LC-MS/MS in GCAP1 pull-down assay from bovine 













































Q9D0E1 Hnrnpm -4.24 0 0 5 5 0 0 
Lamin-B1 P14733 Lmnb1 -4.15 1 1 15 13 0 0 
Oxygen-regulated 
protein 1 
Q8MJ05 RP1 -3.95 0 0 4 4 43 27 
Alpha-internexin Q08DH7 INA -3.67 2 2 18 17 34 19 
40S ribosomal 
protein S9 
A6QLG5 RPS9 -3.58 0 0 3 3 0 0 
Partner of Y14 
and mago 




P05632 ATP5E -3.58 0 0 3 2 0 0 
40S ribosomal 
protein S27 










A member 7 
Q3UIL6 Plekha7 -3.58 0 0 3 3 0 0 
RNA-binding 
protein 14 
Q5EA36 RBM14 -3.58 0 0 3 3 0 0 


















P36225 MAP4 -3.15 6 6 33 21 7 6 
Protein lin-7 
homolog C 
Q0P5F3 LIN7C -3.09 1 1 7 5 0 0 
60S ribosomal 
protein L4 
Q58DW0 RPL4 -3.09 0 0 2 2 0 0 




Q28851 ATP5J2 -3.09 0 0 2 2 11 2 
Caskin-1 Q6P9K8 Caskin1 -3.09 0 0 2 2 0 0 
Charged 
multivesicular 
body protein 2a 
Q9DB34 Chmp2a -3.09 0 0 2 2 2 2 
Coatomer subunit 
epsilon 
Q28104 COPE -3.09 0 0 2 2 0 0 
Complement 




Q3T0B6 C1QBP -3.09 0 0 2 1 5 3 
Disks large 
homolog 4 
Q62108 Dlg4 -3.09 0 0 2 2 6 6 
Eukaryotic 
translation 
initiation factor 2 
subunit 1 
P68102 EIF2S1 -3.09 0 0 2 2 0 0 
Eukaryotic 
translation 
initiation factor 2 
subunit 2 
Q5E9D0 EIF2S2 -3.09 0 0 2 2 0 0 
Fibroblast growth 
factor 2 




Q60668 Hnrnpd -3.09 0 0 2 2 0 0 






Q9Z204 Hnrnpc -3.09 0 0 2 2 0 0 
Histone 
deacetylase 4 
Q6NZM9 Hdac4 -3.09 0 0 2 1 0 0 
 
4.2.2. IMPDH1, a protein involved in de novo synthesis of GTP, associates 
with the RetGC1/GCAPs complex in rod outer segment preparations. 
IMPDH1 is the enzyme that catalyzes the rate-limiting step in de novo GTP 
synthesis, by converting inosine monophosphate (IMP) to xanthosine 
monophosphate (XMP). The robust identification of IMPDH1 in the pull-down 
assay with GCAP1 indicates either a direct interaction with GCAP1 or an indirect 
association to GCAP1 by a direct interaction with RetGC1 or some other component 
in the protein complex responsible for cGMP synthesis.  Despite GCAP1 cytosolic 
distribution in the different photoreceptor cell compartments (López-del Hoyo et al., 
2012) and IMPDH1 reported abundance at the inner segments (Bowne et al., 2006a), 
our results pointed to IMPDH1 association with GCAP1 in the photoreceptor outer 
segments, because pull-down assays were performed on bov ROS.   
In order to validate IMPDH1 association to GCAP1 and/or the 
RetGC1/GCAPs complex we performed co-immunoprecipitation assays in bovine 
whole retinal homogenates and bov ROS (Figure IV.2).  Immunoprecipitation of 
GCAP1 led to co-immunoprecipitation of IMPDH1 in bovine retinal homogenates, 
as well as in bov ROS (Figure IV.2A).  Immunoprecipitation of IMPDH1 in whole 
retinal homogenates led to co-immunoprecipitation of RetGC1 (Figure IV.2B), 
although co-immunoprecipitation of GCAP1 could not be detected, likely because 
of anti-IMPDH1 pAb antibodies interfering with the binding surface (not shown).   
To circumvent immunoprecipitation limitations presented by antibody 
binding to the region of protein-protein interaction, we expressed and purified the 
canonical isoform of IMPDH1 in order to perform pull-down assays.  IMPDH1 pull-
down assays from whole retinal homogenates revealed the binding of RetGC1 
(Figure IV.2C).  When bovine ROS were used in IMPDH1 pull-down assays, 
RetGC1 was detected to an even higher extent (Figure IV.2C).  Taken together, these 
results indicate that IMPDH1 associates to GCAP1 and RetGC1 in native tissue. 
To further confirm this protein association in native tissue and to study 
whether it involved any of the other proteins identified quantitatively in the pull-
down assays (e.g. HSP90α and CKB) bov ROS solubilized in 1% dodecyl maltoside 
were fractionated by size exclusion chromatography.  A 3.5µm-bead size column 
with a separation range of 10kDa-1500kDa was used, and collected fractions were 
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resolved by SDS-PAGE (Figure 2D).  RetGC1, IMPDH1 and HSP90α co-localized Figure IV.2.  IMPDH1 is associated to RetGC1/GCAP1 in native retinal tissue. A. 
Co-immunoprecipitation of IMPDH1 with GCAP1 in bovine whole retina 
homogenates (upper panel) and bovine rod outer segments (bov ROS, lower panel).  
I, Input; FT, flow-through; and E, elution fractions. There are five IMPDH1 
isoforms in the retina, that result from alternative splicing or alternative translation 
start sites(Bowne et al., 2006a) appreciated in the input lanes.  B. RetGC1 co-
immunoprecipitates with IMPDH1 in bovine retinal homogenates. C.  Pull-down 
assays with IMPDH1 (canonical bovine isoform) from bovine retinal homogenates 
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at a fraction at minute 10, corresponding to a molecular weight of about 500-600 
kDa.  Although GCAP1 localized mostly at fractions corresponding to its monomeric 
and dimeric forms, it was also detected at the 10min fraction with RetGC1, IMPDH1 
and HSP90α. Besides, it is well known that the interaction of GCAP1 with RetGC1 
is disrupted by detergents.  Other proteins that were identified robustly in the pull-
down assay with a clear preference for Ca2+-GCAP1 (e.g. CKB) did not co-migrate 
noticeably with RetGC1.  This does not necessarily indicate that CKB does not 
associate with the RetGC1/GCAP1 complex, since low affinity or fast kinetic 
interactions could be lost during this process.   
To rule out contamination of  bov ROS preparations with inner segment 
proteins, we incubated the membrane with an antibody against 14-3-3 protein 
isoforms, which are very abundant at the inner segment but excluded from the outer 
segment compartment (López-del Hoyo et al., 2014).  The absence of 14-3-3 
isoforms in the sample indicated that contamination of inner segments in the bov 
ROS was minimal. 14-3-3 isoforms were clearly detected in SEC fractionation 
experiments from whole retinal homogenates (Figure IV.2E).  We also tested 
whether cone outer segments were present in the preparation. Immunodetection of 
blue opsin indicated that our starting material included at least a fraction of cone 
outer segment organelles.  
Taken together, these results show that IMPDH1 associates with the 









 (top) or bov ROS (bottom) reveal the association of RetGC1.  D.  RetGC1, HSP90α 
and IMPDH1 co-elute during the fractionation of bovROS by size-exclusion 
chromatography (3.5µm-bead size column with a separation range of 10kDa-
1500kDa), at the 10min fraction corresponding to 500-600kDa.  Black line, 
chromatogram of the protein standards.  Red line, chromatogram of bov ROS.  E.  
14-3-3 proteins, very abundant at photoreceptor inner segment compartments, are 
detected in SEC fractionation of whole bovine retinal homogenates.  Therefore, their 
absence in bov ROS preparations indicates that inner segment contamination of the 
samples was minimal. 
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4.2.3. IMPDH1 shows preferential localization to rods, being abundant at 
the inner segment but also present at rod outer segment compartments. 
In order to study whether IMPDH1 co-localizes with the RetGC1/GCAPs 
complexes in retinal sections, we generated a rabbit antibody against the 
recombinant canonical form of IMPDH1.  This antibody (pAb) was highly specific 
for IMPDH1.  When assayed on bovine retinal sections, this anti-IMPDH1 pAb 
yielded a specific signal at the photoreceptor cell layers that was much stronger at 
rods than at cones (e.g. Figure IV.3, E-G).  IMPDH1 primarily accumulated at the 
proximal part of the inner segment layer and at the base of the outer segment of rods, 
as well as at the perinuclear region and at the synaptic terminal of rods and cones 
(Figure IV.3).  At the base of rod outer segments, the IMPDH1 signal partially 
overlapped with rhodopsin (Figure IV.3, A-D).  At cones, the most clear co-
localization of IMPDH1 with GCAP1 was observed at the pedicles, whereas 
IMPDH1 signal at the inner and outer segment of cones was much weaker than at 
rods, although perceptible (Figure IV.3, E-H, and N).  At rods, IMPDH1 co-localized 
with GCAP2 mostly at the proximal part of the inner segments, at the base of the 
outer segments and at the synaptic terminals (Figure IV.3, I-L, and O).  When images 
of IMPDH1 staining were acquired in a confocal microscope requiring much less 
light excitation [Leica hybrid detector (HyD)] photobleaching was heavily reduced 
and images could be acquired at a higher zoom, maximizing discernment of 
subcellular detail.  In these images (Figure IV.3, M), IMPDH1 was also observed to 
be enriched at processes stemming from the outer limiting membrane, that we 
attribute to the microvilli of Muller cells, and at connecting ciliums.  
Co-immunolocalization assays of IMPDH1 and RetGC1 could be performed 
with our highly specific polyclonal antibodies (both made in rabbit), by conjugating 
the anti-IMPDH1 antibody with a 488nm-fluorophore.  Images were acquired at 
increasing magnification (Figure IV.4).  When low excitation light was used for 
image acquisition of a frame encompassing all photoreceptor layers, IMPDH1 was 
most abundant at the inner segment layer and outer plexiform layer, and highlighted 
the connecting cilium of cones and rods - two rows of “spikes” - and the microvilli 
of Muller cells (Figure IV.4A).  Consistent with previous reports, RetGC1 staining 
was predominant at the outer segment layer, stronger at cones than at rods (Figure 
IV.4B).  Using a higher excitation light and higher zoom, IMPDH1 enrichment at 
the inner segment layer and connecting cilium was even more evident, but 
immunostaining was also noticeable at the outer segment compartment and the 
nuclei of photoreceptors (Figure 4D).  The anti-RetGC1 antibody stained the outer 
segment compartment of cones and rods (Figure IV.4E).  Co-localization of 
IMPDH1 with RetGC1 at the connecting cilium of several rods and cones appeared 
evident (Figure IV.4F).  A higher zoom framing the outer segment layer showed 
partial co-localization of IMPDH1 and RetGC1 at this compartment (Figure IV.4, 
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G-I), and Supplementary Figure 1.  A colocalization analysis of RetGC1 and 
IMPDH1 restricted to the rod outer segment layer revealed that 71% of IMPDH1 
colocalizes with RetGC1 (SEM=10%, n=4 images, with each image being the 
average of four consecutive planes from the same z-stack, Figure IV.5).   
A hallmark of IMPDH1 immunolocalization staining is the detection of 
subcellular fiber-like structures, characterized in cells in culture (Chang et al., 2015).  
These structures might appear as punctuate and small spicule-shaped structures 
termed “cytoophidia”; or as larger mature structures termed “rods and rings”,  
suggested to form when de novo purine synthesis is positively regulated (Chang et 
al., 2015).  We routinely observe both types of structures in bovine retinal sections, 
typically covering the cytosolic space of rods and scarcely but also present in the 
cytosol of cones (e.g. Figure IV.3E, I).  Whether their formation shows a correlation 
with dark-adaptation or light exposure of the eyes, and their functional implications 
await further studies.   
Collectively, our immunolocalization studies show co-localization of IMPDH1 
and RetGC1 at photoreceptor outer segments, being particularly strong at the 
connecting cilium.   
 
 
Figure IV.3.  Immunolocalization of IMPDH1 in bovine retinal sections.  IMPDH1 
localization was assayed in bovine retinal cryosections by indirect 
immunofluorescence (green signal in A, E, I, M, N, O), that were also stained for:  
rhodopsin at the rod outer segments (B); GCAP1, that highlights cones due to its 
higher level of expression in cones than rods, but present in both cells at the outer 
segment, inner segment and synaptic terminal compartments (F); and GCAP2, that 
highlights rods, with a strong signal at the outer segment, inner segment and 
synaptic terminals (J).  IMPDH1 is present at both rods and cones, with the rod 
signal being much more intense.  It distributes along the whole cytosolic space of 
the cell, being particularly enriched at the inner segment, the base of the outer 
segment at what appears to be the connecting cilium, as well as filamentous 
structures resembling the microvilli of Muller cells, the perinuclear region at the 
outer nuclear layer and the synaptic terminal of rods and cones (A, E, I).  IMPDH1 
co-localizes with rhodopsin at the base of the outer segment (C); with GCAP1 at 
the base of cone outer segments (G) and cone pedicles (N); and with GCAP2 at rod 
inner segments (K) and rod spherules (O).  Image acquisition using a much lower 
excitation light and higher zoom (Leica HyD hybrid detector, Leica SP5 confocal 
microscope) allows a better discernment of stained subcellular processes (M).  
Scale bar is 25µm in A to L, 10µm in M, N and O.  OS, outer segment; IS, inner 
segment; ONL, outer nuclear layer; OPL, outer plexiform layer. 
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Figure IV.4. Analysis of subcellular co-localization of IMPDH1 and RetGC1. 
Immunolocalization of IMPDH1 in bovine retinal cryosections with an anti-
IMPDH1 pAb conjugated with Alexa 488 (green signal); and of RetGC1 with an 
anti-RetGC1 pAb with an anti-rabbit IgG-Alexa 555 (red signal).  Images at panels 
A-C were acquired at low excitation light in a frame encompassing all 
photoreceptor layers, to show that IMPDH1 is most abundant at the inner segment 
layer, and to remark that IMPDH1 signal highlights the rod connecting cilium 
(upper row of “spikes”); cone connecting cilium (more discontinued middle row of 
“spikes”); and Muller cell microvilli (filamentous structures at lower row), at panel 
A.  RetGC1 signal typically highlights cone outer segments, but is also noticeable 
at rod outer segments and synaptic terminals (panel B).  RetGC1 and IMPDH1 co-
localization is barely perceptible in the merged image at this gain (C).  Images were 
acquired at increasing excitation light and increasing zoom in order to assess co-
localization (panels D-F, and panels G-I).  Although much weaker than at the inner  
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segments, IMPDH1 was also present at rod outer segments (D, G), where it co-
localized with RetGC1 (F, I).  IMPDH1 signal is brighter and co-localizes with 
RetGC1 at the connecting cilium of rods and cones (F, I).  Scale bar is 25µm in A 
to F, and 10µm in G to I.  OS, outer segment; IS, inner segment; ONL, outer nuclear 
layer; OPL, outer plexiform layer.   
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4.2.4. A direct interaction between IMPDH1 and RetGC1 is mediated by 
RetGC1 dimerization/catalytic domain and modulated by IMPDH1 CBS 
domain. 
In order to study whether the observed association of IMPDH1 with the 
RetGC1/GCAPs complex involved a direct interaction between IMPDH1 and 
RetGC1, and to map the region of RetGC1 involved in the interaction, we expressed 
three protein fragments covering the RetGC1 cytosolic domain.  RetGC1 is a type I 
transmembrane polypeptide that contains an extracellular domain (ECD), a 
transmembrane domain (TM) and a cytosolic domain (Figure IV.6.A).  The ECD of 
RetGC1 is intradiscal and dispensable for guanylyl cyclase catalytic activity.  It is 
the cytosolic region of the protein that contains the catalytic domain (CD) and a 
kinase homology domain (KHD) involved in the interaction with GCAP1 and 
therefore critical for Ca2+-regulation of the enzyme (Laura et al., 1996).  The KHD 
and CD are separated by a dimerization domain (DD), which is also required for 
cyclase activity, as RetGC is only functional as a dimer.  Expression of the whole 
cytosolic domain of RetGC1 was deemed practically unfeasible due to its instability 
in solution, even when attempted with different protein tags to promote solubility.  
Therefore, we expressed the human RetGC1 cytosolic domain in two fragments:  
JMD/KHD (residues M496-K806) and DD/CD (N807-S1103), expressed as fusion 
proteins with maltose binding protein (MBP).  A fragment containing the CD domain 
in the absence of the DD was also expressed: CD (G868-S1103).  Residue numbers 
refer to human RetGC1 (NP_000171; GI: 4504217). 
Pull-down assays were performed from whole bovine retinal homogenates 
solubilized in 1% dodecyl maltoside.  The JMD/KHD protein fragment pulled-down 
IMPDH1, HSP90α and Tr α at low but detectable levels (Figure IV.6.B left panels).  
This fragment also pulled-down GCAP1 as expected, although the low levels 
detected are in agreement with previous reports that the presence of detergents 
destabilize the RetGC1-GCAP1 interaction.  The DD/CD protein fragment did not 
pull-down GCAP1, but pulled-down IMPDH1, CKB, HSP90α and Tr α to a much 
higher extent than the JMD/KHD fragment (Figure 5B middle panels).  When only 
the catalytic domain (CD fragment) was used for pull-down, the amount of IMPDH1 
protein bound diminished substantially, and those of CKB, HSP90α and Tr α 
Figure IV.5.  Percentage of RetGC1-IMPDH1 colocalization at the rod outer 
segment layer.  Co-immunostaining of RetGC1 (red) and IMPDH1 (green) in a 
bovine retinal section.  Images were acquired at 100x magnification, applying a 
5x zoom. Each panel is the average image of four consecutive planes from the same 
z-stack, labelled as planes 31-35 (A);  planes 36-40 (B); planes 41-45 (C), and 
planes 46-50 (D) from an original stack of 55 planes. A ROI was selected restricted 
to the rod outer segment layer. E. Table showing Manders’ coefficients for Coloc2 
analysis.  
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diminished dramatically (Figure IV.6.B right panels), which indicates that the 
dimerization domain is required for the association of RetGC1 with IMPDH1, as 
well as with CKB, HSP90α and Tr α.  These results are more apparent at the 
histogram plot in Figure IV.6.C, that represents the fraction of bound protein to each 
RetGC1 region, determined from each immunoblot for each pull-down assay 
(protein density in the elution fraction expressed as a function of protein density in 
the input).  Taken together, our results show that IMPDH1, CKB, HSP90α and Trα 
associate to RetGC1, and that the region of RetGC1 that contributes the most to this 
association is the DD/CD region, indicating that RetGC1 dimerization is likely 
required for these interactions.  
Because the most prevalent adRP10 mutations in IMPDH1 map at the CBS 
domain, we investigated whether this domain was involved in the interaction.  The 
CBS -“similar to cystathione-b-synthase gene”- structural domain of the protein is a 
domain that flanks the α /β barrel structure which performs the enzymatic function, 
dispensable for catalytic activity and of function unknown.  We expressed and 
purified the canonical form of bovine IMPDH1 fused to thioredoxin (Trx-IMPDH1), 
and a deletion mutant lacking both copies of the CBS domain (Trx-IMPDH1ΔCBS).  
Pull-down assays were performed with Trx-IMPDH1 or Trx-IMPDH1ΔCBS on 
whole bovine retinal homogenates solubilized in 1% dodecyl maltoside.  IMPDH1 
pulled-down RetGC1 on solubilized whole retinal homogenates (Figure 5D, left 
panel).  In two independent experiments, we determined that IMPDH1ΔCBS 
induced the binding of RetGC1 to a 1,68-fold higher extent than IMPDH1 (histogram 
in Figure IV.6,D).  These results indicate that the CBS domain in IMPDH1 interferes 
with the association of IMPDH1 with RetGC1 in native tissue, likely serving to 
modulate this interaction depending on the protein functional state.  
To test whether RetGC1 and IMPDH1 established a direct interaction, we 
mixed recombinant-expressed RetGC1-DD/CD with IMPDH1 and performed an 
immunoprecipitation of IMPDH1 to test for co-immunoprecipitation of RetGC1-
DD/CD.  To rule out unspecific binding of RetGC1-DD/CD to the Ab-immobilized 
beads, a fixed amount of RetGC1-DD/CD was mixed with variable amounts of 
IMPDH1, and an excess of anti-IMPDH1 Ab-beads was used for 
immunoprecipitation in all samples.  RetGC1 was co-immunoprecipitated in the 
assay to the extent of IMPDH1 immunoprecipitation (Figure IV.7.A). 
To further prove this direct interaction and to measure its affinity, we monitored 
the interaction by surface plasmon resonance (SPR).  Affinity measurements were 
carried out with a fixed concentration of RetGC1-DD/CD or RetGC1-JMD/KHD 
coupled to the chip (used as ligands), and a range of concentrations of IMPDH1 
passed in solution (analyte).  An affinity analysis was performed based on steady-
state binding levels, by direct analysis of a plot of amount of complex (maximal 
response in resonance units, RU) as a function of IMPDH1 concentration, assuming 
a 1:1 binding model (Figure IV.7.B).  A dissociation constant of 2.09 x 10-6 M was 
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obtained for the RetGC1-DD/CD fragment of the cyclase, and 5.05 x 10-6 M for the 
RetGC1-JMD/KHD fragment.  This result confirms that the interaction is direct, and 
that the DD/CD fragment of the cyclase contributes more to the interaction than the 
JMD/KHD, even though a more substantial difference in the dissociation constants 
was expected based on Figure IV.7 (see Discussion). 
Taken together, our results show that RetGC1 establishes a direct interaction 
with IMPDH1 in the micromolar (physiological) range of affinity, mediated mostly 
by the dimerization/catalytic domain of the protein and likely modulated by 
IMPDH1 CBS domain. 
 
Figure IV.6.  Regions of RetGC1 and IMPDH1 involved in the interaction.  A. 
Organization of RetGC1 in protein domains: ECD, extracellular domain; TM, 
transmembrane domain; KHD, kinase homology domain; DD, dimerization domain; 
CD, catalytic domain.  B. Pull-down assays from solubilized bovine retinas were 
performed with different RetGC1 protein regions fused to Maltose Binding Protein 
(MBP), as indicated by the diagrams.  Input (I); flow-through (FT); washing (W) and 
elution (E) fractions from pull-down assays were resolved by SDS-PAGE and 
immunoblotted for the indicated proteins.  The DD/CD region of RetGC1 was 
substantially more efficient at binding IMPDH1 in pull-down assays than the 
JMD/KHD region.  The dimerization domain of RetGC1 substantially contributes to 
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RetGC1 binding to IMPDH1, creatine kinase B, HSP90α and Transducin α.  C.  
Quantification of pull-down results in the mapping of RetGC1 domains involved in 
the interaction.  The histograms for each protein represent the percentage of bound 
protein relative to the input, to the indicated RetGC1 region (quantitated from a 
density analysis of the bands in the elution and input lanes in the corresponding 
panels, correcting for dilution factors and suppressing the mean background).   D. 
Effect of the IMPDH1 CBS domain in IMPDH1 interaction with RetGC1.  Pull-
down assays were performed from solubilized bovine retinas with IMPDH1 (bovine 
canonical isoform) or IMPDHΔCBS, lacking both copies of the CBS domain. I, 
input; FT, flow-through; E, elution fractions.  The binding of RetGC1 to IMPDH1 
or IMPDH1ΔCBS was compared by densitometry of the RetGC1 band in the elution 
fraction (after input normalization and suppression of background).  The dot plot 
shows single measurements taken from IMPDH1 () and IMPDH1ΔCBS () in 
two independent experiments, and the mean.  Bars represent the range of 
measurements.  RetGC1 showed a higher affinity (1.68-fold higher) for 
IMPDHΔCBS than for IMPDH1. 
 
Figure IV.7.  IMPDH1 and RetGC1 show a direct interaction with micromolar 
affinity.  A. Decreasing amounts of recombinant Thr-IMPDH1 (10, 1 and 0.1µg) 
were mixed with a fixed amount of recombinant MBP-RetGC1-DD/CD (10µg, 
Input), and IMPDH1 in each sample was immunoprecipitated to completion with 
an excess amount of anti-IMPDH1 pAb- protein G-beads (Elution, IMPDH1 
immunoblot).  The level of RetGC1 co-immunoprecipitation (Elution, RetGC1 
immunoblot) was determined by the level of IMPDH1 in the sample, which rules 
out unspecific binding of RetGC1 to the beads. B.  Surface Plasmon Resonance 
(SPR) analysis of the interaction affinity.  The RetGC1-DD/CD or RetGC1-
JMD/JHD fragments of the cyclase were used as ligands covalently attached to the 
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4.2.5. An adRP10 mutation and a rare LCA mutation in IMPDH1 alter its 
interaction to RetGC1. 
Mutations R224P and D226N in IMPDH1 have been associated to autosomal 
dominant retinitis pigmentosa (adRP), whereas mutations R105W and N198K have 
been linked to autosomal dominant rare Lebers Congenital Amaurosis (adLCA).  
The basis of the pathology associated to these mutations has not been established.  
To investigate whether these mutations affect IMPDH1 interaction with RetGC1, we 
expressed thioredoxin fusion forms of IMPDH1 canonical isoform and the individual 
mutants: R105W, N198K, R224P and D226N.   Pull-down assays were performed 
by using a normalized amount of IMPDH1 protein (Figure IV.8. input), using whole 
bovine retinal homogenates solubilized in 1% dodecyl maltoside.  The amount of 
RetGC1 bound by each mutant was expressed as a function of the RetGC1 bound by 
wildtype IMPDH1 (Figure IV.8. histogram).  Values are the mean from three 
independent experiments, with error bars representing the standard error.  The RP10 
mutation R224P substantially impaired binding of RetGC1 to IMPDH1, that 
occurred only to 42% of RetGC1 binding to wildtype IMPDH1.  In contrast, LCA 
mutation N198K enhanced the interaction, promoting RetGC1 binding to a 1.57-fold 
higher extent than normal.  Mutations R105W and D226N did not show statistically 
significant changes in RetGC1 binding when compared to wildtype IMPDH1.   
Taken together, these results show that adRP10 mutation R224P substantially 
diminished IMPDH1 interaction to RetGC1, whereas adLCA mutation N198K 
significantly enhanced it, emphasizing the physiological relevance of this 
interaction. 
 
sensor chip; and the Trx-IMPDH1 protein was passed in the mobile phase as an 
analyte at 2-fold serial dilutions from a 6.71µM stock solution.  The affinity of the 
interaction was determined from measurement of steady-state binding levels as a 
function of analyte concentration, from multi-cycle experiments performed with 
duplicates.   For analysis of the steady-state binding data, a model of 1:1 binding 
was assumed (4-parameter fitting, T200 Biacore analysis software), and the chi-
square value defining the closeness of the fit (describing the deviation between the 
experimental and fitted curves) was 1.57 RU2 for RetGC1-DD/CD (Rmax = 44.1 
RU) and 0.167 RU2 for RetGC1-JMD/KHD (Rmax = 50.5 RU).   Chi-square values 
are typically considered acceptable when they are less than 10% of the 
experimental maximal response. 
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In this study we report the identification of new binding partners of Guanylate 
Cyclase Activating Protein 1 (GCAP1) in the retina that led to the unexpected 
discovery of a direct interaction between IMPDH1 and RetGC1.  Inosine 
monophosphate dehydrogenase 1 (IMPDH1) is the enzyme in the first and rate-
limiting step in de novo synthesis of GTP.  It is abundantly expressed in the retina, 
and mutations in the impdh1 gene have been associated to autosomal dominant 
Retinitis Pigmentosa (adRP) and Leber Congenital Amaurosis (adLCA),  (Bowne et 
al., 2006b, 2002; Kennan et al., 2002).  Retinal guanylate cyclase 1 (RetGC1) is 
responsible for cGMP synthesis in rods and cones.  Mutations in the GUCY2D gene 
encoding RetGC1 have been linked to arLCA and autosomal dominant cone rod 
dystrophy (adCORD), (Boye, 2015; Dizhoor, 2000; Hamel, 2007; Hunt et al., 2010).  
Therefore the RetGC1-IMPDH1 interaction reveals a link between cGMP synthesis 
and de novo GTP supply in photoreceptor cells.  This opens a new scenario for the 
interpretation of the pathophysiology of blindness-causative mutations in IMPDH1 
and RetGC1, and it draws attention to the enzymes involved in guanine nucleotide 
biosynthesis as putative blindness-associated or modifier genes for future genetic 
studies. 
Identified GCAP1 binding partners important for photoreceptor cell 
physiology.  IMPDH1 was one of the proteins identified in a search for novel 
interactors of the calcium sensor GCAP1, a protein that binds to RetGC1 to confer 
it Ca2+-sensitivity.  Parallel pull-down assays were performed with GCAP1 in its 
Ca2+-free or Ca2+-bound forms from bov ROS, and identified proteins were 
Figure IV.8.  Effect of IMPDH1 mutations associated to adRP10 and LCA in 
IMPDH1-RetGC1 interaction.  A.  IMPDH1 mutants associated to adLCA (R105W 
and N198K); and adRP10 (R224P and D226N) were expressed and purified as 
thioredoxin fusion recombinant proteins, and used in pull-down assays from 
solubilized bovine retinas.  Aliquots of IMPDH1-immobilized resin corresponding 
to an identical amount of coupled IMPDH1 in each sample (wildtype and R105W, 
N198K, R224P, and D226N individual mutants, -recombinant protein input panel-) 
were used as baits.  The level of RetGC1 pulled-down by each mutant from a bovine 
retinal extract is shown in the lower -elution- panel.  B. The amount of RetGC1 
bound by each mutant was calculated by densitometry of the corresponding RetGC1 
bands, and expressed for each mutant as a function of the RetGC1 bound by wildtype 
IMPDH1 (lane WT). The dot plot shows measurements taken from three independent 
experiments. Statistical analysis was done with one-way ANOVA, and Dunnett’s test 
to multiple comparisons (α=0.05; p<0.01). Mean±SE; WT () 1±0; R105W () 
1.312±0.15; N198K () 1.576±0.16; R224P () 0.42±0.02; D226N () 0.98±0.11. 
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analyzed by a label-free quantitative approach.  The goal was to identify proteins 
with preferential affinity for one of GCAP1 conformational states, on the basis of 
discerning putative binding targets from the background.  This pursued 
discrimination was particularly successful for proteins showing a fold-
changeCa2+/EGTA >3 (Table IV.1).   
Among the GCAP1 putative binding partners we identified four of the eight 
subunits of the Chaperonin Containing TCP-1 complex (CCT complex).  This 
complex is necessary for the folding of several key signaling and structural proteins 
in rod outer segment formation, according to the analysis of a mouse model with 
suppressed CCT activity (Posokhova et al., 2011).  While GCAP1 or RetGC1 were 
not identified among the folding substrates in these mice, our data would call for a 
revision of RetGC1 and GCAP1 specific alterations in this mouse model, as we 
predict that they are CCT substrates. 
Intriguingly, we also found five proteins associated to Bardet-Biedl Syndrome 
(BBS), a syndromic retinopathy affecting 1/100.000 individuals that curses with 
deafness, obesity and diabetes (Sheffield, 2010).  Enrichment of the BBSome and 
LZTFL1 proteins in our GCAP1 pull-down assay may be explained by the reported 
association of the BBSome to the CCT complex (Posokhova et al., 2011).  
Alternatively, it may point to the BBSome involvement in RetGC1/GCAP1 
trafficking to the cilium.  In this respect, it will be worth to assess whether there are 
specific alterations in the levels of RetGC1 and GCAP1 at the rod outer segment 
compartment of available knockout models in BBSome components (Zhang et al., 
2013), and the Lztfl1 knockout mice (Jiang et al., 2016). 
Table I also included signaling proteins that were likely identified because they 
are co-transported with the RetGC1/GCAPs complex by vesicular trafficking to the 
cilium.  This is the case for PDE6C (cone PDE6 alpha), that fails to reach the cone 
outer segment compartment in RetGC1/RetGC2 double knockout mice (Baehr et al., 
2007).  Other proteins that fail to distribute to the outer segment in the absence of 
functional RetGC1 and RetGC2 in photoreceptors are rod PDE6 and cone transducin 
(Baehr et al., 2007).  Different subunits of PDE6 and rod transducin were identified 
in our pull-down assay with a high number of spectra (Table IV.2), but did not meet 
the criteria to be included in Table IV.1 because their fold-changeCa2+/EGTA did not 
reach our arbitrary threshold.  Since RetGC1 itself did not meet Table I criteria 
(Table IV.2), it is likely that Table IV.2 contains many bonafide interactors of free 
GCAP1 or the RetGC1/GCAP1 complex, that will be further investigated in future 
studies.  We focused this study on demonstrating uncontrovertibly the association of 
IMPDH1 with the RetGC1/GCAP1 complex, to infer putative functional 
implications in the pathophysiology of blindness. 
Characteristics of IMPDH1 direct interaction with RetGC1.  IMPDH1 was 
identified robustly and specifically in the GCAP1 pull-down assay performed on bov 
Results: Chapter IV   
136 
ROS (Figure IV.1).  IMPDH1 was not identified in GCAP1 pull-down assays 
performed on whole bovine retinal homogenates that resulted in similar overall 
sample depth at LC-MS/MS protein identification (data not shown).  Subsequently 
we showed that recombinant IMPDH1 (bovine canonical isoform) efficiently pulled-
down RetGC1 from bovine rod outer segment samples (Figure IV.2), demonstrating 
that IMPDH1 association was to the RetGC1/GCAP1 complex, rather than -or in 
addition to- free GCAP1.  Furthermore, we showed that IMPDH1 co-migrated 
almost entirely with RetGC1 during size-exclusion chromatography fractionation of 
bov ROS, at a fraction that also contained HSP90α another protein identified in table 
I (Figure IV.2).   Co-migration of HSP90α with RetGC1 was consistent with HSP90α 
binding to recombinant RetGC1 DD-CD domains in pull-down assays from bovine 
retinas (Figure IV.6).  These results point to HSP90 association to RetGC1. This 
chaperone has been involved in the stabilization or assembly of other multi-enzyme 
signaling protein complexes, including the “purinosome” involved in de novo GTP 
biosynthesis (French et al., 2013).  Therefore, HSP90 may be an important auxiliary 
chaperone in the assembly or organization of the RetGC1/GCAP1 heterotetramers 
in higher order multi-enzyme complexes.  
We here demonstrate that IMPDH1 association to the RetGC1/GCAP1 complex 
is through a direct interaction with RetGC1, that involves the dimerization and 
catalytic domains of RetGC1.  The dissociation constant of this interaction was 
determined to be in the micromolar range by surface plasmon resonance (SPR) 
(Figure IV.7), which is within the physiological range for protein-protein 
interactions.  The region of RetGC1 that contributed most to the interaction 
comprised the dimerization and catalytic domains, at the C-terminus 
(DD/CD/COOH region), Figure IV.6.  So, IMPDH1 interaction with RetGC1 
primarily involved a region of RetGC1 different from the region reported for GCAP1 
interaction (JMD-KHD) (I. V. Peshenko et al., 2015; I. V Peshenko et al., 2015), 
which our pull-down assays faithfully reproduced (Figure IV.6).  Dimerization of 
RetGC1 is likely required for IMPDH1 interaction, because removing the DD 
domain substantially reduced IMPDH1 binding (Figure IV.6).  Other proteins that 
associate to this complex, like CKB, HSP90α and Trα, followed the same trend 
(Figure IV.6).  The higher contribution of the DD/CD region than the JMD/KHD 
region to IMPDH1 interaction was also reflected in the SPR experiments, that 
yielded dissociation constants of KD = 2.09µM for RetGC1-DD/CD and KD = 
5.05µM for RetGC-JMD/KHD.  We would have expected a bigger difference 
between the KD values based on the 8-fold higher amount of IMPDH1 binding to the 
DD/CD than the JMD/KHD region in pull-down assays (Figure IV.6.C).  However, 
pull-down assays were performed on native tissue (whole retinal homogenates) 
where enzymatic steps (e.g. phosphorylation) or auxiliary proteins (e.g. GCAP1, 
RD3, HSP90) may influence the interaction.  Given that it is ultimately the 
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quaternary structure of RetGC1 that configures the mapping interface, all cytosolic 
RetGC1 domains may contribute to it to different extents. 
Subcellular localization of the IMPDH1-RetGC1 interaction.  Previous 
immunolocalization studies of IMPDH1 in murine retinal sections reported IMPDH1 
localization primarily at photoreceptor inner segment and outer plexiform layers 
(Bowne et al., 2006a; Tam et al., 2008) by using an antibody to canonical IMPDH1 
C-terminus.  Our immunolocalization studies, performed on bovine retinal sections 
with an affinity purified anti-IMPDH1 pAb raised against the whole bovine 
canonical isoform (see methods) were basically consistent with these reports.  In 
bovine retinal sections we also observed that IMPDH1 was predominant at the inner 
segment and outer plexiform layers (Figure IV.3), being much more abundant at rods 
than at cones at the inner segment layer, but equally enriched at rod and cone synaptic 
terminals (Figure IV.3).  Nevertheless, we could now make use of more advanced 
confocal microscope configurations that substantially increase sensitivity to gain 
more insight into subcellular detail.  We here report that IMPDH1 is enriched at the 
connecting cilium of both rods and cones (Figure IV.4) and at microvilli of Muller 
cells (Figure IV.3M).  More importantly, we also show that IMPDH1 is also present 
at the rod outer segment compartment, where its signal is much weaker than at inner 
segments but noticeable; and where it partially co-localizes with RetGC1 (Figure 
IV.4, Figure IV.5).  We also observed strong co-localization at the connecting cilium 
of rods and cones (Figure IV.4).  These findings are in accordance with the 
identification of IMPDH1 in the proteome of the bovine rod outer segment 
compartment (Kwok et al., 2008), and consistent with our identification of IMPDH1 
as a GCAP1 interactor in a pull-down assay performed on bov ROS (Figure IV.1, 
Table IV.1). 
Physiological implications of IMPDH1-RetGC1 interaction: an emerging 
protein network with relevance in the pathophysiology of blindness. 
IMPDH1 is the enzyme in the first and rate-limiting step in de novo synthesis 
of GTP from IMP, by converting inosine monophosphate (IMP) to xanthosine 
monophosphate (XMP) (Figure IV.9).  XMP is further converted to GMP, GDP and 
GTP by Guanosine 5´-monophosphate synthase (GMPS), Guanylate Kinase (GK) 
and Nucleoside-diphosphate kinase (NDK), Figure IV.9.  However, the precise 
contribution of de novo synthesis of GTP to overall GTP supply is not clear, since 
GTP can also be produced by the salvage pathway via the conversion of free purine 
bases (guanine, hypoxanthine) to their corresponding nucleotides by 
phosphoribosylation by the enzyme hypoxanthine-guanine phosphoribosyl 
transferase (HGPRT), Figure IV.9.  It is not known how much each pathway 
contributes to GTP supply.  In dividing cells the salvage pathway sustains normal 
growth, but it is the regulation imposed on de novo synthesis that has a great effect 
upon growth rate during malignant transformation (Zhao et al., 2013).  In 
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photoreceptor cells of the retina the individual contributions have not been 
characterized in detail, but it has been proposed that de novo GTP synthesis is 
responsible for the bulk of GTP supply, based on the strong expression of IMPDH1 
compared to HGPRT at the transcript level (Aherne et al., 2004).  IMPDH1 
(IMPDH2 isoform is not detected in the retina (Aherne et al., 2004)), is therefore a 
relevant enzyme because the retina is one of the most energy-consuming tissues of 
the body, and photoreceptor cells have a high requirement for GTP in the visual 
transduction cycle (Burns and Arshavsky, 2005; Pugh and Lamb, 1990; Wensel, 
2008).  Impdh1-/- mice display a slowly progressive form of retinal degeneration, in 
which visual function becomes gradually compromised.  Interestingly, a progressive 
reduction in the a- and b-wave amplitudes of scotopic electroretinogram responses 
precedes by several months any noticeable photoreceptor cell loss, which likely 
indicates a disturbance in cGMP biosynthesis by progressive GTP depletion (Aherne 
et al., 2004).  This IMPDH1 loss-of-function phenotype is consistent with de novo 
GTP synthesis being required for GTP conversion to cGMP (Figure IV.9); but the 
retinopathy is too mild to explain the much more severe phenotype in  adRP10 
patients (Aherne et al., 2004).  Properties of IMPDH1 mutations other than their 
effect on enzymatic activity have been invoked to explain the human disorder (see 
below).   
What is the physiological significance of IMPDH1-RetGC1 interaction?  We 
propose that the interaction implies an integration of guanine nucleotide metabolic 
pathways (Figure IV.9), based on a number of indications.  First, in the GCAP1 pull-
down assay we also identified guanylate kinase (GK) and the bifunctional enzyme 
AICAR transformylase/IMP cyclohydrolase (ATIC gene, PURH protein), Table 
IV.1.  GK catalyzes the third step in GTP synthesis from IMP, whereas PURH 
catalyzes the ninth and tenth steps in de novo purine synthesis (last two arrowheads 
in the pathway from PRPP (Phosphoribosyl pyrophosphate) to IMP), Figure IV.9.  
Interestingly, a case of an infant with severe neurological defects and congenital 
blindness has been reported to be caused by a mutation in the ATIC gene (Marie et 
al., 2004).  Second, descriptions of dynamic, reversible formation of multi-enzyme 
complexes in nucleotide metabolism are emerging, that portray the channeling of 
nucleotide flux under integrated control (Havugimana et al., 2012; Zhao et al., 2015).  
It is tempting to speculate that the complex responsible for cGMP synthesis in 
photoreceptor cells might associate to other multi-protein complexes in higher order 
assemblies, for an integrated regulation of guanine nucleotide supply depending on 
the light and nutritional state of the cell.  Third, we do not contemplate that IMPDH1 
interaction with RetGC1 responds to a ciliary co-transport requirement, because 
IMPDH1 expression levels or localization are not affected in the rd3 mice, deficient 
in RetGC1 ciliary transport (data not shown).  Overall, we believe that the IMPDH1-
RetGC1 interaction reflects an interplay between cGMP synthesis and GTP supply 
(Figure IV.9).  Further studies based on the electrophysiological analysis of the effect 
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of IMPDH inhibitors on rod responses to light will be necessary to prove this 
interpretation.  
What are the implications for the pathophysiology of inherited retinal 
dystrophies?  Since the first reports of IMPDH1 mutations causing adRP10, it was 
proposed that IMPDH1 should have a distinctive function or property in the retina, 
to explain the retina-specific phenotype of a protein that is ubiquitously expressed 
(Bowne et al., 2002; Kennan et al., 2002).  IMPDH1 expression level is much higher 
in the retina than other tissues, and unique retinal isoforms are predominant, that 
result from alternative splicing and alternate start sites of translation (Bowne et al., 
2006a).  The adRP-associated mutations Arg224Pro and Asp226Asn do not reduce 
catalytic activity (Aherne et al., 2004; Mortimer and Hedstrom, 2005).  Both 
mutations are located in the second cystathione beta synthase (CBS) domain of 
IMPDH1, whose function is not clear yet.  It has been reported that the IMPDH1 
CBS domain binds to single-stranded nucleic acids, and that this binding capacity is 
diminished by adRP10 IMPDH1 mutations.  However, the particular aspect of RNA 
metabolism that could be influenced by IMPDH1 or its physiological effect have not 
been described (McLean et al., 2004; Mortimer and Hedstrom, 2005; Xu et al., 
2008).  More convincing, given the dominant-negative effect of IMPDH1 mutations 
on the adRP10 phenotype, is the proposal that IMPDH1 pathology may rely on the 
observed IMPDH1 tendency to aggregate (Aherne et al., 2004; Tam et al., 2010, 
2008; Wang et al., 2011).  We here show that the CBS domain is not required for 
IMPDH1 binding to RetGC1, but that it likely modulates the interaction, as the 
IMPDH1ΔCBS mutant showed significantly enhanced binding to RetGC1 (Figure 
IV.6).  Our results also show that R224P substantially decreases binding, while 
N198K significantly enhances binding to RetGC1 (Figure IV.8).  Collectively, we 
show that IMPDH1 mutations associated to adRP10 and adLCA alter IMPDH1 
binding to retGC1.  This implies that mutations in IMPDH1 with an autosomal 
dominant pattern of inheritance may cause the pathophysiology by interfering with 
RetGC1 localization or function.  An even more relevant implication of a functional 
coupling of IMPDH1 and RetGC1 (that is, between de novo GTP synthesis and GTP 
conversion to cGMP) is the fact that specific inhibitors of IMPDH could be tested to 
treat the inherited retinal dystrophies: associated to mutations that lead to constitutive 
guanylate cyclase activity (mutations in GUCY2D encoding RetGC1 associated to 
adCD (Hunt et al., 2010); and mutations in GUCA1A encoding GCAP1 
(Olshevskaya et al., 2004; Payne et al., 1998)) or functional impairment of cGMP-
PDE  (mutations in the different PDE subunits or in AIPL1 (Dvir et al., 2010; Huang 
et al., 1995; Kohl et al., 2012; McLaughlin et al., 1993; Ramamurthy et al., 2004; 
Thiadens et al., 2009)). 
Collectively, we show compelling evidence of a direct interaction between 
RetGC1 and IMPDH1 at the rod outer segment compartment where 
phototransduction takes place, that is altered by mutations in IMPDH1 that cause 
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adRP or adLCA.  This unanticipated connection between multienzyme complexes in 
nucleotide metabolism may serve to allow an integrated spatial modulation of purine 
synthesis according to the dark/light physiology requirements in these specialized 
cells.  By bringing together inherited retinal dystrophy-causative genes so far 
considered unrelated, this finding opens a new conceptual framework to study the 



























Figure IV.9.  RetGC1-IMPDH1 interaction points to an interplay between de novo 
synthesis of GTP and its conversion to cGMP that bridges blindness causative genes.  
RetGC1 and IMPDH1 are enzymes involved in guanine nucleotide metabolism, at 
different levels.  IMPDH1 is involved in de novo synthesis of GTP (vertical pathway, 
each arrow representing an enzymatic activity), by catalyzing the production of XMP 
from IMP (the enzyme works in tetramers, in blue at inset).  RetGC1 is an enzyme 
involved in cGMP turnover (cycle), being responsible for the synthesis of cGMP from 
GTP.  RetGC1 is a membrane polypeptide that works in dimers (in grey at inset) in 
a Ca2+ regulated manner through the guanylate cyclase activating proteins 
(GCAPs, orange).  GTP can also be produced by the salvage pathway (by HGPRT: 
hypoxanthine/guanine phosphorybosyl transferase), from guanine or hypoxanthine.  
The direct interaction between RetGC1 and IMPDH1 revealed in this study is shown 
by the thick arrow in the protein network at right, and reveals an interplay between 
the protein complexes responsible for de novo synthesis of GTP and for GTP 
conversion to cGMP, that functionally links distinct forms of inherited retinal 
blindness.  Continuous lines linking circled proteins represent direct interactions 
that are well-established in the literature, while dashed lines represent expected 
functional associations.  The implications of this new scenario are that a mutation at 
the level of IMPDH1 could putatively affect RetGC1 function, or vice versa.  In 
addition, genes encoding other proteins in guanine metabolism might need to be 
considered as putative candidate blindness-causative or modifier genes.   LCA, Leber 
Congenital Amaurosis; adRP, autosomal dominant retinitis pigmentosa; adCORD, 
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Chapter V: Characterization of RetGC1 association to 
Creatine Kinase-B in photoreceptor cells. 
Contributions 
We acknowledge the help of Sergi Tosal in the immunolocalization studies of 
Creatine kinase B, as well as the Proximity ligation assays on retinal sections. For 
Surface Plasmon Resonance studies, RetGC1 fusion proteins were purified by Anna 
Plana, and experiments were performance with the technical assistance of Dr. Marta 
Taulés at the molecular interaction analysis facility of CCiTUB.. 
 My contribution to this Chapter was training and guiding Sergi Tosal with 
the immunolocalization analysis, as well as obtaining the frozen blocks of bovine 
retinas for analysis.  I did the image acquisition and analysis.  I did the biochemical 
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Chapter V: Characterization of RetGC1 association to Creatine 
Kinase-B in photoreceptor cells. 
5.1. Rationale 
Among the 37 proteins identified in our GCAP1 pull-down assay with a fold-
changeCa2+/EGTA > 3 (scatter plot in Figure IV.1, Chapter 4), was creatine kinase B 
(brain type).  Creatine kinase B (CKB) was identified with 19 peptides (114 spectra) 
in the Ca2+-condition, and only one spectra in the EGTA condition (Table IV.1, 
Chapter 4).  That is, it was one of the most abundant proteins among the proteins that 
bound to Ca2+-GCAP1.  Creatine kinase B was not identified in the negative control 
pull-down assay with Ran, which indicates that creatine kinase B association to 
Ca2+-GCAP1 was also specific.  Furthermore, CK-B has been found to associate to 
the DD-CD-C-terminus region of RetGC1, in pull-down assays performed with 
different regions of the RetGC1 cytosolic region (Figure IV.5, Chapter 4).  That is, 
our proteomic results point to an association of CK-B to the RetGC/GCAPs complex. 
Creatine kinase (CK) catalyzes the reversible transphosphorylation from ATP to 
creatine (Cr) to yield phosphocreatine (PCr). The action of CK contributes to 
maintain the cellular energy homeostasis by guaranteeing stable and locally buffered 
ATP/ADP ratios (Andres et al., 2008; Wallimann et al., 1998), by generating an 
intracellular pool of PCr which represents a temporal energy buffer that prevents a 
fall on ATP levels in high cell energy requirements scenarios. Cytosolic and 
mitochondrial CK are specifically localized in those focus of high ATP consumption 
of the cell, like ATPases of different ions pumps, myosin ATPase of contractile 
muscle apparatus, or the calcium pumps in the sarcoplasmic reticulum.  In that 
respect, the synthesis of cGMP by the RetGC/GCAPs complex is known to require 
ATP, in addition to the GTP substrate.  The reason for this ATP requirement for 
RetGC1 catalytic activity is currently not understood, despite the fact that ATP has 
to be added to extracts when assaying retinal guanylyl cyclase activity in 
reconstituted systems. 
To address whether there was a functional association between RetGC1 and 
CK-B at photoreceptor outer segments, as the robust proteomic data is indicating, 
we analyzed CK-B co-localization with GCAP1, as well as with RetGC1 and 
GCAP2, in bovine retinal sections.  We also performed Proximity Ligation Assay, 
to determine whether at any particular cell compartment these proteins localize at a 
proximity of 40nm or less, which would be indicative of a putative interaction.  
Finally, we analyzed whether CK-B interacted directly with RetGC1 and we 
measured the affinity of the interaction by monitoring direct binding of RetGC1 and 
CK-B recombinant proteins.  
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5.2 Localization of CKB in bovine retinas 
In order to characterize the precise localization of CKB in bovine retinas, 
bovine retinal cryosections were stained with different monoclonal and polyclonal 
antibodies against human CKB. A collection of antibodies against CKB was 
generously provided by Drs. Theo Wallimann (ETH Zurich) and Uwe Slachttner 
(University of Grenoble). Our results indicate that CKB is more abundantly 
expressed in cones than in rods (Figure 1.B), where it is enriched at the inner segment 
compartment and at the synaptic terminal (Figure V.1. B, E and H), but also clearly 
present at the cone outer segment compartment (Figure V.1 E).  An identical pattern 
of CK-B staining was obtained with antibodies addressed to the C-terminal part of 
the protein (rabbit monoclonal EPR3927, GeneTex), or to the N-terminal part 
(mouse monoclonal 21E10, Sistermans et al. 1995).  CK-B showed an almost 
complete co-localization with GCAP1 at all cellular compartments (Figure V.1 C, F, 
I), which would be consistent with a functional association of these proteins.  
Consistently, the proximity ligation assay performed with these same two antibodies 
to GCAP1 and CK-B, revealed that both proteins localize at a proximity of 40nm or 
less at the inner and outer segment of cones (Figure V.1.J-L).  Surprisingly, a positive 
signal was also obtained at rod outer segments, which indicates that the proximity 
ligation assay amplification is more sensitive than regular indirect fluorescence 
detection (Figure V.1.J and L). 
CK-B appears to be much more abundant at cones than at rods.  When a co-
immunolocalization study was carried between CK-B and GCAP2, CK-B 
highlighted cones while GCAP2 highlighted preferentially rods, therefore giving rise 
to a mutually exclusive staining pattern (Figure V.2).  
Collectively, our results point to CK-B associating to either free GCAP1 or to 
the RetGC1/GCAP1 complex in cones.  To address whether CK-B associated to 
RetGC1/GCAP1 complex in cones, we performed RetGC1 and CK-B co-
immunostaining studies.  These studies revealed that RetGC1 and CK-B co-localize 
at cone outer segments (Figure V.3, D, E and F).  Furthermore, RetGC1 and CK-B 
yielded a positive PLA signal at cone outer segments (Figure V.3, H and K). 











Figure V.2. Co-immunostaining of CKB with GCAP2. CKB indirect immunostaining 
(red signal in B and E), and GCAP2 indirect immunofluorescence (in green in A and 
D) shows that GCAP2 is much more abundant in rods than cones, whereas CK-B is 
predominant in cones. Therefore, a mutually exclusive pattern of localization is 
apparent (C and F). 
Figure V.1. Co-immunostaining of CK-B and GCAP1 in bovine retinal sections, and 
Proximity ligation assay. GCAP1 immunostaining by indirect immunofluorescence 
(green signal, panels A, D, G); and CK-B immunostaining by indirect 
immunofluorescence (red signal in B, E and H) show co-localization of GCAP1 and 
CK-B at outer segments , inner segments (D, E, F) and at synaptic terminals (G, H 
and I). The proximity ligation assay produced a positive signal at the inner and 
outer segments of cones, indicating that both protein are closer than 40nm in these 
compartments (J and L).  
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Figure V.3. Co-localization of CKB with RetGC and Proximity ligation assay. 
Indirect immunofluorescence of CKB (red signal in B and E), and indirect 
immunostaining of RetGC (in green in A and D) reveal colocalization of both 
proteins at the outer segment of cones.. A Proximity ligation assay positive signal 
is appreciated at cone inner and outer segments (H and K).  
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5.3. Monitoring recombinant RetGC1 and CK-B binding by Surface 
Plasmon Resonance (SPR). 
Pull-down assays with different fragments of RetGC1 had already indicated 
an association of CK-B to the DD-CD-C-terminus part of RetGC1 cytosolic region 
(Chapter 4. Figure IV.6). In order to study whether this interaction is direct, and to 
measure its affinity, we performed steady-state binding measurements with a fixed 
concentration of RetGC (MBP-DD/CD/C-term) and a range of concentrations of 
CK-B.  




This result indicates that CK-B establishes a direct interaction with RetGC1, 
in the micromolar range, which is in the physiological range of protein-protein 
interactions that could have physiological relevance.  This result is consistent with 
previous pull-down assay results, with our GCAP1 pull-down assay and with the co-
localization of these three proteins at cone outer segments.  Collectively, our results 
Figure V.5. CKB and RetGC1 show a direct interaction with micromolar affinity. 
Surface Plasmon Resonance (SPR) analysis of the interaction affinity. The RetGC1-
DD/CD fragment of the cyclase were used as ligand covalently attached to the 
sensor chip; and the CKB protein was passed in the mobile phase as an analyte at 
2-fold serial dilutions from a 264.8µM stock solution. The affinity of the interaction 
was determined from measurement of steady-state binding levels as a function of 
analyte concentration, from multi-cycle experiments performed with duplicates. For 
analysis of the steady-state binding data, a model of 1:1 binding was assumed (4-
parameter fitting, T200 Biacore analysis software), and the chi-square value 
defining the closeness of the fit (describing the deviation between the experimental 
and fitted curves) was 8.68 RU2 (Rmax = 76.26 RU). Chi-square values are typically 
considered acceptable when they are less than 10% of the experimental maximal 
response. 
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point to a role of CK-B at providing local ATP in the environment of the cyclase.  
However, the physiological relevance of this finding, and why this phenomenon 




Rods and cones must respond to a high range of light intensities. In darkness, 
both rods and cone have a similar darkness current, by what they have a similar ATP 
consumption, however their responses in light are different (Nikonov et al., 2006). 
Rods have higher light sensitivity than cones, responding to a very low light 
intensities but they are saturated at low light intensities. 
On the other hand, cones present a higher dynamic range than rods, with a 
lower light sensitivity but a faster kinetic response and over a higher range of light 
intensity. In this way, energy requirements of cones are higher than rods. Therefore, 
cones may need a fast energetic system to maintain the energy requirements of the 
cell. CKB could supply the ATP needed for cones phototransduction, as coefficient 
diffusion of PCr is higher than ATP (Hubley et al., 1995), and maintain a high 
concentration of ATP locally.  
Taken together, CKB could provide a fast energy supply in cones because of 
its higher energetic requirements than rods. 
On basis of our results of Chapter IV and data collected from Surface plasmon 
resonance data (Figure V.5), CKB has been demonstrated to interact directly with 
RetGC, may supply the ATP required in maintaining the cGMP levels. In cones, the 
current through cGMP-gated channels never falls further of half of darkness even in 
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Global discussion and future perspectives. 
The overall goal of this study was to advance the knowledge of how the 
protein complex responsible for cGMP synthesis in rods and cones, the 
RetGC/GCAPs complex, is assembled, transported to rod outer segments, organized 
and regulated in vivo.  Because cGMP is the second messenger in the light response, 
this protein complex plays a key role in the physiology of photoreceptors.  Despite 
its extensive characterization in vitro by biochemical and structural studies, 
fundamental questions remain open on the function of this protein complex in vivo, 
in the context of the living cell:  - How is the complex assembled? – How is the 
complex transported from the inner to the outer segment compartment where 
phototransduction takes place? – What confers this protein complex “ciliary 
destination” rather than “synapse fate”, during vesicular polarized trafficking? – Is 
this protein complex anchored at rod outer segment disc membranes? – How is it 
organized, how does it fit in with other signaling complexes in the light response, to 
guarantee the rapid kinetics of the light response?   
This study aimed at setting the ground to address some of these questions.  We 
wanted to sustain this study on two main methodologies: i) proteomics and protein 
biochemistry, to identify new protein interactors of the complex that would give us 
clues as to its organization in vivo; and ii) genetics, to test the functional significance 
of identified interactions.    
Because of the complexity of the visual system, and the extremely high 
compartmentalization of retinal photoreceptor cells, the use of cells in culture or 
reconstituted systems is of limited use.  Because of our interest in doing the studies 
in living animals, we first put our effort into implementing mouse genetic techniques 
to transfect photoreceptor cells that by-passed conventional transgenic strategies. We 
focused on in vivo DNA electroporation.  We set to implement the methodology 
developed by Connie Cepko at Harvard for in vivo DNA electroporation in the retina, 
and particularly in rod photoreceptors (Matsuda and Cepko, 2004). During the course 
of this study, we successfully implemented this methodology in the lab (Appendix I. 
Figure I).  
This methodology was very useful to study how mutation in the GCAP 
proteins affected subcellular localization (chapter III). However, one limitation of 
this method is that it yields mosaic expression, and transfection levels are not enough 
to allow biochemical analysis of transfected tissue. 
With the goal of exploiting the potential of in vivo DNA electroporation for 
the generation of stable transgenics, we tried to achieve the transfection of 
spermatogonial stem cells in mice, as described (Dhup and Majumdar, 2008).  
Conceptually, we thought it would be easier to transfect dividing stem cells than the 
highly differentiated neurons of the retina.  However, after very extensive work at 
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developing injection and electroporation surgical procedures, and improving the 
transgene cassette design, we observed Sertoli and Leydig cell transfection, but not 
transfected spermatogonial or sperm cells.  After optimizing the plasmid backbone, 
promoter and flanking DNA insulator sequences of the transgene expression 
cassette, the maximum transfection of sperm cells with a fluorescent reporter was 
determined to be 1.3% of cells analyzed by the cell sorter.  This methodology was 
deemed unpractical (Figure II.10 and table II.8).  One possible explanation for the 
failure of this technique may rely on the difficulty to modify the genome of stem or 
pluripotent cells.  In this sense, it may be worth to try to modify the genome with the 
CRISPR/Cas9 system rather than trying to insert foreign DNA, in future studies. 
By applying in vivo DNA electroporation after subretinal injection we were 
able to study the molecular determinants for GCAPs subcellular distribution 
(Chapter III).  The most important conclusion of this study was its demonstration 
that GCAPs direct binding to RetGC1 is required for the GCAPs to distribute to the 
outer segment.  This is in line with what was expected (Baehr et al., 2007; Karan et 
al., 2010; Peshenko et al., 2014), but it had not been demonstrated.  In addition, we 
observed an effect of myristoylation in GCAP1 distribution.  Myristoylation is also 
required for GCAP1 distribution to rod outer segments.  This might be explained by 
the observation that myristoylated GCAP1 has a higher apparent affinity for the 
cyclase (so, unmyristoylated GCAP1 has a lower affinity for the cyclase); or it may 
imply an additional regulatory step in trafficking (Chapter III, Figure III.5).  Future 
studies will be addressed at distinguishing these two alternatives.  
On the other hand, GCAP2 subcellular distribution presents a more complex 
regulation because of its phosphorylation at the COOH-terminus (López-del Hoyo 
et al., 2014). About half the normal complement of GCAP2 is phosphorylated under 
standard light conditions in wildtype mice.  Phosphorylation of GCAP2 at 
S201determines its binding to 14-3-3 and its sequestration at the inner segment.  This 
appears to be a mechanism in place to regulate GCAP2 subcellular distribution 
(López-del Hoyo et al., 2014).  However, when overly desregulated, like in the 
transgenic mouse model described in López-del Hoyo et al. 2014, that expresses a 
form of GCAP2 impaired to bind Ca2+, its massive phosphorylation and retention 
leads to a severe toxicity.  By showing that the bG161R-GCAP2 is retained at the 
inner segment in a high fraction of transfected cells we are indicating that this 
pathway of toxicity is very likely to contribute to the pathophysiology of the 
hG157R-GCAP2 mutation linked to adRP in human patients.  
In parallel to these genetic studies, we performed proteomic and biochemical 
analysis with the aim of identifying new protein interactors of the RetGC/GCAPs 
complex.  We performed a comparative proteomic approach from a pull-down of 
bovine ROS preparations with GCAP1, either in Ca2+ or EGTA conditions.  A 
rigorous label-free quantitative analysis, and a comparison of results with a negative 
control pull-down, allowed us to identify the “bonafide” putative candidates.  Among 
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them, we first focused on inosine monophosphate dehydrogenase (IMPDH1), the 
rate limiting enzyme in de novo synthesis of GTP, as IMPDH1 is directly linked to 
inherited retinal dystrophies. The importance of this protein interaction was also 
highlighted by the fact that we identified two other proteins involved in de novo GTP 
synthesis (GUK1 and the product of the ATIC gene), Figure IV.1 and Table IV.1. 
The question at stake was whether the de novo synthesis of GTP was linked 
to GTP conversion to cGMP in photoreceptor cells.  To test that, we first showed 
that IMPDH1 associated not only to GCAP1 but also to RetGC1 in rod outer segment 
preparations, and that these proteins co-migrated by size-exclusion chromatography 
fractionation of ROS homogenates.  We then established that the IMPDH1 
interaction with RetGC1 was direct, with a dissociation constant in the micromolar 
range.  In addition, we mapped the interaction and showed that it involved the 
dimerization of the cyclase.  We showed the implication of IMPDH1 CBS domain 
at modulating this interaction, and how human mutations clustering in this domain 
altered the efficnity of the interaction. Our results showed that the adRP R224P 
mutant of IMPDH1 substantially decreased the interaction with RetGC (40% in 
relationship to WT), while the N198K mutation associated to adLCA enhanced the 
interaction (1.57 times more than WT) (Figure IV.7).  
We conclude that the pathway of de novo GTP synthesis is coupled to the 
conversion of GTP to cGMP.  This unanticipated connection between multienzyme 
complexes in nucleotide metabolism may serve to allow an integrated spatial 
modulation of purine synthesis according to the dark/light physiology requirements 
in these specialized cells.  By bringing together inherited retinal dystrophy-causative 
genes so far considered unrelated, this finding opens a new conceptual framework to 
study the pathophysiology of these disorders (Figure 4.8).  The implications of this 
new scenario are that a mutation at the level of IMPDH1 could putatively affect 
RetGC1 function, or vice versa. Another relevant implication is that specific 
inhibitors of IMPDH could be tested to treat the inherited retinal dystrophies 
associated to mutations that lead to constitutive guanylate cyclase activity (mutations 
in GUCY2D encoding RetGC1 associated to adCD (Hunt et al., 2010); and 
mutations in GUCA1A encoding GCAP1 (Olshevskaya et al., 2004; Payne et al., 
1998)) or functional impairment of cGMP-PDE  (mutations in the different PDE 
subunits or in AIPL1 (Dvir et al., 2010; Huang et al., 1995; Kohl et al., 2012; 
McLaughlin et al., 1993; Ramamurthy et al., 2004; Thiadens et al., 2009)).  
Future experiments will be addressed at characterizing the precise 
contribution of the de novo and salvage pathways to GTP supply for 
phototransduction. By using IMPDH1-specific inhibitors, as well as inhibitors of the 
salvage pathway, we will try to determine the precise contribution of each route to 
photoreceptor cell physiology. 
Another important question to address in the characterization of this assembly 
of protein complexes in a macromolecular multienzyme complex, is whether 
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assembly and dissociation of the partners in light dependent.  - Is it regulated by 
light? - How? – What is the functional significance of this coupling? 
On the other hand, we have also identified and characterized an interactor of 
RetGC1 that appears highly specific of cone cells: the Creatine Kinase Brain-type, 
CKB (Figure V.1, V.2, V.3). Creatine Kinase is an enzyme involved in energy 
metabolism that is abundantly expressed in tisssues with high energy demand, like 
muscle and brain.  We here show that there is a clear colocalization of CKB with 
RetGC1, that is specific of cone outer segments. 
- Why is CK-B so abundant at cone outer segment and why does it associate 
to RetGC/GCAP complexes?  One explanation could be that cones presents a higher 
dynamic range than rods, with lower light sensitivity but faster response kinetics, 
and they respond to light over a higher range of ambient light intensities.  In this 
way, the energy requirement of cones could be higher than that of rods. Therefore, 
cones may rely on a fast energy supply system to maintain the local ATP 
requirements of the cell. The coefficient diffusion of PCr is higher than ATP (Hubley 
et al., 1995), and PCr would help to maintain a high concentration of ATP locally. 
 Further experiments will be needed to elucidate the precise role of CKB at 
maintaining light response kinetics and light adaptation capacity.  Future studies will 
base on using specific inhibitors of CKB on living mice while performing ERG 



































































1. The transgenesis methodology based on in vivo DNA electroporation reported 
by Dhup & Majumdar, Nature Methods 2008, when strictly reproduced as 
reported, results in a maximum efficiency of 1.43% of spermatozoid 
transfection, which yields it unpractical.   
   
2. In the absence of GCAP1 binding to RetGC1 there is no GCAP1 distribution 
to rod outer segments.  Assembly of the RetGC1/GCAP1 complex precedes 
its transport.  
 
3. GCAP1 myristoylation is required for GCAP1 distribution to rod outer 
segments. 
 
4. The human G157R-GCAP2 mutation linked to autosomal dominant retinitis 
pigmentosa leads to abnormal protein retention at the inner segment, which 
results in cell toxicity by a mechanism independent of cGMP metabolism. 
 
5. GCAP1 and RetGC1 pull-down assays, as well as size-exclussion 
fractionation from bovine rod outer segment preparations reveal an 
association of IMPDH1 to the RetGC/GCAPs complex. 
 
6. Retinal Guanylate Cyclase 1 (RetGC1) establishes a direct interaction with 
Inosine Monophosphate Dehydrogenase 1 (IMPDH1), the first and rate-
limiting step in de novo GTP synthesis.  This interaction has a dissociation 
constant in the micromolar range. 
7. The RetGC1 region involved in IMPDH1 interaction is the catalytic domain 
and C-terminal region of the protein.  This interaction requires the 
dimerization domain of RetGC1. 
 
8. The “Cystathione beta Synthase” domain of IMPDH1 regulates this 
interaction. 
 
9. Mutation R224P in IMPDH1 linked to autosomal dominant Retinitis 
Pigmentosa 10 (RP10) decreases the RetGC1-IMPDH1 interaction. 
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10.  Mutation N198K in IMPDH1 linked to rare Leber Congenital Amaurosis (ad 
rare LCA) enhances the RetGC1-IMPDH1 interaction. 
 
11. RetGC1 and IMPDH1 co-localize at the connecting cilium of rods and cones, 
and at rod outer segments where phototransduction takes place. 
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Conclusiones 
1. Cuando estrictamente reproducimos la metodología de transgénesis basada 
en la electroporación de DNA in vivo, publicada por Dhup & Majumdar, 
Nature Methods 2008, resulta en una eficiencia máxima del 1,43% de 
espermatozoides transfectados, cuyo rendimiento es impráctico. 
 
2. En ausencia de unión de GCAP1 a RetGC1, GCAP1 no se distribuye al 
segmento externo. El ensamblaje del complejo RetGC1/GCAP1 precede a su 
transporte. 
 
3. La miristoilación de GCAP1 es necesaria para su distribución al segmento 
externo.   
 
4. La mutación humana G157R_GCAP2, ligada a Retinitis Pigmentosa 
autosómica dominante  conduce a una retención anormal de la proteína en el 
segmento interno, lo que resulta tóxico para la célula mediante un mecanismo 
independiente del metabolismo de cGMP. 
 
5. Ensayos Pull-Down con GCAP1 y RetGC, así como cromatografía de 
exclusión de tamaño de preparaciones de segmentos externos de bastones, 
revelaron la asociación de IMPDH1 con el complejo RetGC/GCAPs. 
 
6. La guanilato ciclasa de retina (RetGC1) establece una interacción directa con 
la inosina monofosfato deshidrogenasa 1 (IMPDH1), la enzima responsable 
del paso limitante de la síntesis de novo de GTP. Esta interacción tiene una 
constante de disociación en el rango micromolar. 
 
7. La región del dominio catalítico y la del C-terminal de RetGC1 participan en 
la interacción con IMPDH1. Esta interacción requiere del dominio de 
dimerización de RetGC1. 
 
8. El dominio “Cystathione-β-Synthase” de IMPDH1 regula esta interacción.  
 
9. La mutación R224P de IMPDH1, ligada a Retinitis Pigmentosa autosómica 
dominante 10 (adRP10) disminuye la interacción de IMPDH1 con RetGC1. 
 
  Conclusiones 
166 
10. La mutación N198K de IMPDH1, ligada a una forma rara de Amaurosis 
Congénita de Leber (adLCA) aumenta la interacción entre IMPDH1 y 
RetGC1 
 
11. RetGC1 e IMPDH1 colocalizan en el cilio de conos y bastones y en el 
segmento externo, donde tiene lugar la fototransducción. 
 
12. La isoforma cerebral de la creatina quinasa se asocia a RetGC1 en el 
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Chapter VII: Materials and Methods 
Pertaining to animal research, this study was conducted in accordance with the 
ARVO statement for the use of animals in ophthalmic and vision research and in 
compliance with acts 5/1995 and 214/1997 for the welfare of experimental animals 
of the autonomous community (Generalitat) of Catalonia, and approved by the ethics 
committee on animal experiments of the University of Barcelona. 
7.1. Mouse Strains used and genotyping protocols. 
The following mouse strains have been used in this work: 
- C57Bl/6J (Charles River).  
- GCAP1 and GCAP2 double knockout mice (Mendez et al., 2001) (from here on 
referred to as GCAPs-/-). This transgenic line lacks the expression of both 
GCAP1 and GCAP2. 
- GCAPs-/- bGCAP2+ (Mendez et al., 2001)(also referred to as GCAP2 WT-E 
line). This transgenic line expresses bovine GCAP2 in the GCAPs-/-genetic 
background. 
 
For genotyping of the different mouse strains, genomic DNA was obtained from a 
small piece of tail, by digesting the tissue at 55ºC overnight in 250µl of tailing buffer 
[50mM TrisHCl pH8.0; 100mM EDTA; 0.5% SDS] with 0,5mg/ml of Proteinase K. 
125µl of 8M NH4OAc and 750µl of 98% ethanol were added to precipitate DNA.  
After DNA precipitation and washing, the DNA pellet was further purified by 
standard phenol-chloroform (Phenol-Chlorophorm-Isoamylalcohol 25:24:1) 
extraction and ethanol precipitation, and quantified. 
Polymerase Chain Reaction (PCR) genotyping was performed in 20µl 
reactions, by mixing 2µl of 10x PCR buffer with 0.16µl of deoxy nucleotide mix 
(dATP, dCTP, dGTP, dTTP, 25mM each), 0.6µl of 50mM MgCl2, 0.5µl of primer 
mix (forward and reverse primers at 20 pmol/µl each), 1µl of tail genomic DNA, and 
0.12 µl of Taq DNA Polymerase. PCR cycles typically included one initial 
dissociation step at 95oC for 3.5min; 30 cycles of amplification (94oC 30sec; 63oC 
30sec; 72oC 1min); and a final extension step of 72oC for 10min.  The annealing 
temperature was adjusted for each genotyping protocol depending on the pair of 
primers.  The pair of primers used for genotyping of each strain is indicated in 
Appendix II).  Amplified DNA bands were analyzed by electrophoresis in a 0.8% 
agarose gel in 1xTAE buffer. 
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7.2. Bacterial Strains used for cloning work and protein expression.  
All bacterial strains used in this study were commercial modifications from E. coli. 
7.2.1. Cloning strains: 
- XL1-Blue. This strain was used for general cloning purposes and site-directed 
mutagenesis. Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)]. 
- DH10β. For general cloning purposes. Genotype: F– endA1 deoR+ recA1 galE15 
galK16nupG rpsL Δ(lac)X74 φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mr
r-hsdRMS-mcrBC) StrR λ–. 
- GT115 (Invivogen). This strain was used for cloning and maintaining pCpG 
plasmids devoid of CpG dinucleotides. Genotype: F- mcrA ∆(mrr-hsdRMS-
mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 rspL (StrA) endA1 ∆dcm uidA(∆MluI)::pir-
116 ∆sbcC-sbcD. 
- Dam-/Dcm- (#C2925 from NEB). Methyltransferase deficient E. coli cells suitable 
for growth of plasmids free of Dam and Dcm methylation. Genotype: ara-14 leuB6 
fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1 
R(zgb210::Tn10) TetS endA1 rspL136 (StrR) dam13::Tn9 (CamR) xylA-5 mtl-1 thi-
1 mcrB1 hsdR2 
 
7.2.2. Protein expression strain: 
- BL21(DE3). High-efficiency of protein expression under control of T7 promoter. 
This strain allows control of expression by IPTG. Genotype:F–, ompT, hsdSB (rB–
, mB–), dcm, gal, λ(DE3). 
 
7.3. Competent bacterial cells for DNA transfection: 
7.3.1. For DNA electroporation.  
Molecular Cloning (Sambrook and Russel, 2001): chapter 1, protocol 26. 
Briefly, bacteria are grown to mid-log phase, chilled, centrifuged, and washed 
extensively with an ice-cold buffer or H2O to reduce the ionic strength of the cell 
suspension, and then suspended in an ice-cold buffer containing 10% glycerol. We 
typically obtain a cloning efficiency of 109-10transformants/µg of DNA with this 
protocol. 
7.3.2. Chemically competent cells by TSS method.  
Modified from Chung et al (Chung et al., 1989). This protocol typically yields 
an efficiency of 107transformants/µg of DNA. Briefly, TSS buffer is prepared (LB 
medium supplemented with 10% (w/v) PEG 8000, 30mM MgCl2, 5% (v/v) DMSO. 
pH6,5), sterilized by filtration (0.22μm filter) and chilled in advance. 50ml of LB 
media are inoculated with 500ul of an overnight cell culture, and bacteria are grown 
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to mid-log phase. (OD600 of 0.2 - 0.5). Carry out all subsequent steps at 4ºC. Cell 
pellets are obtained by centrifugation for 10 minutes at 3000 rpm at 4oC and 
resuspend in 5ml of TSS buffer. 100 μl aliquots into pre-chilled eppendorfs were 
stored at − 80oC. For transformation, TSS cells were thawed on ice. DNA was added 
and the mix was incubated for 30min on ice. The mix was then incubated at 42oC for 
30sec (heat shock) and returned to ice for 2min. Cells were allowed to recover in 
SOC medium for 1h at 37°C under shaking, and plated.  
7.4. cDNA cloning and generation of expression vectors. 
7.4.1. Materials used in PCR work.  
The following DNA polymerases were used, following manufacturer’s 
instructions: 
- PCR amplification in genotyping reactions:  Taq polymerase (Invitrogen) or 
BioTaq (Bioline). 
- PCR amplification for DNA cloning purposes: High-Fidelity PCR DNA 
polymerases: Pfu Ultra II Turbo HS (Agilent) or KOD polymerase (Millipore). 
7.4.2. Total RNA extraction and cDNA synthesis from RNA. 
Retinas for RNA extraction were dissected in ice-cold PBS. RNA was 
extracted by homogenizing each murine retina in 200µl of Trizol reagent 
(Invitrogen), adding 40µl of CHCl3, vortexing for 1min and letting sit on ice for 
15min. Samples were centrifuged at maximal speed for 15min at 4ºC, and the 
aqueous phase transferred to a new tube, where it was mixed with a volume of 
isopropanol and kept at -80ºC until use. RNA precipitation was performed by 
centrifugation at maximal speed for 30min at 4ºC. After washing and drying, the 
RNA was resuspended in 20µl of RNAase-free water. cDNA synthesis was 
performed with the High-capacity cDNA reverse transcription kit 
(#4368814.ThermoFisher Scientific), following manufacturer’s instructions.  
 
 7.4.3. Generation of mammalian expression vectors for in vivo DNA 
electroporation. 
For cloning of reporter genes into a plasmid completely devoid of CpG islets, 
the  pCpG-free plasmid was purchased from Invivogen (#pcpgf-mcs) and the cDNA 
for the enhanced green fluorescent protein (EGFP) was amplified from the pL_UG 
plasmid (#L01GLUG001XA. SignalingGateway) with primers P5-P6 and cloned 
into the BglII and NheI sites of pCpG-free. The cDNA for Mito-DsRed (the reporter 
gene encoding the DsRed fluorescent protein fused to a mitochondrial localization 
signal) was amplified from pDsRed2-Mito (#632421. Clontech, a gift from Dr. Anna 
Aragay); with primers P4-P52, digested with BamHI/KpnI and cloned into the 
BglII/KpnI sites of pCpG-free. 
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For generation of the mammalian expression vectors based on the different 
versions of the Mouse Opsin Promoter (MOP), a deletion by PCR strategy was used 
(Imai et al., 1991), using MOP-I plasmid as the original template.  
 First, 2kb upstream of Enhancer was deleted by amplification of plasmid 
MOP-I as template, with primers P9-P10, and the fragment was self-ligated to 
generate 2Kb-MOP. The CpG island of pMOP was removed using the same strategy, 
using as template 2Kb-MOP and primers P11-P12, generating pMOPII. For 
generation of pMOP-III, primers P10&P11 were used and pMOP-I as template. 
To generate pMOPII flanked by HS4 DNA barrier insulator sequences, two 
copies of HS4 were cloned upstream of the expression cassette. For this purpose, 
HS4 was amplified with primers P15-P16 from p1Fel (a gift from Dr. Lluis 
Montoliú) and inserted at the KpnI site of pMOPII. Clones with two tandem inserts 
in the same orientation were selected by restriction mapping analysis. One copy of 
HS4 was inserted into downstream of the expression cassette. HS4 was amplified 
from p1Fel with primers P17 -P18 and cloned into the EagI site of pMOPII. 
For cloning the MOP-GCAP2-pA expression cassette into pCpG plasmid, the 
pCpG plasmid was amplified with primers P13-P14 to add KpnI and XbaI sites to 
the pCpG plasmid, and the fragment KpnI-MOP-GCAP-pA-XbaI inserted.  
For generation of a mammalian expression vector of hGCAP1 under the MOP, 
hGCAP1 cDNA was amplified from pET21b-hGCAP1 plasmid (see below) with 
primers P19-P20 and inserted into the XhoI/BamHI sites of pMOP.  
The collection of GCAP1 and GCAP2 mutants generated for subretinal 
injection and electroporation, presented in chapter III, were generated by site-
directed mutagenesis using the Quick-Change kit (Stratagene) and primers P21 to 
P36 (Appendix II). 
 
7.4.4. Generation of bacterial expression vectors for protein expression. 
The plasmid for human GCAP1 expression in bacteria was originally 
developed in Dr. James Hurley´s laboratory, and contains the human GCAP1 cDNA 
into the NdeI and BamHI sites of pET21b (Novagen, Merck Millipore). Two 
different bacterial expression vectors for IMPDH1 were obtained based on the cDNA 
of the bovine IMPDH1 canonical isoform into different plasmids. The cDNA  of 
IMPDH1 canonical isoform (514 aa, UniprotKB/Swiss-Prot: A0JNA3.2; 
GI:378548423) was obtained from total RNA from bovine retina using the High-
capacity cDNA reverse transcription kit from ThermoFisher Scientific, and 
amplified by PCR using the KOD hot start DNA polymerase (Millipore), using either 
the pair of primers P1-P2 or P3-P4 (see Appendix II for primers sequences). Bovine 
IMPDH1 cDNA was introduced into the NdeI-BamHI sites of pET15b (Novagene, 
Merck Millipore, therefore creating a fusion protein with a His.tag at the NH2-
terminus) or BglII- XhoI sites of pET32a-LIC (a gift from Dr. Cheryl Arrowsmith 
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obtained from Addgene, creating a fusion protein with Thioredoxin-His.tag at the 
NH2-terminus). The IMPDH1ΔCBS construct (which lacks the tandem repeats of 
the CBS domain at residues E111-K242) was generated from plasmid pET32a-LIC-
bIMPDH1 by PCR deletion with primers P5-P6. Plasmid pET32a-LIC-bIMPDH1 
was also used as template for generation of the R105W, N198K, R224P, and D226N 
individual mutants, by using the Site-directed mutagenesis kit from Agilent, and 
primers P7-P14. All cloning work in the generation of E. coli expression vectors was 
confirmed by sequencing. Human retinal guanylate cyclase bacterial expression 
vectors:  RetGC-JMD/KHD (M496-K806), RetGC-DD/CD (N807-S1103), and 
RetGC-CD (G868-S1103) were a generous gift from Dr. Karl W. Koch (University 
of Oldenburg) and consisted of the corresponding cDNA fragments cloned into 
pDB.His.MBP (from the Berkeley Structural Genomics Center through the DNASU 
Plasmid Repository), that adds a His-tag and Maltose Binding Protein (MBP) at the 
NH2-terminus in frame with the gene of interest. Plasmid containing NH2-terminus 
fusion protein of His-tag with creatine kinase human isoform was purchased from 
DNASU (pMCSG7-hCKB, #HsCD00343148). 
 
7.5. Bacterial Protein Expression. 
For protein expression, chemical transformation was performed on E. coli BL-
21(DE3) strain.  Cells were grown at 37°C in 500 ml cultures in Luria Broth medium 
with antibiotic (100µg/ml Ampicillin or 50µg/ml Kanamycin) to an OD600 of 0.5, 
and protein expression was induced by addition of 1mM IPTG for 4h.  For 
myristoylation of GCAP1, cells were cotransformed with pBB131 plasmid encoding 
N-myristoyl transferase (NMT) (a gift from Dr. J. Gordon, Washington University 
School of Medicine, Missouri, USA), and free myristic acid was added to a final 
concentration of 50µg/ml 30 min before of induction of expression. In the case of 
GCAP1 and the MBP-fused RetGC1 fragments the proteins were in the insoluble 
fraction of bacterial extracts, and had to be purified from inclusion bodies. Briefly, 
inclusion bodies were obtained in a series of steps of bacterial lysis by sonication 
followed by sedimentation, in lysis buffer (100mM Sodium phosphate pH8, 150mM 
NaCl, 1mM PMSF, 1mg/ml lysozyme). Purified inclusion bodies were solubilized 
in 6M Guanidinium-HCl in 100mM sodium phosphate pH8, 150mM NaCl, 25mM 
Imidazole, clarified by centrifugation at 30000g for 30min and loaded to a pre-
equilibrated 5ml HisTrapTM Chelating HP Columns (GE Healthcare). A protocol 
for on-column refolding was then performed by first exchanging 6M urea for the 6M 
guanidinium-HCl in the running buffer (100mM sodium phosphate pH8, 150mM 
NaCl, 25mM Imidazole, pH8.0) and then subjecting the column to a decreasing 
gradient of urea (6M to 0M in running buffer, in 30 column volumes). Proteins were 
then eluted in 100mM sodium phosphate pH8, 150mM NaCl, 500mM imidazole, 
and concentrated with 10 kDa MWCO Amicon Ultra-15 centrifugation filter units 
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(Millipore) for the removal of imidazole. Protein stocks were either kept at -80oC 
(GCAP1) or kept at 4oC and used shortly after purification (RetGC1 fragments). 
Bovine His.IMPDH1 expressed from plasmid pET15b in E coli BL21 was 
mostly insoluble and had to be purified from inclusion bodies and refolded. Inclusion 
bodies were obtained and solubilized in 6M guanidinium-HCl as indicated above. 
After clarification (12000rpm, 20min, 4oC), the protein was purified by metal 
chelation with 5ml HisTrapTM Chelating HP Columns (GE Healthcare) in the 
presence of 6M Guanidinium-HCl (Running buffer: 20mM Hepes, 200mM NaCl, 
6M Guanidinium-HCl, 10mM β-mercaptoethanol, 10mM imidazole, pH8.0) and 
eluted with 500mM imidazol in running buffer. His.IMPDH1 was refolded by three 
steps of dialysis, to gradually decrease the urea concentration: 1) against dialysis 
buffer (20mM Hepes pH 8.0; 200mM NaCl) with 6M urea; and 2) against dialysis 
buffer with 3M urea; and 3) against dialysis buffer with 1M urea and 0.4M arginine. 
The presence of 1M urea and 0.4M Arginine (Wang et al., 2011) was required to 
maintain the protein in soluble form. His.IMPDH1 was concentrated using 10 kDa 
MWCO Amicon Ultra-15 centrifugation filter units to obtain a protein stock at 
2.5mg/ml (in 1M urea, 0.4M Arg), that was either used for injecting rabbits for 
antibody production, or crosslinked to an Aminolink Resin (ThermoFisher 
Scientific) to generate IMPDH1-immobilyzed resin for pull-down assays. 
Thioredoxin-fused IMPDH1 (Trx.His.IMPDH1), IMPDH1ΔCBS and the four 
mutants (R105W, N198K, R224P, and D226N) were partially soluble when 
expressed from pET32a-LIC-bIMPDH1 plasmid in E coli BL21 strain. Proteins 
could be purified from the soluble fraction of bacterial extracts. Briefly, bacterial 
cells were lysed in Lysis Buffer (100mM Sodium phosphate pH8, 150mM NaCl, 
25mM Imidazole, 1mM PMSF, 1mg/ml lysozyme, 5ug/ml DNaseI and 5ug/ml 
RNaseA) and sonicated (pulses) for 1min in ice. After clarification at 20000g for 
30min at 4oC, the soluble fractions were bound to TALON® Metal Affinity Resin 
by metal chelation to the His.tag (#635501, Clontech).  Trx.His.IMPDH1-
immobilized resin (wildtype protein and the four mutants) was kept and directly used 
in pull-down assays to test the effect of the mutation on the RetGC interaction. To 
obtain a soluble source of Trx.His.IMPDH1 for Surface Plasmon Resonance (SPR) 
binding studies, the protein was eluted in 20mM Hepes pH 8, 115mM KCl, 10mM 
NaCl, 10mM MgCl2, and 500mM Imizadole. The protein was kept at 4oC and used 
shortly after purification. His.hCKB was purified from supernatant fractions as 
Trx.His.IMPDH1 
7.6. Southern Blot 
Southern transfer and hybridization (Southern, 1975) is typically used to study 
how genes are organized within genomes by mapping restriction sites in and around 
segments of genomic DNA for which specific probes are available. Genomic DNA 
is first digested with one or more restriction enzymes, and the resulting fragments 
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are separated according to size by electrophoresis through a standard agarose gel. 
The DNA is then denatured in situ and transferred from the gel to a solid support 
(usually a nylon or nitrocellulose membrane). The DNA attached to the membrane 
is hybridized to a labeled DNA, RNA, or oligonucleotide probe, and bands 
complementary to the probe are located by an appropriate detection system, for 
example, by autoradiography. By estimating the size and number of the bands 
generated after digestion of the genomic DNA with different restriction enzymes, 
singly or in combination, it is possible to place the target DNA within a context of 
restriction sites(Sambrook and Russel, 2001). 
10µg of genomic DNA obtained from mouse tails were digested with 
affordable selected restriction enzyme, maintaining a ratio of 10u/µg of DNA. After 
complete digestion, loading buffer (0.04% xylene cyanol FF, 2.5% Ficoll (Type400) 
in H2O) was added to the samples, and samples were run in a 1% agarose gel without 
Ethidium bromide or Sybr Safe. (No more than 10ng of an internal control of digested 
pMOP-I plasmid was added as internal reference of molecular weight). Immediately 
after the run, the gel was transferred to a glass baking dish, and a razor blade was 
used to trim away unused areas of the gel, including the section of gel above the 
wells. A small triangular piece from the bottom left-hand corner of the gel was cut 
off for orientation purposes. The gel was incubated for 10min in 0.2N HCl, and 
rinsed in ddH2O several times. To denature the DNA, the gel was soaked in 
Denaturation Solution (1.5M NaCl, 0.5M NaOH) for 45min, and rinsed with ddH2O. 
The gel was incubated for 45min in Neutralization Buffer (1M Tris-HCl pH7.4, 1.5M 
NaCl). A piece of nylon membrane (Byodyne B Nylon membrane. Pall) was cut 
about 1mm larger than gel. Two sheets of thick blotting paper (3MM Whatman) were 
cut to the same size as the membrane. The nylon membrane was floated on the 
surface of a dish of ddH2O until it was completed wet, and then immersed in 5xSSPE 
[20x SSPE (3M NaCl, 0.2M NaH2PO4, 0.02M EDTA, pH7,4)] for at least 5min. The 
corner of the membrane was marked to match the corner cut from the gel. An upward 
capillary transfer system was assembled by placing a long Whatmann 3MM paper 
covering the support in direct contact with the inverted gel. The Nylon membrane 
was placed in direct contact with the gel avoiding any bubbles. The membrane was 
covered with some sheets of Whatmann 3MM and about a 5cm-thickness of paper 
towels. A weight was placed on top, to allow the transfer to proceed overnight.  
Once the transfer was done, DNA in the membrane was cross-linked to it 
under UV light. The membrane was rinsed with ddH2O, dried and kept until use.  
For the labelling by hybridization, a probe was synthesized by radiolabeling 
of DNA fragments by extension of oligonucleotides [Molecular Cloning, Chapeter 
9, protocol 1]. Briefly, 25ng of PCR-amplified DNA of the desired probe was mixed 
with 125 ng of random hexamers in 30µl of water (50µM), boiled for 2 minutes and 
placed on ice for 1 minute. To the 30µl mixture, the following reagents were added:  
8µl of ddH2O, 1µl dNTPs 5mM each excluding dCTP (dATP, dGTP, dTTP, without 
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dCTP), 5µl of 10x NEB2 Buffer (500mM NaCl, 100mM Tris-HCL pH 7.9, 100mM 
MgCl2, 10mM DTT), 5 units of Klenow DNA polymerase and 5µl of 10mCi/ml α-
32P dCTP. After 1h incubation at RT (25ºC), 10µl of NA Stop/Storage Buffer was 
added (50mM Tris-Cl pH7.5, 50mM NaCl, 5mM EDTA, 0,5% (w/v) SDS). The 
labelled probe was purified with an Elutip-D Colunm (Whatman), and its activity 
measured at the scintillation counter. The membrane was hydrated with wash 
solution #1 (2xSSPE) and prehybridized for a minimum of 1h at 65ºC in pre-warmed 
hybridization solution (10% (w/v) dextran sulphate, 5xSSPE, 2% (w/v) SDS) at 65ºC 
containing 1xDenhardt’s [50x Denhardt’s Solution:1% (w/v) Ficoll 400, 1% (w/v) 
polyvinylpyrrolidone, 1% (w/v) Bovine serum albumin]and boiled salmon sperm 
DNA 10µg/ml (Agilent). For hybridization, the dsDNA probe was denatured by 
incubation at 95ºC for 5min and immediate placement on ice. Prehybridization 
solution was replaced with fresh hybridization solution containing 1xDenhardt’s and 
boiled salmon sperm DNA and the probe. As little solution as possible was used. 
Hybridization was allowed to proceed overnight at 60ºC. Subsequently the 
membrane was carefully removed from the hybridization solution and placed into a 
clean container for washing. Membrane was washed twice at room temperature in 
Solution #1, twice for 15min at 55ºC with Solution #2 (2xSSPE, 1% (w/v) SDS) and 
twice for 15min at 55ºC with Solution #3 (0.1x SSPE). Membrane was exposed in 
darkroom to X-ray film for 24-48h at -80ºC. 
 
7.7. In Vivo DNA electroporation in the retina  
In vivo DNA electroporation in the retina following DNA injection in the 
subretinal space was developed by C. Cepko´s laboratory (Matsuda and Cepko, 
2004) at Harvard in 2004. This technique allows transient expression of a gene of 
interest into photoreceptor cells, if a photoreceptor-specific promoter is used.  
We have implemented Cepko´s procedures in the laboratory with minor 
modifications. The plasmid DNA was amplified in bacteria and purified by maxiprep 
(Qiagen plasmid maxi kit. Qiagen). A DNA solution (6µg/µl) in PBS and fast green 
0,1% dye was prepared by mixing the expression vector of interest (circular plasmid) 
with a GFP encoding plasmid (pL_UG) at a molar ratio of 2:1. The plasmid encoding 
EGFP is added to easily identify the injection area at the step of analysis, 25 days 
later. For in vivo DNA electroporation, new born mouse pups at postnatal day 1 are 
used. Briefly, pups are anesthetized by submersion in ice for 4min.  At a stereo 
microscope, an opening is performed with a scalpel following the natural line of the 
eyelid, after cleaning the zone with povidone-iodine solution. A small incision is 
then performed on the sclera, with a 30-gauge needle. For DNA injection, we used 
customized capillary glass pipettes [(#300048. Harvard Apparatus), pulled in a 
Puller P-97 from Sutter Instruments according to the following parameters: 
heat=650, Pull=60, Velocity=60, Time=200)]. The capillary glass pipettes were 
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attached to a nanoinjector (Drummond Nanoject) and were managed by a 
micromanipulator. After inserting the glass pipette in the eye, and carefully 
micromanipulating it to reach the subretinal space (reached when the pipette meets 
the resistance of the back of the eye upon touching the choroid), approximately 0,5-
1µl of circular naked DNA were delivered. After DNA injection, tweezer-type 
electrodes briefly soaked in PBS were placed to softly hold the heads of the pups 
placing the positive electrode of the tweezer over the injected eye, and five square 
pulses of 80V of 50-ms duration with 950-ms intervals were applied by using a pulse 
generator (CUY21, Nepagene). Pups were left to recovery over a thermal blanket 
until the end of procedure, returned to their cage and raised in normal conditions. 
Mice were processed at postnatal day 25-30.  
 
 
7.8. In Vivo DNA electroporation into the male germ line of mice 
C57Bl/6J males at 30 days-of-age were used in the electroporation procedures. 
Mice were anesthetized with ketamine (40mg/kg) and xylacine (check spelling) 
(5mg/kg) by intraperitoneal injection, and buprenorphine (0,012mg/kg) by 
subcutaneous injection. The area of the scrotum was shaved with an electric razor-
blade, and cleaned with ethanol 70º and povidone-iodine solution. A small incision 
was performed following the scrotal raphe so that both testis were exposed.  
In hemicastration procedures, the right testis was castrated by knotting the vas 
deferent and associated arteries and veins, and cutting through them. The left testis 
B A 
Figure VII.1. A. Image showing the eyelid and an outline of the incisura that will be 
cut with a scalpel, following that natural opening line of the eyelid. B. Schematic 
figure of injection and electroporation. Adapted from Matsuda & Cepko 2004. 
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was injected with a solution of DNA (0,5µg/µl) in PBS with Trypan Blue 0,04% as 
a tracer. In contrast to the procedure of DNA electroporation in the retina, in which 
circular plasmid DNAs are injected for transient transgenic expression, DNA 
injected in the testis proceeds from bacterial maxipreparations, but was purified by 
CsCl gradient (Sambrook and Russel, 2001) and linearized,  given that what we 
pursue is DNA integration in the genome.  Typically, DNA is linearized by overnight 
restriction digestion and subsequently purified by phenol-chlorophorm extraction 
and ethanol precipitation. About 25µl (12µg) of DNA solution is injected into each 
testis at three different locations, by using a 28gauge bevel-end needle coupled to a 
Hamilton syringe (#7636-01, Hamilton Company). It is crucial that the injection does 
not affect the internal pressure of the testis so it is important to do it slowly. After 
DNA injection, tweezer-type electrodes briefly soaked in PBS were placed over the 
testis and two rounds of four square pulses of 60V of 50-ms duration with 950-ms 
intervals alternating direction of electric field were applied by using a pulse 
generator (CUY21, Nepagene). The electroporated testis is repositioned into the 
scrotum and stitched with vicryl 5-0 sutures (J303H, Johnson and Johnson). After 
the surgery, and once the anaesthesia effect is extinguishing, meloxicam 5mg/kg 
(Metacam 5mg/ml. Boehringer Ingelheim) is applied by subcutaneous injection.  
An alternative procedure for DNA injection avoiding surgery was also 
performed. In this procedure, mice were injected through the scrotum wall, by 
injecting each testis with 20-25 µl DNA solution. Both testis were held 
simultaneously with the electroporator tweezers and electroporation was performed 
as described above. Thirty-five days after injection, electroporated mice were mated 
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7.9. Immunofluorescence localization assays in bovine or murine 
retinas. 
For immunofluorescence localization assays in bovine eyes, bovine eyes were 
obtained approximately 10min postmortem and were immediately processed on 
location.  Mice were opened by a clean cut to remove the cornea, and submerged in 
fixative (4% paraformaldehyde in phosphate buffer saline pH7.4) for 2h at room 
temperature. For mice eyes, mice were sacrificed and eyes were marked at the 
superior center for orientation purposes. Immediately after enucleation the eyes were 
punctured with a needle and submerged in fixative (4% paraformaldehyde; 0.02% 
glutaraldehyde in phosphate buffer saline at pH7.4). The cornea was excised, and at 
Figure VII.2. Schematic procedures for in vivo DNA electroporation at the gonad. 
A. Surgery with hemicastration (H) and DNA injection at remaining testis. B. 
Surgery with injection of both testis (S). C. Invasive injection trans-scrotum (T). 
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1h in fixative, the lens was removed and the eyecups were further fixed for a total of 
2 h at room temperature. Eyecups were washed in PBS and then infiltrated in 
acrylamide (8.4% acrylamide, 0.014% bisacrylamide in PBS pH7.4 for 14 h before 
acrylamide polymerization was induced), included in OCT compound and frozen in 
liquid nitrogen. OCT blocks were stored at -80oC until used.  Cryosections along the 
vertical axis of the eyecup were obtained at 20 µm-thickness using a CM1510S Leica 
cryostat (Leica Microsystems).  
Sections were incubated with blocking solution (3% normal goat serum, 1% 
BSA, 0,3% Triton-X100 in PBS pH7.4, 1 h at room temperature); first antibody (16h 
at 4ºC), secondary antibody (1h 30min at room temperature), and fixed for 15 min 
in 4% paraformaldehyde prior to being mounted with Mowiol [Calbiochem 475904]. 
Images were acquired at a laser scanning confocal microscope (Leica TCS-
SL and TCS-SP2). Images were processed with Leica confocal software Lite and 
ImageJ. 
 
7.10. Bovine Retinal Fractionation and preparations of bovine rod 
outer segments. 
Bovine eyes were obtained at a local slaughterhouse at about 15min 
postmortem and were dark adapted for 1h in oxigenated Locke’s Buffer (10mM 
HEPES pH7.4, 136mM NaCl, 3.6mM KCl, 2.4mM MgCl2, 1.2mM CaCl2, 20mM 
NaHCO2, 0.02mM EDTA, 10mM Glucose, 1mM PMSF) in ice. From that point on, 
the retinal dissection and tissue fractionation procedure were performed under dim-
red light.  Pools of ten retinas were collected in SS34 centrifuge tubes, in 15ml of 
Buffer A (100mM NaH2PO4.H2O pH6.5, 0,1mM EDTA, 2mM MgCl2) with 25% 
sucrose. Rod outer segments were gradually collected in five cycles of mechanical 
disruption of this organelle from the retinas by vortexing (2min vortex at 1800rpm 
in buffer A with 25% sucrose) followed by its collection from the supernatant 
fraction after centrifugation at 180g, 10min, 4oC. The combined supernatant 
fractions from these cycles were diluted in 2 volumes of buffer A and rod outer 
segments were pelleted by centrifugation (40000g, 15min, 4oC). The pellet was 
resuspended in 2ml of buffer A and loaded on top of a two-step 30%-35% sucrose 
cushion in buffer A (16ml:16ml), and centrifuged at 140000g for 90min at 4oC. ROS 
were collected at the interface, diluted in buffer A and pelleted at 40000g, 15min and 
4oC. Pellets were resuspended in 20mM HEPES pH7.4 and stored in aliquots at -
80°C. Rhodopsin concentration was calculated using as molar extinction coefficient 
Ɛ500=40600 M/cm. 
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7.11. Proteomic studies and protein biochemical analysis: 
immunoprecipitation and pull-down assays, liquid chromatography 
and mass spectrometry. 
7.11.1. GCAP1 pull-down assays in the proteomic approach to identify new 
GCAP1 interacting proteins. 
100µg of GCAP1 were crosslinked to 10mg of magnetic beads (Dynabeads® 
M-270 Epoxy, ThermoScientific) according to manufacturer’s instructions. GCAP1-
immobilized beads were divided into two equal aliquots to perform parallel pull-
down assays in Ca2+ or EGTA conditions. Each aliquot was incubated for 1h at 
room temperature with 1.5mg of bovine ROS solubilized in 1% Triton X100 in 
binding buffer (20mM HEPES pH7.4, 135mM NaCl, 5mM KCl, 1mM NaF, 1mM 
PMSF, 1mM β-mercapto-ethanol, 1% Triton X-100, cOmplete™ Mini EDTA-free 
Protease Inhibitor Cocktail) containing either 5mM CaCl2 (Ca2+-condition) or 4mM 
EGTA/1.5mM MgCl2 (EGTA-condition). After the binding step the beads were 
washed and bound material was eluted with 0.2M Glycine-HCl pH 2.5. The beads 
were washed and used on two more 1h serial binding steps with the sample. Serial 
elution fractions were combined, neutralized, and concentrated by ethanol 
precipitation. 
A parallel pull-down assay was performed with Ran (a cytosolic protein 
similar in size to GCAP1), under identical Ca2+ or EGTA conditions using the same 
bov ROS as starting material, as a negative control.  For LC/MS-MS samples were 
treated and analyzed as previously detailed (López-del Hoyo et al., 2014), with the 
modifications here detailed.  For LC/MS-MS analysis, samples were reduced; 
alkylated; precipitated; resuspended in 1.6M urea and digested with trypsin (37oC, 
14h).  Tryptic peptides were separated by nano liquid chromatography [Proxeon 
EASY-nLC, EASY C18 trap column, EASY C18 analytical column (Thermo Fisher 
Scientific)].  A 0-40% buffer B linear gradient in 90min was employed, using solvent 
B (97% ACN, 0.1% formic acid) and solvent A (3% ACN, 0.1% formic acid).  
MS/MS analysis was performed using an LTQ Orbitrap Velos (Thermo Fisher 
Scientific) with a nano electrospray ion source with precursor ion selection in the 
Orbitrap at 30000 resolution, selecting the 20 most intense precursor ions in positive 
ion mode.  MS/MS data acquisition was completed using Xcalibur 2.1 (Thermo 
Fisher Scientific). For identification of peptides, collision energy (CE) of 35% was 
the fragmentation method used.  For protein identification, data was processed using 
Proteome Discoverer 1.4.1.14 (Thermo Fisher Scientific). 
For database searching, raw mass spectrometry files were submitted to the in-
house MOUSE-BOVIN_UP_SP_r_2014-5.fasta Swiss-Prot database (released 
February 2014; 22460 protein entries) using SEQUEST version 28.0 (Thermo Fisher 
Scientific).  The criteria used to accept identification included a minimum of 2 
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peptides matched per protein, with a false discovery rate (FDR) of 1%.  All proteins 
were treated as ungrouped.   
For label-free quantitative proteomic analysis the “GCAP1-Ca2+” and 
“GCAP1-EGTA” protein lists were filtered to remove any duplications resulting 
from the use of bovine and mouse fasta sequence libraries, and only those proteins 
unequivocally assigned by at least a unique peptide were retained.  The equation in 
Fig 1 was applied, where for each protein RSC (Ratio from Spectral Count) is the log2 
ratio of abundance between Samples 1 (Ca2+) and 2 (EGTA); n1 and n2 are spectral 
counts for the protein in Samples 1 and 2, respectively; t1 and t2 are total numbers of 
spectra over all proteins in the two samples; and f is a correction factor set to 0.5.  
This expression corrects for differences in sampling depth between both conditions, 
and avoids the discontinuity seen in simple count ratios when a protein shows 
spectral count = 0 in one of the samples.   
 
 7.11.2. Immunoprecipitation of GCAP1 and IMPDH1 
For immunoprecipitation assays of GCAP1 or IMPDH1, 2µg of monoclonal 
Ab α-GCAP1 (MAI-724, Thermo Scientific) or purified polyclonal antibody α-
IMPDH1 (generated in the lab) were incubated for 15min with 40µl of Dynabeads-
Protein G (LifeTechnologies). Following washing and pre-equilibration in 
homogenization Buffer [20mM HEPES pH7.2, 115mM KCl, 10mM NaCl, 10mM 
MgCl2, 1.3mM D(+)-Trehalose, 1mM n-Dodecyl β-D-maltoside  (DDM), 1mM 
PMSF, 1mM NaF, 0.5mM CaCl2, 1mM β-Glycerophosphate, 1mM ATP, 1mM IMP, 
1mM NAD+, 0.2mM Mycophenolic acid (MPA)], the beads were incubated with 
4mg of total bovine retinal extracts or 2mg of bovine ROS preparations in 
homogenization buffer with 20mM DDM and 1mM MPA for 1h at RT. The beads 
were washed and boiled in 1x Laemmli SDS sample buffer, for SDS-PAGE analysis.  
In a typical experiment, 2% of the input and flow through fractions were loaded 
adjacent to 100% of the bound fraction. Proteins in the gels were transferred to 
nitrocellulose membranes and immunoblotted with the different host antibodies 
listed in annex table II. Secondary antibodies were conjugated to fluorescent dyes 
for use in the Odyssey scan system. Images were acquired at the Odyssey Imaging 
System (LI-COR, Lincol, Nebraska USA). 
 
7.11.3.  IMPDH1 pull-down assays performed on whole retinal 
homogenates. 
For IMPDH1 pull-down assays on whole retinal homogenates, a recombinant 
form of the bovine canonical IMPDH1 protein fused to a His tag (His.IMPDH1) was 
immobilized to Aminolink Plus Coupling Resin (#20501. ThermoFisher Scientific). 
IMPDH1-immobilized resin (corresponding to about 100µg of bovine His.IMPDH1 
crosslinked to Aminolink resin) was used per pull-down assay, using 10mg of total 
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bovine retina extract or 2mg of bROS in the homogenization buffer used for 
immunoprecipitation assays.   
 
 7.11.4. IMPDH1 pull-down assays to study the effect of IMPDH1 
blindness-associated mutations on the affinity of IMPDH1 for RetGC1. 
For the pull-down assays comparing individual IMPDH1 mutants, mutant 
IMPDH1 protein was bound to TALON resin by metal chelation (based on the His 
tag in the recombinant proteins), and aliquots of IMPDH1-immobilized resin 
corresponding to an equal amount of IMPDH1 in each sample (wildtype and R105W, 
N198K, R224P, and D226N individual mutants) were used as bait in pull-down 
assays of 10mg of total bovine retinal extracts in homogenization buffer.  For 
Western blot detection, nitrocellulose membranes were incubated with anti-RetGC1 
pAb and IRDye 800CW Donkey anti-rabbit antibody (LI-COR Biosciences).  
Images were acquired and band densities were quantified with Odyssey application 
software 3.0.  Statistical analysis was done with the GraphPad Prism 6, with one-
way ANOVA by Dunnett’s test (α=0.05).  RectGC1 pull-down assays were 
performed with the truncated forms of the protein as detailed, using whole retinal 
homogenates as starting material. 
 
7.11.5. Pull-down assays with the different RetGC fragments.  
RectGC1 pull-down assays were performed with the truncated forms of the 
protein (write-down here the three fragments used in the RetGC pull-down figure) 
by binding the corresponding recombinant proteins to His-chelating columns (Ge 
Healthcare) , washing and pre-equilibrating, before performing the binding step with 
whole retinal homogenates.  After extensive washing on the columns, acidic elution 
was performed with Glycine pH2.0.  Bound proteins were identified by SDS-PAGE 
and Western Blot. 
 
7.12. Size Exclusion Chromatography 
A fraction corresponding to 1mg total protein of bov ROS was solubilized in 
solubilization buffer (20mM HEPES pH7.2, 115mM KCl, 10mM NaCl, 10mM 
MgCl2, 1.3mM D(+)-Trehalose, 20mM DDM, 1mM PMSF, 1mM NaF, 1mM β-
Glycerophosphate, 0.5mM CaCl2 or 5mM EGTA), clarified and injected into a pre-
equilibrated 3.5µm-bead size column with a separation range of 10kDa-1500kDa  
[XBridge Protein BEH SEC Column, 450Å, 3.5 µm, 7.8 mm X 300 mm (Waters 
Chromatography)] in Running Buffer (20mM HEPES pH7.2, 115mM KCl, 10mM 
NaCl, 10mM MgCl2, 1.3mM D(+)-Trehalose, 1mM DDM, 1mM PMSF, 1mM 
NaF, 0.5mM CaCl2 or 5mM EGTA) at a flow rate of 0.86ml/min.  Fractions were 
collected every 30s from exclusion time 6min up to 15min, precipitated with 10 
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volumes of cold-acetone and resolved by 12% SDS-PAGE.  Proteins were 
transferred to a nitrocellulose membrane, that was incubated with different 
antibodies as detailed in Appendix III.  
 
7.12. Surface Plasmon Resonance Interaction Analysis.   
A Biacore T200 system was used (GE Healthcare). The MBP.RetGC-DD/CD 
or MBP.RetGC-JMD/JHD fragments of the cyclase were covalently attached to two 
different channels of a CM5 sensor chip using amine coupling chemistry, to a 
theoretical response level of 200-400 resonance units (RU). Reference channels were 
activated and deactivated in the absence of ligand.  The Thio.His.IMPDH1 protein 
was passed as an analyte at 2-fold serial dilutions from a 0.48mg/ml stock solution, 
at:  6.71; 3.36; 1.68; 0.84; 0.42; and 0.21 µM concentrations. The interaction affinity 
was determined from measurement of steady-state binding levels as a function of 
analyte concentration, from multi-cycle experiments performed with duplicates. For 
analysis of the steady-state binding data, a model of 1:1 binding was assumed (4-
parameter fitting, T200 Biacore analysis software), and the chi-square value defining 
the closeness of the fit (describing the deviation between the experimental and fitted 
curves) was 1.57 RU2 for RetGC-DD/CD (Rmax = 44.1 RU) and 0.167 RU2 for 
RetGC-JMD/KHD (Rmax = 50.5 RU). Chi-square values are typically considered 
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Figure Appendix I.1. Representative efficiency of transfection obtained by subretinal 
electroporation. A. Eye-cup of an electroporated retina with GFP coding plasmid 
under UV-light. B. Cross-section of a retina electroporated with a plasmid encoding 
GFP. Photoreceptor cells layer, bipolar cells prolongations and amacrine cells are 
distinguishable.  





Figure Appendix I.2. Analyzed cells for GCAP1_WT and G2A. 
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Figure Appendix I.2. Analyzed 
cells for GCAP1_K23D, W94A 
and P50L. 
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Figure Appendix I.3. Analyzed cells for 
GCAP2_WT, G2A, S201G and S201D. 








Figure Appendix I.4. Analyzed cells for GCAP2_G161R. 
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Appendix II. Primer List 
 
Appendix II. Primers List 
ID Name Sequence 
P1 Rh1.1 GTGCCTGGAGTTGCGCTGTGGG 
P2 p24_rv TGGCCTCCTCGTTGTCCGGGACCTT 
P3 pL_UG_Fw GGGGTTGGCGAGTGTGTTTTGTGA 
P4 pL_UG_Rv GGTGGTGCAGATGAACTTCAGGGT 






P9 2Kb_ups_MOP_del_Fw CCATTCTCTCCCTGGGTCAGCC 
P10 T7_Rv GGTACCCTATAGTGAGTCGTATTA 
P11 CpG_MOP_Del_Fw GGAGAAGTGAATTTAGGGCCCAAGGG 
P12 CpG_MOP_Del_Rv GCAGGAGGGGCGTAAGAAGTTTTGC 
P13 Fw_CpG_KpnI GCGATCGGTACCTTTTAATCTGCTGTTT
GCTCACAT 
P14 Rv_CpG_XbaI GCGATCTCTAGACAGTCAATATGTTCACCCCAAAAA 
P15 KpnI_HS4_Fw GCGCCCGGTACC CTGTCATTCTAAATCTCTCTTTCA 






P19 hGCAP1_Fw GCATGCCTCGAGATGGGCAACGTGATGGAGGGAAAGTCAGTG 
P20 hGCAP1_Rv GCATGCGGATCCTCAGCCGGCTGCCTCAGCGGCCTCGTCAGC 
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P21 GCAP2_G2A_Fw GGGCCAGGATGGCGCAGCAGTTCAG 
P22 GCAP2_G2A_Rv CTGAACTGCTGCGCCATCCTGGCCC 
P23 GCAP2_G161R_Fw CCTTCTGGTGGATGAAAATCGAGATGG
TCAGCTG 
P24 GCAP2_G161R_Rv CAGCTGACCATCTCGATTTTCATCCACCAGAAGG 









P29 GCAP1_G2A_Fw CCTCCATCACGTTGGCCATCTCGAGGCTG 






P33 GCAP1_P50L_Fw AAGAACCTGAGCCTGTCGGCCAGCCAG 
P34 GCAP1_P50L_Rv CTGGCTGGCCGACAGGCTCAGGTTCTT 
P35 GCAP1_W94A_Fw GTGGAACAGAAGCTCCGCGCGTACTTC
AAGCTCTATGA 
P36 GCAP1_W94A_Rv TCATAGAGCTTGAAGTACGCGCGGAGCTTCTGTTCCAC 





















P43 bIMPDH1_N198K_Rv CTGCGCTGCAGAATCTCCTTTGCCTCTTTCAATGTT 






P47 bIMPDH1_R224P_Fw TGGCCATCATTGCCCCCACTGACCTGAAGAAGAACC 
P48 bIMPDH1_R224P_Rv GGTTCTTCTTCAGGTCAGTGGGGGCAATGATGGCCA 




P51 T3 ATTAACCCTCACTAAAG 
P52 T7 TAATACGACTCACTATAGGG 
P53 T7_terminator GCTAGTTATTGCTCAGCGG 
P54 SP6 ATTTAGGTGACACTATAG 
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Appendix III. List of Antibodies used 
Appendix III. List of Antibodies used 
Primary Antibodies 







Scientific monoclonal mouse 1:2000 1:500 
GCAP2 MA1-725 
Thermo 
Scientific monoclonal mouse 1:2000 1:500 
GCAP1   polyclonal rabbit 1:2000 1:100 
GCAP2   polyclonal rabbit 1:2000 1:100 
Rhodopsin   
Monoclonal 
1D4 mouse 1:10000 1:8000 
IMPDH1 MABN291 Millipore monoclonal mouse 1:2000 DW 
IMPDH1   polyclonal rabbit 
1:5000-
10000 1:500 
CKB HM2110 Hycult 
Monoclonal 
21E10 mouse 1:10000 1:5000 
CKB GTX62373 Genetex 
Monoclonal 
EPR3927 rabbit 1:2000 1:500 
RetGC   polyclonal rabbit 1:2000 1:200 
RetGC   polyclonal rabbit 1:2000 1:200 
GFP 
11 814 460 
001 Roche 
Monoclonal 
7.1&13.1 mouse 1:2000 NT 
Tranducin alpha  polyclonal rabbit 1:5000 NT 
HSP90 PA3-013 
ThermoS
cientific polyclonal rabbit 1:2000 DW 
14-3-3 ab14110 Abcam 
Monoclonal 
3F7    










Host Specificity Ligand Dilution Brand 
Donkey rabbit IRDye680 
1:5000-
25000 LI-COR Biosciences 
Donkey rabbit IRDye800 1:5000-25000 LI-COR Biosciences 
Goat mouse IRDye680 1:5000-
25000 
LI-COR Biosciences 
Goat mouse IRDye800 
1:5000-
25000 LI-COR Biosciences 
 Protein G IRDye800 1:5000 Rockland Immunochemicals 
Donkey rabbit Alexa488 1:500 LifeTechnologies 
Donkey rabbit Alexa555 1:500 LifeTechnologies 
Donkey rabbit Alexa647 1:500 LifeTechnologies 
Goat mouse Alexa488 1:500 LifeTechnologies 
Goat mouse Alexa555 1:500 LifeTechnologies 
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AICART Aminoimidazolecarbox- Amide Ribonucleotide 
Transformylase 
AIRS Aminoimidazole Ribonucleotide Synthetase 
AMP Adenosine Monophosphate 
ASL Adenylosuccinate Lyase 
ATIC Bifunctional enzyme composed of AICART And 
IMPCH 




BBSome Complex of Seven Bardet–Biedl Syndrome (BBS) 
Proteins 




Ca2+ Calcium Ion 
CAIRS Carboxyaminoimidazole Ribonucleotide Synthase 
(CAIRS) 
CBS Cystathione-Β-Synthase Domain 
CC Connecting Cilium 
CD Cyclase Domain 
CD Cone Dystrophy 
cDNA Complementary DNA 
CEP290 Centrosomal Protein 290kda 
cGMP Cyclic Guanosine Monophosphate 
CKB Creatine Kinase Brain-Type 
CKM Creatine Kinase Muscle-Type 
CORD Cone-Rod Dystrophy 
CpG Regions of DNA where a cytosine nucleotide is 
followed by a guanine nucleotide 
Cr Creatine 
CRISPR/Cas9  Clustered Regularly Interspaced Short Palindromic Re
peats/Cas9 Nuclease 
Crx Cone-Rod Homeobox Gene 
C-Term Carboxyl-Terminal 
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D 
DD Dimerization Domain Of Retgc1 





ECD Extracellular Domain Of Retgc1 
EDTA Ethylene Diamine Tetra acetic Acid 








GAP GTP-ase-Activating Proteins 
GARS Glycinamide Ribonucleotide Synthetase 
GCAP1 Guanylyl Cyclase Activating Protein 1 
GCAP2 Guanylyl Cyclase Activating Protein 2 
GCAPs Guanylyl Cyclase Activating Proteins 
GDP Guanosine Diphosphate 
GEF Guanine Nucleotide Exchange Factors  
GMP Guanosine Monophosphate 
GRK1-7 Rhodopsin Kinase 
GTP Guanosine Triphosphate 
Gαβγ Α, β and γ subunits of Transduncin 




HDAC Histone Deacetylase 
HEPES 2-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Ethanesulfonic 
Acid 
HGPRT Hypoxanthine Guanine Phophoribosyl Transferase 
HS4 Felsenfeld Insulator At The 5' End Of The Chicken 




ICFO Institut De Ciencies Fotoniques 
IMP Inosine Monophosphate 
IMPCH Inosine Monophosphate Cyclohydrolase 
IMPDH1 Inosine Monophosphate Dehydrogenase 1 
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Kd Dissociation Constant 
KDa Kilo Dalton 










MAR Matrix-Attachment Region 
Mg2+ Magnesium 
mM Mili Molar 
MOP Mouse Opsin Promoter 





Na2CO3 Sodium Bicarbonate 
Nacl Sodium Chloride 
NAD+ Nicotinamide Adenine Dinucleotide 
NaFl Sodium Flouride 
NaH2PO4  Sodium Phosphate 
NCS Neuronal Calcium Sensor 
nM Nanomolar 




ONL Outer Nuclear Layer 
OPL Outer Plexiform Layer 
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PAICS Bifunctional Enzyme (PAICS) which is composed of  
Carboxyaminoimidazole Ribonucleotide Synthase 
(CAIRS) and Succinoaminoimidazolecarboxamide 
Ribonucleotide Synthetase (SAICARS) 
PBS Phosphate Buffered Saline 
PCr Phosphocreatine 
PCR Polymerase Chain Reaction 
PDE Phosphodiesterase 
PDE6 Phosphodiesterase 6 
PLA Proximity Ligation Assay 
PMSF  Phenylmethanesulfonylfluoride 
PPAT Phosphoribosylpyrophosphate Amido- Transferase 
PPRP Phophoribosyl Pirophosphate 




R9AP RGS9 Anchoring Protein 
RD3 Retinal Degeneration 3 
RER Rhodopsin Enhancer Region 
RetGC1 Retinal Guanylate Cyclase 1 
RGS9 Regulator Of G-Protein Signaling 9 
ROI Region of Interest 
RP Retinitis Pigmentosa 
RPE Retinal Pigmented Epithelium  
RPGR Retinitis Pigmentosa GTP-ase Regulator 
RPGRIP1 Retinitis Pigmentosa GTP-ase Regulator Interacting 
Protein 1 




SAICARS Succinoaminoimidazolecarboxamide Ribonucleotide 
Synthetase 
sGC Soluble Guanylate Cyclase 
SMGT Sperm-Mediated Gene Transfer 
SP Signal Peptide 




TALEN Transcription Activator-Like Effector Nucleases 
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TM Transmembrane Domain 
TMGT Testi-Mediated Gene Transfer 
TOPORS TOP1 Binding Arginine/Serine Rich Protein 
TrifGART Trifunctional Enzyme (TGART) which is composed of 
Glycinamide Ribonucleotide Synthetase (GARS), GAR 
Formyltransferase (GART) And Aminoimidazole 
Ribonucleotide Synthetase (AIRS) 
Trx Thioredoxin 
TSS Transcription Start Site 




uMT-CK Ubiquitous Mitochondrial Creatine Kinase 
UNC119 Protein Unc-119 Homolog 













XlRP Chromosome X-Linked Retinitis Pigmentosa 




ZFN Zinc-Finger Nuclease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
